UBC Theses and Dissertations

UBC Theses Logo

UBC Theses and Dissertations

Biochemical characterization of signaling pathways regulating cell survival Schubert, Kathryn M 2000

Your browser doesn't seem to have a PDF viewer, please download the PDF to view this item.

Item Metadata

Download

Media
831-ubc_2001-61171X.pdf [ 7.47MB ]
Metadata
JSON: 831-1.0090421.json
JSON-LD: 831-1.0090421-ld.json
RDF/XML (Pretty): 831-1.0090421-rdf.xml
RDF/JSON: 831-1.0090421-rdf.json
Turtle: 831-1.0090421-turtle.txt
N-Triples: 831-1.0090421-rdf-ntriples.txt
Original Record: 831-1.0090421-source.json
Full Text
831-1.0090421-fulltext.txt
Citation
831-1.0090421.ris

Full Text

B I O C H E M I C A L C H A R A C T E R I Z A T I O N OF SIGNALING P A T H W A Y S REGULATING CELL SURVIVAL  By Kathryn M . Schubert  B.Sc. (Honours), University of British Columbia, 1994 A THESIS SUBMITTED IN P A R T I A L F U L F U L L M E N T OF THE REQUIREMENT FOR THE D E G R E E OF DOCTOR OF PHILOSOPHY  Faculty of Graduate Studies Experimental Medicine Graduate Program  We accept this thesis as conforming To the required standard  THE UNIVERSITY OF BRITISH C O L U M B I A 2000 © Kathryn M . Schubert, 2000  04/16/01  MON 11:00  In  FAX 604  presenting  degree at the  this  875  thesis in  partial fulfilment  of  University of  British Columbia,  I agree  freely available for reference copying  of  department  and study.  by  his  or  her  the  requirements  I further agree  this thesis for scholarly purposes or  @ 003  JACK BELL RESEARCH  4497  representatives.  may be It  is  that the  for an advanced  Library shall make it  that permission for extensive granted by the understood  head  that  publication of this thesis for financial gain shall not be allowed without permission.  Department of frt&^JTI/A'fout  UlUpUCtCnJ^  The University of British Columbia Vancouver, Canada  Date  DE-6 (2/88)  QjOAl'Jj  /o  J  of my  copying  or  my written  ABSTRACT  The granulocyte/macrophage colony stimulating factor (GM-CSF) exerts its antiapoptotic effects on hemopoietic cells by activating multiple cellular signaling pathways including the phosphatidylinositol 3'-OH kinase (PI3K) cell survival pathway and the Ras-Raf-MEK-ERK kinase cascade. I hypothesized that cytokines activate each of these pathways to regulate components of the apoptotic machinery, including members of the Bcl-2 family. The mechanism by which cytokines such as GM-CSF regulate expression of Bcl-2 family members was examined in several models, including primary human eosinophils and basophils, and the hemopoietic cell lines TF-1 and M C / 9 . Protein expression of one pro-survival Bcl-2 family member, Mcl-1, was found to be dependent upon phosphatidylinositol (PI) 3-kinase. The cytokine-induced increase in Mcl-1 mRNA transcription was not dependent upon PI3K, thus dissociating the immediate-early transcription factors responsible for Mcl-1 transcription from the PI3K signaling pathway.  In contrast, Mcl-1 mRNA levels were dependent upon M E K activation,  suggesting a role for the Ras-MEK-ERK pathway in Mcl-1 transcription.  However,  activation of PI3K was shown to be necessary for G M - C S F to stimulate Mcl-1 protein translation. This was not due to any effect on prolonging the half-life of the protein. I was also interested in other pathways that may regulate PI3K and Mcl-1 to affect cell survival. The second messenger ceramide has been implicated in a host of cellular processes including growth arrest and apoptosis.  The relationship between ceramide  signaling and the activation of PI3K and its downstream target, protein kinase B (PKB) was examined in detail. P K B activation was observed following stimulation of cells with GM-CSF. Addition of cell-permeable analogs, C2- or C6-ceramide, caused a partial loss  ii  (50-60%) of P K B activation and resulted in reduced Mcl-1 translation. These reductions were not a result of a decrease in PI(3,4,5)P3 or PI(3,4)P2 generation by PI3K. Two residues of P K B (threonine 308 and serine 473) require phosphorylation for maximal P K B activation.  Ser  473  ceramide, whereas T h r  308  phosphorylation was consistently reduced by treatment with phosphorylation remained unaffected.  ceramide appeared to accelerate Ser  473  In further experiments,  dephosphorylation, suggesting the activation of a  phosphatase. Consistent with this, the reduction in Ser  473  phosphorylation was inhibited  by the phosphatase inhibitors okadaic acid and calyculin A .  Surprisingly, T h r  308  phosphorylation was abolished in cells treated with these inhibitors, revealing a novel mechanism of regulation of T h r  308  phosphorylation.  PDK2-catalyzed phosphorylation of Ser  473  These results demonstrate that  is the principal target of a ceramide-activated  phosphatase, which may regulate cell survival by reducing the level of pro-survival proteins such as Mcl-1.  iii  TABLE OF CONTENTS ABSTRACT  ii  T A B L E OF CONTENTS  iv  LIST OF T A B L E S  vii  LIST OF FIGURES  viii  LIST OF A B B R E V I A T I O N S  xi  QUATION  xiii  1.  INTRODUCTION  1  1.1.  HEMOPOIETIC C Y T O K I N E RECEPTOR SIGNALING  1  1.1.1. Receptor Structure and Function  1  PI3K SIGNAL T R A N S D U C T I O N P A T H W A Y  3  1.2.1. PI3K Family of Enzymes  3  1.2.2. PI3K and Cell Survival  9  1.2.3. Downstream Targets of PI3K 1.2.3.1. Ras-ERK Signaling Pathway  11 12  P K B : A M U L T I F U N C T I O N A L M E D I A T O R OF PI3K A C T I V A T I O N  14  1.3.1. P K B Structure  14  1.3.2. P K B and Cell Survival  18  1.3.3. Downstream Targets of P K B  20  APOPTOSIS  24  1.4.1. Bcl-2 Family Members 1.4.2. Caspases  24 32  S P H I N G O M Y E L I N SIGNAL T R A N S D U C T I O N P A T H W A Y  34  1.2.  1.3.  1.4.  1.5.  iv  1.5.1. Ceramide Generation and Metabolism 1.5.2. Ceramide and Apoptosis 1.5.3. Direct Targets of Ceramide Action  1.6.  SUMMARY  34 36 38  40  1.6.1. Hypotheses 1.6.2. Objectives  41 41  2.  MATERIALS AND METHODS  42  2.1. 2.2. 2.3. 2.4. 2.5. 2.6. 2.7. 2.8. 2.9. 2.10.  Antibodies and Reagents Cell Culture Conditions and Stimulations RNase Protection Assays Stimulations and Immunoblotting Determination of Mcl-1 Half-life Translation Studies Stimulation and Immunoprecipitation Conditions P K B Kinase Assays HPLC Analysis of PI(3,4,5)P and PI(3,4)P Metabolic Labeling of Bad, Bcl-x , Bak and Bax  42 43 43 44 45 46 46 48 49 49  3.  3  2  L  A N A L Y S I S O F B C L - 2 F A M I L Y M E M B E R R E G U L A T I O N IN MULTIPLE HEMATOPOIETIC C E L L TYPES  50  3.1.  R A T I O N A L E A N D HYPOTHESIS  50  3.2.  RESULTS  50  3.3.  DISCUSSION  68  4.  DISTINCT R O L E S O F C E R A M I D E , E R K , A N D PI3K IN MCL-1 REGULATION  71  4.1.  R A T I O N A L E A N D HYPOTHESIS  71  4.2.  RESULTS  71  4.3.  DISCUSSION  84  v  5.  E X A M I N A T I O N OF PROTEIN KINASE B (PKB)AS A POTENTIAL TARGET OF CERAMIDE ACTION  90  5.1.  R A T I O N A L E A N D HYPOTHESIS  90  5.2.  RESULTS  90  5.3.  DISCUSSION  104  6.  6.1. 6.2.  O V E R A L L DISCUSSION  108  6.3. 6.4. 6.5. 6.6. 6.7. 6.8. 6.9.  Phosphorylation of Bcl-2 Family Members in Hemopoietic Cells Analysis of Bcl-2 family Expression in Murine and Human Hemopoietic Cells GM-CSF selectively regulates Mcl-1 expression Role of M E K in Mcl-1 Transcription Role o f P D K in Mcl-1 Translation SHIP as a regulator of BC1-XL Ceramide negatively regulates Mel-1 protein translation Ceramide inhibits P K B by promoting dephosphorylation of Ser Summary  109 110 112 114 116 118 1 19 120  7.  BIBLIOGRAPHY  122  473  vi  108  LIST OF T A B L E S  C H A P T E R 3. A N A L Y S I S OF BCL-2 F A M I L Y M E M B E R R E G U L A T I O N IN M U L T I P L E HEMATOPOIETIC C E L L TYPES Table 1. Analysis of potential phosphorylation sites for various Bcl-2 family members  vn  LIST O F F I G U R E S  C H A P T E R 1. INTRODUCTION Figure 1.1. Isoforms and domain organization of the PI3K regulatory subunits  4  Figure 1.2. Isoforms and domain organization of the PI3K catalytic subunits  5  Figure 1.3. Structure and phosphorylation of phosphatidylinositol by PI3K  6  Figure 1.4. Structure and organization of the P K B isoforms  16  Figure 1.5. Downstream targets of P K B activity  22  Figure 1.6. Bcl-2 family members  25  Figure 1.7. Ceramide synthesis pathways  34  C H A P T E R 3. A N A L Y S I S OF BCL-2 F A M I L Y M E M B E R R E G U L A T I O N IN M U L T I P L E HEMATOPOIETIC C E L L TYPES Figure 3.1. The pro-apoptotic protein Bax is expressed in MC/9 cells  53  Figure 3.2. The pro-apoptotic protein Bak is present in MC/9 cells  55  Figure 3.3. Bak is not phosphorylated in response to GM-CSF stimulation in MC/9 cells  56  Figure 3.4. Bcl-x is not phosphorylated in MC/9 cells in response to G M - C S F stimulation  57  Figure 3.5. Bcl-x coimmunoprecipitates with phosphorylated Bad  58  Figure 3.6. Total R N A isolated from MC/9 cells  60  Figure 3.7. Mouse Bcl-x mRNA level increases in response to GM-CSF stimulation  61  Figure 3.8. Protein levels of Bak, Bax, and Bcl-x do not change in response to GM-CSF or IL-3 stimulation  63  Figure 3.9. G M - C S F treatment increases Mcl-1 and Bcl-x mRNA levels  64  Figure 3.10. Analysis of BC1-XL, Bax and Mcl-1 protein levels following stimulation with GM-CSF  65  L  L  L  L  L  viii  Figure 3.11. Mcl-1 mRNA level is higher in eosinophils whereas Bcl-x mRNA level is higher in basophils  L  67  C H A P T E R 4. DISTINCT ROLES OF C E R A M I D E , E R K , A N D PI3K IN MCL-1 R E G U L A T I O N Figure 4.1. M E K activity is required for GM-CSF induced upregulation of Mcl-1 mRNA  72  Figure 4.2. PI3K activity and M E K activity are required for GM-CSF-induced Mcl-1 upregulation  74  Figure 4.3. PI3K activity has no effect on the half-life of Mcl-1  76  Figure 4.4. Regulation of Mcl-1 protein synthesis by PI3K- and ceramide-dependent pathways  77  Figure 4.5. p70 activity is partially required for Mcl-1 upregulation  78  Figure 4.6. Inhibition of P K B and E R K by various inhibitors  81  Figure 4.7. C -ceramide inhibits GM-CSF induced increase in Mcl-1 protein levels  83  Figure 4.8. The mRNA levels of various Bcl-2 family members tested are present in equal amounts in SHIP+/+ and SHIP -/- B M M C s  84  Figure 4.9. Bcl-x protein levels are elevated in SHIP knockout cells  86  S6K  6  L  C H A P T E R 5. E X A M I N A T I O N OF PROTEIN K I N A S E B (PKB) A S A POTENTIAL T A R G E T OF C E R A M I D E A C T I O N Figure 5.1. C -ceramide attenuates P K B activation by GM-CSF  91  Figure 5.2. C -ceramide and LY-294002 do not affect E R K phosphorylation  92  Figure 5.3. C -ceramide does not affect PI3K-generated PI(3,4)P or PI(3,4,5)P  94  Figure 5.4. Ceramide specifically reduces P K B Ser  96  6  6  6  2  3  473  phosphorylation  Figure 5.5. PI3K inhibition, but not ceramide, block P K B T h r phosphorylation  ix  308  97  Figure 5.6. Ceramide accelerates P K B Ser  phosphorylation  98  Figure 5.7. P K B Ser  473  is a substrate for a ceramide-activated phosphatase  100  Figure 5.8. P K B Ser  473  is a substrate for a ceramide-activated phosphatase  101  308  Figure 5.9. Okadaic acid inhibits Thr  phosphorylation  Figure 5.10. Calyculin A restores ceramide inhibition of Ser  x  102 473  104  LIST O F ABBREVIATIONS 4-OHT AIF ANT APAF-1 Bad Bak Bax Bim BH BMMC Btk CAPP Caspase CARD DED Erk FADD GAP GM-CSF GSK-3 HPLC jCAD  IL ILK JAK JNK kDa LY MAPK MEK mTOR MW NGF pllO*:ER™ PAGE PD PDGF PDK-1 PH PI PI3K PKB PKC PTB  4-hydroxytamoxifen Apoptosis inhibiting factor Adenine nucleotide translocator A protease activating factor-1 Bcl-XL-associated death inducer Bcl-2 homologous antagonist/killer Bcl-2 associated factor X Bcl-2 interacting mediator of cell death Bcl-2 homology Bone marrow derived mast cell Bruton's tyrosine kinase Ceramide-activated protein phosphatase Cysteine-aspartic acid specific protease Caspase recruitment domain Death effector domain Extracellular regulated kinase Fas-associated protein with death domain GTPase activating protein Granulocyte-macrophage colony-stimulating factor Glycogen synthase kinase-3 High pressure liquid chromatography Inhibitor of caspase-activated deoxyribonuclease Interleukin Integrin-linked kinase Janus tyrosine kinase c-Jun N-terminal kinase Kilodalton LY-294002 Mitogen activated protein kinase M A P K / E r k kinase Mammalian target of rapamycin Molecular weight Nerve growth factor p i 10-estrogen receptor molecule (tamoxifen mutant) Polyacrylamide gel electrophoresis PD98059 Platelet-derived growth factor 3-Phosphoinositide dependent kinase-1 Pleckstrin homology Phosphatidylinositol Phosphatidylinositol 3'-OH kinase Protein kinase B Protein kinase C Phosphotyrosine binding domain  XI  PTEN SAPK SDS SH2 SHIP SOS STAT TLC VDAC WM  Phosphatase with homology to Tensin Stress activated protein kinase Sodium dodecyl sulphate Src-homology-2 SH2-domain containing 5'-inositol phosphatase Son of sevenless Signal transducers and activators of transcription Thin layer chromatography Voltage-dependent anion channel Wortmannin  Xll  C o u r a g e is the price that L i f e exacts for granting peace, T h e soul that knows it not, knows no release F r o m little things.  - Amelia Earhart  xiii  1. 1.1.  INTRODUCTION HEMOPOIETIC CYTOKINE RECEPTOR SIGNALING  1.1.1. Receptor Structure and Function A plethora of extracellular molecules control cell growth, differentiation and survival. In the hemopoietic system, granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin 3 (IL-3) bind to cell surface receptors resulting in the activation of several intracellular signal transduction cascades. IL-3 acts as a panspecific hemopoietin stimulating the growth, survival and differentiation of erythroid and myeloid cells, eosinophils, basophils, mature macrophages,  megakaryocytes and mast cells  (Miyajima et al., 1993). G M - C S F is more restricted in its action, promoting the growth of macrophages, neutrophils and eosinophils (Miyajima et al., 1993). The IL-3 receptor (IL-3R) and the GM-CSF receptor (GM-CSFR) are comprised of a ligand-specific a chain and a common p chain ((3 ; Nishinakamura et al., 1995). The C  murine IL-3R has two types of (3 chains, an IL-3-specific (3-subunit and a common Psubunit (Nishinakamura et al., 1995). Studies of cytokine receptors in knockout mice reveal functional redundancy in the biological roles of GM-CSF and IL-3. For example, double-knockout mice lacking both the p chain and the IL-3 gene display defects that are c  similar to those observed in the p chain knockout mice, suggesting that in hemopoietic c  cells there are other cytokines that can compensate for the loss of IL-3 and GM-CSF signaling (Nishinakamura et al., 1996). Relatively little is known about cytokine-induced signaling via the a-chain.  However, studies suggest an intact p chain is required to c  mediate a-chain-dependent cell signaling (Nishinakamura et al., 1995).  1  GM-CSFR and IL-3R belong to the cytokine receptor superfamily, members of which have a conserved extracellular domain homologous to the fibronectin type-Ill domain. This 200 amino acid region contains four conserved cysteine residues and a conserved W S X W S sequence motif that may be involved in protein folding or ligand interaction (Bazan, 1990; Hilton et al., 1995; Yoshimura et al., 1992). The intracellular portion of the (3 has no intrinsic enzymatic activity and is divided into membrane-distal C  and membrane-proximal domains.  Cytokine-induced signaling is initiated by ligand-  induced heterodimerization of a and p  c  receptor subunits followed by receptor  oligomerization and activation of associated tyrosine kinases (Brown et al., 1997; Lia et al., 1996).  Members of the Janus tyrosine kinase family (JAK) are constitutively  associated with conserved domains in the juxtamembrane region of the |3 chain called C  Boxl and Box2 (Mirua et al., 1993; Da Silva et al., 1994). J A K activity is required for the phosphorylation of specific tyrosine residues in the receptor subunits that then act as binding sites for proteins containing phosphotyrosine binding (PTB) domains (van der Geer and Pawson, 1995) or Src-homology (SH)-2 domains (review by Pawson, 1994), such as STATs (signal transducers and activators of transcription).  Once bound to  phosphotyrosine residues, STAT molecules are phosphorylated by JAKs resulting in the formation of STAT homo- and heterodimers, which then translocate to the nucleus where they function as transcription factors (Ihle, 1995; Yoshimura, 1998). For example, work by Ihle (1995) revealed that IL-3 and G M - C S F stimulation results in JAK2 activation and the recruitment and subsequent tyrosine phosphorylation of STAT5. Additional tyrosine kinases involved in IL-3 and GM-CSF signaling include Lyn, Fes, Tec, Yes, Fyn and Btk (Parganas et al, 1998). Further, the receptor-associated proteins She, SHIP and PI3K, are  2  also involved in IL-3 and G M - C S F mediated signal transduction (Sato et a l , 1993; Y i et al., 1993: Gold et al., 1994). SHIP and PI3K will be discussed in greater detail below.  1.2.  PI3K Signal Transduction Pathway  1.2.1. PI3K Family of Enzymes The PI3K family of lipid kinases exists as heterodimers consisting of a regulatory/adapter subunit tightly associated with a catalytic subunit.  PI3K can be  divided into 3 categories on the basis of sequence homologies, lipid substrate specificity and structure (review by Vanhaesebroeck et al., 1997a). The class l a PI3K consist of several isoforms of both the adapter/regulatory and the catalytic subunits. There are three highly homologous, class l a catalytic subunit isoforms, p i 10a, p i 10(3 and p i 108 (Hiles et al., 1992; Hu et al., 1993; Vanhaesebroeck et al., 1997b). The p i 10 a and p isoforms are thought to mediate receptor tyrosine kinase signaling and are widely expressed. Expression of the 5 isoform is restricted to hemopoietic cells, p i 10 isoforms contain a Cterminal kinase domain and a N-terminal regulatory domain. In addition, the amino terminus of p i 10 contains a Ras-binding site, which may play a positive role in PI3K activation.  3  SH3  PI  |  pes*  pSSul  BH  P2  SH2  piio  r w  binding  4fc^  SH2  |  1  p5i3a  p5Qi  p85,J  p55j. 32-34-a m i no-aci d extension with 80% homology  Figure 1.1. Isoforms and domain organization o f the P I 3 K regulatory subunits. (2000). Vanhaesebroeck, B . , and Alessi, D . R . Biochem. J., 346, 561-76.  There are two isoforms o f the class designated p85a and p85p\  l a PI3K  adapter/regulatory  subunits  Both isoforms contain two src-homolgy 2 (SH2) domains  and an inter-SH2 domain (iSH2; Dhand et al., 1994; Otsu et al., 1991; Escobedo et al., 1991;  Skolnik et al., 1991; Klippel et a l , 1994). The i S H 2 region mediates interaction  between subunits and is required for the catalytic activity o f p i 10 (Cohen et al., 1995). The role o f the S H 2 domains is two-fold: (1) to activate the p i 10 catalytic subunit by coupling p85 isoforms to tyrosine phosphorylated receptors, receptor associated proteins and cytosolic proteins  containing the consensus sequences p Y X X M  or  pYMXM  (Songyang et al., 1993), and (2) to bring the catalytic subunit in proximity to its major substrate, PI(4,5)P2, at the plasma membrane (Kelly et al., 1993; Ricort et al., 1996; Nave  4  et al., 1996). N-terminal to the SH2 domains, p85 isoforms contain a SH3 domain, a Bcr/Rac GTPase-activating protein (GAP) homology domain and two proline-rich domains (Gout et al., 1992). The proline-rich domains and the SH3 domain may play important roles in the association of PI3K with other proteins, such as dynamin (Gout et al., 1993), pl25Fak (Guinebault et al., 1995), Grb2 (Wang et al., 1995), a-actin (Shibaski et al., 1994) and the Src family of tyrosine kinases (Pleiman et al., 1994).  Further,  intramolecular interactions between the SH3 and the proline-rich regions of p85 may provide an autoregulatory mechanism analogous to that used by the Src family kinases (Andreotti et al., 1997).  Figure 1.2. Isoforms and domain organization of the PI3K catalytic subunits. (2000). Vanhaesebroeck, B., and Alessi, D.R. Biochem. J., 346, 561-76.  5  The class l b PI3K consist of a distinct family of adapter proteins that are activated by binding of P y subunits of heterotrimeric G-proteins to specific sites in both the pi01 adapter subunit and the catalytic subunit (Stephens et a l , 1997; Stoyanov et al., 1995). Much less is known about the class 2 and class 3 PI3K and these will not be discussed further here. Once recruited to the inner surface of the plasma membrane, PI3K catalyze the transfer of the y-phosphate from A T P to the D-3 position of the inositol ring of phosphoinositides yielding 3'-phosphorylated phosphoinositides (Carpenter and Cantley, 1996).  The principal phospholipids generated  phosphatidylinositol  3,4,5  triphosphate  by class l a PI3K activation are  PI(3,4,5)P3  and  phosphatidylinositol  3,4  biphosphate PI(3,4)P (Vanhaesebroeck and Alessi, 2000). 2  AOP  Figure 1.3. Structure and phosphorylation of phosphatidylinositol by Vanhaesebroeck, B., and Alessi, D.R. (2000). Biochem. J., 346, 561-76.  6  PI3K.  The levels of PI(3,4,5)P is tightly controlled in cells by the lipid phosphatases, 3  P T E N (phosphatase with homology to tensin) and SHIP (SH2 domain-containing inositol phosphatase).  PTEN is a D-3 specific inositol phosphatase that dephosphorylates  PI(3,4,5)P yielding PI(4,5)P (Stambolic et al., 1998). 3  2  SHIP, on the other hand,  dephosphorylates PI(3,4,5)P at the 5' position generating PI(3,4)P and is the major 5'3  2  phosphatase in hemopoietic cells (Damen et al., 1996; Lioubin et al., 1996; Kavanaugh et al., 1996). Through the dephosphorylation of PI(3,4,5)P , PTEN and SHIP constitute an 3  important class of negative regulators. Moreover, by increasing the levels of surrogate lipid species, lipid phosphatases may function to activate alternate signaling pathways. PI3K-generated phospholipids can regulate downstream signal transduction cascades through direct binding to the gleckstrin homology (PH) domains of target proteins. First recognized in a protein called pleckstrin, P H domains have been identified in over 100 proteins and are thought to mediate protein-lipid and protein-protein interactions (Haslam et al., 1993; Mayer et al., 1993; Shaw, 1996). Proteins that contain PI(3,4,5,)P -binding P H domains include:  |3-spectrin (Macias et al., 1994), dynamin  3  (Ferguson et al., 1994; Salim et al., 1996), Bruton's tyrosine kinase (Btk; Salim et al., 1996), son of sevenless (SOS; Wang et al., 1995), phospholipase C (Cifuentes et al., 1993; Lomasney et al., 1996), protein kinase B (PKB) and 3-phosphoinositide-dependent kinase-1 (PDK1) (Alessi et a l , 1997a; Stokoe et al., 1997). Several mechanisms have been identified by which phospholipid-PH domain interactions can alter the activity of downstream effector molecules: targeting:  (1) membrane  recruitment of downstream effectors to the inner surface of the plasma  7  membrane may bring target molecules into proximity of regulatory kinases and various signaling complexes;  (2) allosteric regulation:  phospholipids may function in an  allosteric manner to alter the catalytic activity of substrates; and (3) conformational changes: binding of phosphoinosititides to the P H domains may induce conformational changes required for full activation of the P H domain containing protein (Alessi and Cohen, 1998a; review by Blomberg et al., 1999). A good example of this is P K B , which will be discussed in more detail below. To assess the role of PI3K in a variety of cellular processes, two specific and cellpermeable pharmacological inhibitors have been employed: (1) wortmannin (Okada et al., 1994) and (2) LY-294002 (Vlahos et al., 1994). The fungal metabolite wortmannin is a potent (IC50 ~3nM) and irreversible inhibitor of mammalian class l a PI3K. Wortmannin forms covalent bonds with L y s  802  in the ATP-binding site of PI3K, resulting in alkylation  of the nucleophilic residue and inhibition of PI3K catalytic activity. The bioflavonoid 2(4-morpholinyl)-8-phenylchromone (LY-294002) is also a specific and efficient inhibitor of PI3K (IC ~1.40uM). LY-294002 functions as a competitive antagonist for the ATP50  binding site of PI3K. The main disadvantage in using these biochemical reagents is that both LY-294002 and wortmannin can affect the activity of other enzymes. For example, both LY-294002 and wortmannin can inhibit the mammalian target of rapamycin (mTOR) (Brunn et al., 1996:Abraham, 1998).  Additionally, at high concentrations  (>100nM), wortmannin can inhibit phopholipase D (Bonser et al., 1991), myosin light chain kinase (Nakanishi et al., 1992), phospholipase A (Cross et al., 1995b) and 2  PI4kinase (Nakanishi et al., 1995).  8  A number of molecular tools have been developed to define the role of class l a PI3K in various intracellular signaling cascades. For example, dominant negative forms of the p85 subunit that are unable to bind p i 10 inhibit endogenous PI3K activity by competing for phosphotyrosine  docking sites (Hara et al., 1994).  Likewise,  overexpression of a catalytic-inactive p i 10 subunit blocks signaling by class l a PI3K. (Takayanai et al., 1996).  Addition of a N-terminal myristoylation motif and an N -  terminal fragment of the p85iSH2 domain to the p i 10 catalytic subunit (pi 10*) results in constitutive PI3K activity independent of p85 regulation (Hu et al., 1995).  Work by  Klippel and coworkers (1998) describe an inducible system for studying the role of PI3K. In this system PI3K activity is induced by the addition of a cell permeable estrogen analog, 4-hydroxytamoxifen (4-OHT), to cells overexpressing a chimeric p i 10:estrogen receptor molecule (pi 10*:ER ). rM  Finally, biologically active  membrane-permeable  forms of PI(3,4,5)P and PI(3,4)P have recently been developed to further define the role 3  2  of PI3K in growth factor signaling (Jiang et al., 1998).  1.2.2.  PI3K  and Cell Survival  PI3K was first identified as an important regulator of growth-factor survival in studies by Yao and Cooper (1995) which demonstrated that treatment of PC 12 cells with PI3K inhibitors blocks nerve growth factor (NGF) mediated cell survival.  Further,  platelet derived growth factor (PDGF) stimulation is unable to promote cell survival in PC 12 cells overexpressing mutant PDGF receptors incapable of recruiting PI3K. Analogous studies revealed that PI3K is required for growth factor-dependent  cell  survival in a variety of cell types including fibroblasts, hemopoietic cells and neurons  9  (Scheid et a l , 1995; Yao and Cooper 1995; Takashima et al., 1996; Vemuri and McMorris 1996; Dudek et al., 1997; Philpott et al., 1997; Berra et al., 1998; Crowder and Freeman 1998; Stambolic et al., 1998). Additionally, overexpression of constitutively active PI3K is sufficient to abrogate cytokine withdrawal-induced apoptosis (Yao and Cooper 1995; Chen et al., 1998; Crowder and Freeman 1998). Further support for PI3K as a key player in cell survival is provided from studies involving PTEN and SHIP. As discussed above, PTEN and SHIP are phosphatidylinositol phosphatases that act upon PI(3,4,5)P to generate PI(4,5)P and PI(3,4)P respectively. PTEN knock out mice have 3  2  2  elevated levels of PI(3,4,5)P and die during embryogenesis as a result of a failure in 3  developmental apoptosis (Stambolic et al., 1998; Suzuki et al., 1998). Additionally, PTEN-deficient immortalized mouse embryonic fibroblasts are resistant to various apoptotic stimuli and have an increased propensity to form tumors. These data strongly suggests that PTEN decreases the apoptotic threshold for a cell by limiting the amount of PIP in the cell. 3  Similarly, SHIP loss-of-function transgenic mice display impaired  apoptosis and have excessive myeloid cell survival. This suggests that PI(3,4,5)P is a 3  key mediator of PI3K-dependent cell survival (Helgason et al., 1998; Liu et al., 1998). Consistent with this theory, overexpression of SHIP in hemopoietic cells is sufficient to induce apoptosis (Liu et al., 1997).  Finally the transforming efficiencies of various  oncogenes, including activated Ras and Bcr/Abl, depends in part on their ability to increase intracellular PI3K activity (Skorski et al., 1997).  10  1.2.3. Downstream Targets of PI3K Numerous enzymes have been shown to be regulated by PI3K, one of which is the p70 ribosomal protein S6 kinase (p70 ). p70 s6k  s6k  is a cytoplasmic serine/threonine kinase  that phosphorylates key residues in the S6 protein of the 40S ribosomal subunit. These phosphorylation events are necessary for translational initiation, protein synthesis and entry into S phase. There is strong evidence to indicate that activation of PI3K is both necessary and sufficient for activation of p70 . For example, inhibition of PI3K activity s6k  by use of dominant negative p i 10 subunits (Burgering et al., 1995), mutated receptors that can no longer bind p85 (Chung et al., 1994; Ming et a l , 1994), or pharmacological inhibitors of PI3K all abolish p70  s6k  activity (Cheatham et al., 1994; Moule et al., 1995;  Weng, et al., 1995). Further, addition of 4-OHT to cells overexpressing the conditionally active pllO*:ER™ chimera results in an increase in PI3K activity and a concomitant increase in p70 P  Thr  421  70  s 6 k  s6k  phosphorylation (Klippel et al., 1998).  has 8 phosphorylation sites; Thr , Ser , Thr , Ser , Ser ", Ser ,  and Ser  229  424  371  389  404  (Pullen and Thomas, 1997). Phosphorylation of T h r  389  4  418  is wortmannin  sensitive and may be an in vivo target of P K B activity (Dennis et al., 1996). Conversely, phosphorylation of Thr  is wortmannin-insensitive and may be a target of PDK1 activity  (Dennis et al., 1996). The immunosuppressant rapamycin inhibits mTOR resulting in the activation of phosphatases that can dephosphorylate T h r  389  and inactivate p70  s6k  (Pullen  and Thomas, 1997; Dennis et al., 1996). Work by several groups revealed that indirect inhibition of p70  s6k  with rapamycin has no effect on growth factor mediated survival  indicating that PI3K promotes survival independently of p70 1996; Yao and Cooper, 1996; Kaufmann-Zeh et al., 1997).  11  s6k  activity (Scheid et al.,  1.2.3.1. R a s - E R K Signaling Pathway The extracellular regulated kinases 1 and 2 (ERK 1 and E R K 2) are members of the mitogen-activated family of protein kinases and were originally described as proteins that undergo growth factor-mediated tyrosine phosphorylation (Ray and Sturgill, 1988; Rossomando et al., 1998).  E R K 1 and E R K 2 are proline-directed serine/threonine  kinases (Boulton et al., 1991; Charest et al., 1993; Clark-Lewis et al., 1991) that serve to rsk  activate a broad spectrum of downstream kinases including p90  (Blenis, 1993), M n k l  (Fukunaga and Hunter, 1997; Waskiewicz et al., 1997), Mnk2 (Waskiewicz et al., 1997), Rsk2 (Xing et al., 1996) and mitogen-activated protein kinase-activated protein ( M A P K A P ) kinase-5 (Ni et al., 1998). Additionally, E R K regulates the transcriptional activity of E L K 1 , Sapl and c-Myc, which in turn regulate the expression of many genes critical to mitogenesis, such as, cyclin D l (Greulich and Erikson, 1998; Lavoie et al., 1996). Several research findings support the idea of PI3K as an upstream regulator of M E K and E R K in some model systems.  Wortmannin can partially inhibit cytokine-  stimulated E R K activation in a MEK-dependent manner (Karnitz et al., 1995; Cross et al., 1994; Sakanaka et al., 1994). As well, overexpression of constitutively active, membranebound p i 10 results in Ras and E R K activation (Hu et al., 1995). Finally, PI3K has been shown to be required for Raf-induced E R K activation (Ferby et al., 1994). The mechanism by which PI3K impacts on E R K is at present not clear. E R K 1 and E R K 2 are targets of M A P kinases termed M E K 1 and M E K 2 (ERK kinase). M E K 1 and M E K 2 are dual-specificity kinases that activate ERK1 and ERK2 by phosphorylating threonine and tyrosine residues of the T E Y motif (Brott et al., 1993; Crews et a l , 1992; 12  Zheng and Guan, 1993). The amino terminus of MEK1 and M E K 2 contains a nuclear export signal (NES) and an ERK-binding site which functions to anchor E R K in the cytoplasm (Fukuda et al., 1997). Following stimulation, E R K and M E K translocate to the nucleus and M E K subsequently relocalizes back into the cytosol. Numerous research findings have placed M E K and E R K activation downstream of the small monomeric G-protein Ras (de Vries-Smits et al., 1992; Leevers and Marshall, 1992). Ras proteins are localized at the inner surface of the plasma membrane in an inactive GDP-bound form.  Cytokine-stimulated receptor activation triggers the  exchange of GDP for GTP on Ras and is catalyzed by the nucleotide exchange factor SOS.  Thus Ras proteins act as molecular switches that are inactive in the GDP-bound  form and active in the GTP-bound form. A constitutively active Ras (Val ) mutant can rapidly activate E R K , whereas, a dominant interfering Ras (Asn ) mutant blocks growth 17  factor mediated E R K activation. Together these data suggest that M E K and E R K are downstream targets of active Ras (de Vries-Smits et al., 1992). The best-described effectors of GTP-bound Ras are the serine/threonine protein kinases Raf-1 and A-Raf. Raf proteins contain an N-terminal Ras-binding domain and exhibit a greater affinity for GTP-bound Ras compared to GDP-bound Ras (Vojtek et al., 1993).  In its GTP-bound form, Ras recruits Raf to the plasma membrane where it  becomes phosphorylated within the R S X S X P motif and interacts with members of the 143-3 family of proteins (Thorson et al., 1998). The precise mechanism by which Raf becomes activated is poorly defined (Vojtek et al., 1993; review by McCubrey et al., 2000).  13  Research by seyeral groups revealed that Raf is an upstream component of E R K activation, for example, over-expression of activated Raf leads to Ras-independent activation of E R K (Kyriakis et a l , 1992; Dent et a l , 1992; Howe et al., 1992).  In  addition, MEK1 and M E K 2 are activated by phosphorylation on two serine residues by Raf. Taken together, these results reveal a linear phosphorylation-signaling cascade of Ras->Raf->MEK->ERK. Some studies have suggested that PI3K-activated pathways may act upon specific isoforms of Raf (Sutor et al., 1999), thus providing a route for PI3K to E R K . This effect appears to be cell type specific, since studies by Scheid and Duronio (1996) revealed that PI3K activity is neither sufficient nor necessary for E R K activation in the mast cell line MC/9.  Therefore, when examining the effects of PI3K inhibition on a cell response,  attention should be made as to whether E R K activation is similarly affected.  1.3.  PKB: A MULTIFUNCTIONAL MEDIATOR OF P I 3 K ACTIVATION  1.3.1.  P K B structure  P K B is 57 kDa serine/threonine protein kinase originally cloned in screens to identify proteins homologous to the catalytic domains of P K A and P K C (Coffer and Woodgett, 1991; Jones et al., 1991). P K B (c-AKT) is the cellular homologue of the transforming oncogene product v - A K T , isolated from the A K T 8 retrovirus (Bellacosa et al., 1991, 1993). Sequence analysis of viral- and cellular-PKB cDNAs revealed that vP K B is a gag-c-PKB fusion protein resulting from a recombination event between viral gag sequences and the N-terminal region of the c-PKB gene (Staal et al., 1987; Staal 1997).  Proteins encoded by v-PKB and c-PKB differ in their post-translational  14  modification, subcellular localization, and oncogenic potential.  The viral gag-PKB  protein is myristoylated at its N-terminus and is targeted to membrane surfaces where it becomes phosphorylated and active. Cellular P K B is primarily localized in the cytosol (Ahmed et al., 1993). There are three known mammalian isoforms of P K B encoded by three different genes sharing 90% sequence homology (Coffer and Woodgett, 1991; Jones et al., 1991; Bellacosa et al., 1993). P K B a and PKB(3 are widely expressed while PKBy expression is restricted to the brain, testes, heart, spleen, lung and skeletal muscle. A l l P K B isoforms contain an N-terminal P H domain (Mayer et al., 1993; Musacchio et al., 1993; Datta et al. 1995), a proline rich C-terminal tail and a central kinase domain with serine/threonine specificity (Bellacosa et al., 1991; Coffer and Woodgett 1991). The P H domain is responsible for lipid-protein interactions between PI3Kgenerated phospholipids and the  amino-terminus  of P K B .  Direct binding of  phosphoinositides to the PH domain results in membrane translocation and is critical for P K B activation (Franke et al., 1995, 1997; Bellacosa et al., 1998; Sable et al., 1998). Phospholipid-mediated membrane targeting brings P K B in close proximity to activating kinases (Andjelkovic et al., 1996; Bellacosa et al., 1991; Coffer and Woodgett 1991; Burgering and Coffer 1995; Kohn et al., 1996b; Soskic et al., 1999). Research by the Alessi group (1996a) revealed that phosphorylation of P K B is mediated by kinases that are themselves a target of PI3K activity. Four sites of P K B phosphorylation exist in vivo: Ser , Thr , T h r 124  Ser  308  450  and Ser . 473  Mutational analysis revealed that phosphorylation of  and Thr  is both sufficient and necessary for full enzymatic activity (Alessi et al.,  308  is located in the activation loop of the central kinase domain of P K B and  1996a). Thr  15  is phosphorylated by PDK1 (Alessi et al., 1997b). PDK1 is a 63 kDa serine/threonine kinase with a C-terminal PH domain and a N-terminal kinase domain (Alessi et al., 1997a; Stephens et al., 1998; Hanks et al., 1998). PDK1 is constitutively active under basal conditions and its activity does not increase upon cytokine stimulation (Alessi et al., 1997a). Following stimulation, phosphoinositides bind to the P H domain of PDK1 and anchor it to the plasma membrane where it phosphorylates members of the A G C subfamily, such as P K B (Alessi et al., 1997b; Stokoe et al., 1997; Walker et al., 1998), PKC (Le Good et a l , 1998), P K A (Cheng et al., 1998) and p70  s6k  (Alessi et al., 1998b;  Pullen et al., 1998). Kinase rJvriah  Activation LOOP  (A)  ij;i P K B x PKBfr  Hydrophobic rrxstil I |_ | (4WinPKBa 481 in PKiBfJ  PKBf  jft>3m  < A » ' « -*T*,1  Ser 47  1  479  in PKBf)  PDK1  (Ala" ~* valj 7  PRK2  RHO-BTNDNG sftes  F r  (C)  v~Aki ' v-PKrki  Viral Gag 512  proiatn  PU  TfsjflBG  SOI'  748  Figure 1.4. A . Structure and organization of the P K B isoforms. B . Structure of PDK1 and potential interaction with PRK2. C . v-Akt is a fusion protein consisting of P K B and an N terminal viral gag protein. Myristoylation of the gag protein results in membrane targeting. Vanhaesebroeck, B., and Alessi, D.R. (2000). Biochem. J., 346, 561-76.  16  Some studies suggest that binding of phospholipids to the P H domain of P K B induces a critical conformational change permitting phosphorylation of T h r  308  by PDK1.  T AO  For example, in vivo phosphorylation of Thr  by PDK1 is abolished by mutations  affecting P K B P H domain function. Further, P K B mutants lacking a P H domain undergo in vitro PDK1 phosphorylation in the absence of lipid (Stokoe et al., 1997; Alessi et al., 1997b). The identity of the Ser  473  kinase is currently unknown, however, it is thought to  function in a phospholipid-dependent manner and is therefore operationally termed PDK2. Ser  473  is located in the carboxy-terminal regulatory domain of P K B .  kinase-2, a member of the p38 M A P K phosphorylate Ser  473  MAPKAP  stress activated signaling pathway, can  in vitro, however, stress stimuli that enhance in vivo M A P K A P  kinase-2 activity fail to induce P K B activation. Moreover, P K B activation still occurs in the presence of the potent and specific p38 inhibitor, SB203580 (Alessi et al., 1996b). Some groups postulate that the integrin-linked kinase, ILK, is the elusive PDK2 (Delcommenne et al., 1998). I L K can phosphorylate Ser  473  in vitro and its activity is  directly regulated by phosphoinositides, presumably through binding of the lipids to a cryptic P H domain within ILK. Moreover, a kinase-dead mutant of ILK inhibits in vivo phosphorylation of Ser . Recent studies by Balendran and co-workers (1999) suggest 473  that PDK1 may complex with the C-terminus of PRK-2 to phosphorylate Ser . On the 473  other hand, Toker and Newton (2000) suggest that P K B undergoes autophosphorylation at Ser . Some of these issues have been resolved using PDK1-deficient embryonic stem 473  cells. In this model, P K B activity is abolished, consistent with a lack of T h r phosphorylation. Interestingly, PDK1 knockout cells still undergo Ser 17  473  308  phosphorylation  in response to insulin-like growth factor 1 (IGF1) suggesting that PDK1 is not required for in vivo P K B Ser  473  phosphorylation. Moreover, P K B is inactive in PDK1 deficient  cells revealing that P K B does not undergo autophosphorylation at Ser  473  (Williams et al.,  2000). Taken together, these results suggest four mechanisms by which PI3K-generated phospholipids act to regulate P K B activation: (1) phospholipids anchor P K B to the plasma membrane (Andjelkovic et al., 1997; Meier et al., 1997; Wijkander et a l , 1997; Sable et al., 1998); (2) phospholipids elicit an "activating" conformational change in P K B , permitting phosphorylation in the activation loop (Datta et al., 1996; James et al., 1996; Franke et al., 1997; Freeh et a l , 1997; Klippel et al., 1997); (3) phospholipids regulate upstream activating kinases of P K B (Currie et al., 1991); and (4) some studies suggest that phospholipid  binding is responsible  for  the  formation  of P K B  homomultimers (Datta et al., 1995; Franke et al., 1997; Alberti 1998).  1.3.2. P K B and Survival P K B is emerging as a key player in cytokine-regulated signaling. For example, stimulation of 32D cells with IL-3 results in a rapid increase in P K B activity, while dominant-negative mutants of P K B block IL-3-stimulated proliferation (Songyang et al., 1997).  Further, overexpression of wild-type P K B protects 32D cells from cytokine-  withdrawal-induced apoptosis (Songyang et al., 1997). Similar studies in a variety of cell types reveal that constitutively active P K B can inhibit TNF-oc-, drug- and ionizingradiation-induced apoptosis (Chen et al., 1998; Dudek et al., 1997; Kauffmann-Zeh et al., 1997; Kennedy et al., 1997; Khwaja and Downward, 1997; Kliwaja et a l , 1997; Kulik et  18  al., 1997; Philpott et al., 1997; Xiong and Parsons 1997; Crowder and Freeman 1998; Eves et al., 1998; Gerber et a l , 1998; Hausler et al., 1998; Kulik and Weber, 1998; Rohn etal., 1998; Blair etal., 1999). Several dominant-negative forms of P K B have been generated to examine the role of P K B in cytokine-mediated survival. However these constructs contradictory results.  often provide  For example, overexpression of wild-type P K B containing a  RasCAAX membrane targeting sequence ( C A A X - P K B ) inhibits growth factor-induced PKB-mediated cell survival (van Weeren et al., 1998), whereas, expression of N terminally myristoylated P K B enhances the survival promoting ability of platelet derived growth factor (PDGF) (Kohn et al., 1996a; Andjelkovic et a., 1997). Dominant-negative P K B mutants may function by altering endogenous P K B activity or by directly interacting with specific downstream targets of P K B . On the other hand, dominant-negative P K B mutants may act non-specifically by binding to other P H domain-containing proteins or by sequestering PI3K-generated phospholipids away from other P H domain-containing proteins. Genetic analysis of the Drosophila P K B homologue, d A K T l , provides additional support for PKB-dependent cell survival. Drosophila with loss of function d A K T l alleles show significant ectopic apoptosis and die during embryogenesis (Staveley et al., 1998).  This lethality is suppressed by transgenic expression of wild type P K B ,  supporting the existence of a PKB-mediated anti-apoptotic signaling pathway. One mechanism by which P K B may mediate cell survival signaling is by inactivating members of the death-promoting machinery.  19  This theory has led to  systematic examination of putative P K B phosphorylation sites in members of the apoptotic machinery, which is discussed below.  1.3.3. Downstream Targets of P K B Several components of the apoptotic machinery contain the P K B consensus phosphorylation sequence, R X R X X S / T and have proven to be downstream targets of P K B activity (Alessi et al., 1996b; Walker et al., 1998). The first Bcl-2 family member found to be a substrate for P K B was the pro-apoptotic protein Bad. In vitro analysis revealed that P K B preferentially phosphorylates Bad at Ser Additional support for P K B as a potent Bad Ser  136  (Datta et al., 1997a).  kinase is provided by overexpression  studies. Constitutively active P K B is sufficient to induce Ser endogenous and transfected  136  136  phosphorylation of both  Bad, whereas kinase-dead P K B inhibits Bad Ser  136  phosphorylation (Datta et al., 1997a; Blume-Jensen et al., 1998; Wang et al., 1999a,b). Further, constitutively active P K B alleles are unable to rescue cells coexpressing Bad mutants in which Ser  136  has been converted to alanine (Datta et al., 1997a; Blume-Jensen  et al., 1998; Wang et al., 1999a). Work by Scheid and Duronio (1998) suggested the existence of PKB-independent pathways leading to Bad phosphorylation.  For example, GM-CSF stimulates Bad  phosphorylation in the absence of P K B activation. Additionally, IL-4 promotes P K B activation in a PI3K-dependent manner but does not induce phosphorylation of Bad. Taken together, these results suggest that PKB-mediated cell survival occurs by Bad phosphorylation-dependent and -independent pathways.  20  The mammalian Ced-3 homologue, caspase-9, may also function as a downstream target of P K B activation. Human caspase-9 has two A K T motifs, Ser Ser  196  183  (RTRTGS) and  (RRRFSS). Work by Cardone and coworkers (1998) revealed that Ser  196  is the  primary P K B phosphorylation site and that phosphorylation of this site inhibits caspase-9 protease activity. This phosphorylation event is thought to be biologically significant as overexpression of constitutively active P K B alleles can suppress caspase-9-induced cell death. Further, ectopic apoptosis observed in fruit flies with loss of function mutations in the d A K T l gene, can be rescued by expression of P35, an inhibitor of caspase-9 activation (Morris et al., 1996; Staveley et al., 1998).  A recent study by Fujita and  coworkers (1999) revealed that the P K B phosphorylation site found in human caspase-9 is absent in mouse, dog and rat caspase-9, suggesting that inhibition of caspase-9 activation by PKB-dependent phosphorylation is not evolutionarily conserved, raising concerns over the significance of this phosphorylation for preventing apoptosis. In addition to regulating cytoplasmic apoptotic events, there are several nuclear targets of P K B activation. The mechanism by which P K B translocates to the nucleus is poorly defined, however, neither the P H domain nor kinase activity is required for this process (Andjelkovic et al., 1997). Once in the nucleus, P K B targets members of the Forkhead family of transcription factors. originally identified in genetic  The Forkhead family member, D A F 16, was  screens for suppressors of daf-2  mutations  in  Caenorhabditis elegans (Lin et al., 1997). Three DAF-16 orthologs have been identified in mammalian cells, F K H R , F K H R L , A F X (Davis et al., 1995; Sublett et al., 1995; Borkhardt et a l , 1997; Hillion et al., 1997).  21  Apoptosis Downstream targets of P K B activity. Greenberg, M.E. (2000). Genes Dev., 13, 2905-2927. Figure  1.5.  Datta, S.R., Brunet, A . , and  A l l Forkhead family members have a C-terminal transcriptional activation domain and a central DNA-binding domain termed the 'Forkhead domain' (Kops et al., 1999). Sequence analysis of daf-16 and the three human Forkhead isoforms revealed three consensus P K B phosphorylation motifs.  Expression of constitutively active P K B is  sufficient to induce phosphorylation at all three sites; however, the major in vitro target of P K B phosphorylation is located within the DNA-binding domain (Brunet et al., 1999;  22  Kops et a l , 1999; Rena et al., 1999; Tang et al., 1999). Consequent to phosphorylation, Forkhead family members are sequestered in the cytosol, away from their nuclear targets, through interaction with 14-3-3 proteins (Brunet et al., 1999). Forkhead family members bind to insulin-response sequences within the insulinlike-growth-factor-binding-protein-1 promoter (Brunet et al., 1999; Kops et al., 1999; Tang et al., 1999) and to Forkhead binding sites within the Fas ligand promoter (Brunet et al. 1999). Once bound to the promoters, Forkhead isoforms may exert their pro-apoptotic effects through the upregulation of death promoting genes.  For example, Forkhead  family members may induce expression of endogenous FasL, which in turn can trigger a death-signaling cascade (Le-Niculescu et al., 1999; Brunet et al., 1999). In contrast to P K B effects on restricting expression of pro-apoptotic proteins through Forkhead phosphorylation, recent studies suggest that P K B can also mediate the upregulation of survival promoting genes.  For example, P K B can enhance the  degradation of the NF-Kp inhibitor IKP, permitting  NF-KP  nuclear translocation where it  can initiate transcription of various pro-survival genes, such as B f l - l / A l and the caspase inhibitors c-IAPl and C-IAP2 (Ozes et al., 1999; Hu et a l , 1998). Through its control of GSK-3, P K B has been found to regulate a number of metabolic processes including membrane translocation of the glucose transporter 4 (GLUT4), induction of G L U T 1 synthase and the activation of 6-phosphofructose-2kinase (PFK2) (Kohn et al., 1996a, 1998; Deprez et al., 1997; Tanti et a l , 1997; Hajduch et al., 1998; Summers et al., 1998; Wang et al., 1998). Glycogen synthase kinase (GSK3) inhibits the synthesis of glycogen from glucose by phosphorylating and inactivating glycogen synthase.  Phosphorylation of GSK-3 leads to its inactivation and promotes  23  glycogenesis. Sequence analysis of GSK-3 isoforms has identified Ser  21  in G S K 3 a and  Ser in GSK3P as potential targets of PKB-mediated phosphorylation (Cross et al., 9  1995a).  1.4.  APOPTOSIS  1.4.1. Bcl-2 Family Members Programmed cell death or apoptosis is a cell suicide mechanism that plays a critical role in development, tissue homeostasis and protection against pathogens. Intranucleosomal D N A fragmentation, chromatin condensation, membrane blebbing and cell shrinkage are all characteristics of the apoptotic phenotype. The process of apoptosis allows the efficient removal of tissues without the peripheral damage caused by inflammation during necrosis. Apoptotic morphology can be induced by D N A damage, ultraviolet- and x-irradiation, chemotherapeutic drugs, cytokine deprivation and coupling of death receptors. Dysregulation of apoptosis can result in pathologies including cancer, autoimmunity and neurodegenerative disorders. Genetic analysis has identified a family of genes that are essential for programmed cell death in Caenorhabditis elegans, including ced-9, ced-4, and ced-3 (Hengartner 1996). Cloning of the C. elegans ced-9  gene revealed that it is structurally and functionally homologous to the mammalian cell survival mediator Bcl-2. Bcl-2 was originally isolated from the t(14;18) chromosomal translocation found in human follicular lymphomas and was subsequently shown to inhibit cytokine withdrawal-induced apoptosis in hemopoietic cells. Analogous studies in other cell lines confirmed Bcl-2's ability to promote survival in the presence of various apoptotic stimuli (Tsujimoto et al., 1985; Bakhshi et al., 1985; Cleary and Sklar, 1995).  24  Pro-survival i  Bciil Subfamily o1 i—l  m Bcl-x  i  —I  i T  II TT  z—;  i  Pore tormation  «2 a3 a4 a5 if I  Membrane anchor 1  i—i  ly 3ax  "WWW  I-  llfffllfll  I  m  IBWI  3ak  ,t~  Bd-w  Bok  Mcl-1  @ S u l ifamily  A1  3:k  NR-13  m  BHRF1  •mm-  Hrk  LMW5-HL  BNIP3  ORF16  Bim  KS-Bd-2  L  3ac  E1B-19K CED-9  Ligand domain  at6 a?  BH4  -I  L  Dimerization (receptor) domain  Regulation  —CZJ-  -  Bid -O-  EGL-1  Figure 1.6. Bcl-2 family members. Adams, J.M., 1322-1336.  and Cory, S. (1998). Science, 281,  Following the initial identification and description of Bcl-2, other apoptosis regulators have been identified by sequence homology and in cell survival genetic screens. This growing family consists of proBok  (Bad,  Bak, Bax,  Bcl-x Bid, Bik, Bim, s  Blk,  (Mtd), M e l - l ) and anti-apoptotic ( A l , Bcl-2, Bcl-w, Bcl-x , Boo, Mcl-1 L,) proteins s  L  that can be divided into three subfamilies on the basis of shared conserved regions termed Bcl-2 homology domains-1 through 4 (BH1 to BH4; 1998).  review by Chao and Korsmeyer,  A l l members of the Bcl-2 subfamily contain the BH1 and BH2 conserved  sequence motifs and promote survival. Bax, Bak, Bcl-xs, and Bok are members of the  25  Bax subfamily and contain BH1, BH2 and BH3 domains. The BH3 group consists of Bad, Bid, Bik, Bim, Blk, H R K , Mcl-1 , NIP3, NIX and the nematode homologue EGL-1. s  Overexpression studies reveal that the BH3 domain of pro-apoptotic family members is both necessary and sufficient to induce apoptosis (Conradt and Hovitz, 1998; Chittenden etal., 1995a). One way in which Bcl-2 family members are thought to function is via heterodimerization, in which the BH3 domain of a pro-apoptotic protein inserts into a hydrophobic binding cleft created by the BH1, BH2 and BH3 regions of a pro-survival protein (Sattler et al., 1997). The Bcl-2 homologous antagonist/killer, Bak, was originally described as a cellular host protein that could interact with the adenovirus E1B 19K protein to promote apoptosis of virally infected cells (Farrow et al., 1995; Chittenden et al., 1995b; Kiefer et al., 1995).  In uninfected cells Bak may promote apoptosis by  binding to and inhibiting the pro-survival proteins Bcl-2 and BC1-XL (Chittenden et al., 1995b). Similarly, the BH3 cohort, Bax, was first identified by coimmunoprecipitation with Bcl-2 (Oltvai et al., 1993).  Work by several goups revealed that Bax  homodimerization is both sufficient and essential for Bax-dependent apoptosis (Gross et al., 1998; Ink et al., 1997). However, recent work by Hsu and Youle (1998) suggests that Bax homodimerization may be a detergent-induced phenomenon and may not be required for Bax- mediated cell death. Three-dimensional structural analysis of BC1-XL revealed seven a helices and a nonconserved, flexible loop located between the a helices 1 and 2 (Muchmore et al., 1996). Helices a5 and a6 contain the BH1 and BH2 region of BC1-XL and are similar to the pore-forming domains of some bacterial toxins, suggesting that Bcl-2 family  26  homologues having BH1 and BH2 conserved sequence motifs may regulate cell survival by forming pores in organelles, such as the mitochondria (Muchmore et al., 1996; Sattler et al., 1997).  In keeping with this hypothesis, Bcl-2, Bcl-x , and Bax can form ion  channels in lipid bilayers  L  in vitro  and this channel formation requires intact BH1 and BH2  domains (Minn et al., 1997; Antonsson et al., 1997; review by Schendel et al., 1998). In addition to Bcl-2 homology domains, many pro- and anti-apoptotic molecules are targeted to various intracellular membranes via a carboxy-terminal transmembrane domain (Nyguyen et al. 1993). Work by Reed and coworkers showed that Bcl-2 and BclXL are localized at the outer mitochondrial membrane, the endoplasmic reticulum, and the nuclear envelope (1993).  While anchored at the mitochondria, Bcl-2 and BC1-XL are  thought to inhibit mitochondrial membrane permeability transition (PT) (Vander Heiden et al., 1997) and the subsequent release of apoptogenic factors, such as cytochrome c and apoptosis-inducing factor (AIF; Yang et al., 1997). Mitochondrial PT is characterized by a loss in membrane potential (Ay) and requires *  *  2+  an increase in cytoplasmic Ca . Work by several groups suggest that Bcl-2 and BC1-XL may promote cell survival by maintaining A\\i through enhanced proton efflux and by *  2+  inhibiting the release of Ca  from the mitochondrial matrix (Susin et al., 1996; Shimizu  et al., 1998). Alternatively, Bcl-2 and BC1-XL may suppress apoptosis by inhibiting the release of mitochondrial caspases such as caspase-2 and -9 (Susin et al., 1999). The Bcl-2 interacting mediator of cell death, Bim, also contains a C-terminal hydrophobic region. However unlike Bcl-2 and Bcl-x , pro-apoptotic Bim is localized to L  the microtubule-associated dynein motor complex in healthy cells (Puthalakath et al. 1999). Following a death signal, Bim dissociates from the microtubules and translocates 27  to the mitochondria where it antagonizes Bcl-2 and Bcl-x -mediated cell survival. L  Likewise, Bax translocation from the cytosol to the mitochondria requires an intact Cterminal transmembrane domain (Wolter et al., 1997; Xiang et al., 1996). Once localized at the mitochondria, pro-apoptotic Bcl-2 homologues mediate mitochondrial dysregulation and antagonize Bcl-2 and Bcl-x  L  survival promoting  activities. For example, recombinant Bax, Bak, and Bid can induce mitochondrial membrane permeabilization in vitro (Minn et al., 1997; Antonsson et al., 1997; Schendel etal., 1999) Mitochondrial PT involves the opening of an oligo-protein channel called the PT pore. The PT pore consists of the voltage-dependent anion channel (VDAC), the adenine nucleotide translocator (ANT) and cyclophilin D (Kroemer et al., 1998). Although the exact mechanisms by which Bak and Bax function to induce apoptosis are not known, some studies suggest that mitochondrial-based Bak and Bax may interact with the V D A C to promote A\|/-loss (Narita et al., 1998; Shimizu et al., 1999) and with the A N T to promote cytochrome c release (Marzo et al., 1998; Saito et al., 2000).  Conversely,  research by Eskes and colleagues (2000) suggests that oligomeric Bax functions independently of the PT pore complex to form a nonspecific membrane channel thereby promoting A\|/-loss and cytochrome c release. In addition to subcellular localization and dimerization, some Bcl-2 homologues are regulated by phosphorylation. Bcl-2 and Bcl-x are regulated by phosphotransfer at L  evolutionarily conserved sites in the flexible loop region located between the BH3 and the BH4 domain (Chang et al., 1997; Ito et a l , 1997; Maundrell et al., 1997). For example, IL-3 stimulates Bcl-2 Ser phosphorylation by P K C a leading to enhanced cell survival 70  28  (May  et al., 1994; Ruvolo et al., 1998). Recent work by Deng and coworkers (2000)  revealed direct phosphorylation of Bcl-2 Ser by E R K 1/2 and suggests the existence of 70  PKC-dependent and -independent pathways leading to Bcl-2 mediated cell survival. Likewise, a current study by the Craig group (2000) demonstrated phosphorylation of the pro-survival protein Mcl-1 L in a PKC-and ERK-dependent manner; however, the biological significance of this phosphorylation event has yet to be  determined.  Microtubule-damaging drugs such as paclitaxel and vincristine induce PKA-mediated Bcl-2 hyperphosphorylation and promote apoptosis, presumably by altering the stability of Bcl-2:Bax heterodimers (Srivastava et al., 1998; Ito et al., 1997; Haldar et al., 1998; Yamamoto et al., 1999). Chemotherapeutic drugs, such as taxol, stimulate Bcl-2, BC1-XL and Mcl-1 L phosphorylation and are associated with decreased cell viability (Domina et al., 2000).  Taxol-induced Bcl-2 phosphorylation may be mediated by the mitogen-  acitivated protein kinase pathway member Raf or by the stress activated protein kinase JNK  (Haldar et al., 1998).  Taken as a whole these findings revealed that multiple  signaling pathways converge on Bcl-2 family members and suggest that phosphorylation may be a general mechanism employed by various signaling pathways to regulate the function of pro-survival Bcl-2 family members.  Moreover these studies revealed that  phosphorylation of anti-apoptotic molecules can provide both growth inhibitory and growth promoting effects depending on stimulus and co-stimulatory signals. The death agonist Bad (Bcl-x /Bcl-2-associated death promoter) was first L  described as a protein that heterodimerizes with Bcl-2 and BC1-XL to promote apoptosis (Yang et al., 1995).  Following cytokine stimulation mitochondrial-based Bad is 112  phosphorylated on Ser  136  and Ser  and dissociates from Bel- XL to form an inactive  29  complex with the cytoplasmic sequestering factor 14-3-3 (Zha et al., 1996; Datta et al., 1997a; del Peso et al., 1997).  Bad Ser" is directly phosphorylated by p90 2  rsk  via a  PKC/MEK-dependent pathway (Scheid et al., 1999; Tan et al., 1999), whereas phosphorylation of Bad Ser  is mediated by PKB-dependent and independent pathways  depending on cell type (Scheid and Duronio, 1998; Datta et al., 1997a; Blume-jennson et al., 1998). Recent work by several groups have identified Ser  155  as a novel site of Bad  phosphorylation and demonstrated the direct phosphorylation of Bad Ser  155  by P K A  (Datta et al., 2000). In the presence of a death signal, cytosolic Bad is dephosphorylated by the Ca -activated protein phosphatase calcineurin and relocalizes to the mitochondria 2+  where it antagonizes the pro-survival functions of Bcl-2 and BC1-XL (Wang et al., 1999). Bcl-2 family members may also be regulated by proteolytic cleavage. In healthy cells, the BH3 family member Bid is localized in the cytosol (Gross et al., 1999). Upon exposure to a death signal, p22 Bid is cleaved by a cysteine-aspartic acid specific protease, caspase-8, generating a pi5 carboxy-terminal cleavage fragment  (tBid).  Cytosolic p21 Bax also undergoes amino-terminal cleavage by the calcium-dependent cysteine protease, calpain, resulting in a pi8 carboxy-terminal fragment (Wood and Newcomb, 2000).  Following caspase cleavage, tBid and pi8 Bax translocate to the  mitochondria where they regulate apoptotic mitochondrial changes.  Interestingly, the  truncated forms of both Bax and Bid possess greater intrinsic cytotoxity compared to their full-length counterparts (Wood and Newcomb, 2000;Wood and Newcomb, 1999). Bcl-2 and BC1-XL are also substrates for caspase activity. Surprisingly, proteolytic cleavage of Bcl-2 and BC1-XL by caspase-3 and caspase-1, respectively, converts these pro-survival factors into potent death effectors (Clem et al., 1998; Kirsch et a l , 1999).  30  In addition to post-translational modifications, alternative splicing of pre-mRNAs regulates the function and sub-cellular location of some Bcl-2-family proteins.  For  example, the Mcl-1 splice variant of Mcl-1 lacks the membrane-anchoring domain s  present on Mcl-1 L and antagonizes the pro-survival function of Mcl-1 L (Bingle et al., 2000; Bae et a l , 2000). Similarly, the Bcl-2 p isoform of Bcl-2 lacks the c-terminal transmembrane region found in Bcl-2a and exhibits diminished pro-survival activity (Hockenbery et al., 1990; Tanaka et al., 1993). Functionally distinct isoforms have also been described for Bax (Bax-a, Bax-P, Bax-y), Bcl-x (Bcl-x and Bcl-x ) and Bim L  s  (BimEL, BimL, BimS; review by Jiang and Wu, 1999) Some pro-survival Bcl-2 homologues undergo transcriptional regulation, for example, de novo gene expression of Bfl-1 is induced by inflammatory cytokines, tumor necrosis factor and interleukin-1 (Karsan et al., 1996).  Moreover, recent studies  identified Bfl-1 as a direct target of NF-Kp transactivation (Hu et al., 1998; Zong et al., 1999; Lee et al., 1999; Wang et al., 1999). Mcl-1 is a moderate viability-promoting member of the Bcl-2 family first identified as an early gene induced during differentiation of ML-1 myeloid leukemia cells (Kozopas et a l , 1993). Work by Chao and coworkers (1998) revealed that Mcl-1 is regulated at the transcriptional level in response to cytokine stimulation, further, this group suggests that induction of Mcl-1 transcription occurs via a PI3K-PKB-dependent pathway (1999; discussed further in Chapter 4).  1.4.2.  Caspases  The ced-3 gene product is homologous to the mammalian family of cysteineaspartic acid specific proteases termed caspases (Yuan et al., 1993; Thornberry et al.,  31  1992).  Caspases are expressed as proenzymes containing an N-terminal polypeptide  (prodomain) and a large (-20 kDa) and small (~10 kDa) subunit (Nicholson and Thornberry, 1997).  Zymogen activation involves autocatalysis or caspase-mediated  proteolysis at an interdomain linker segment allowing the large and small subunit to associate to form a heterodimeric enzyme. The prodomain is highly variable in sequence and length and is involved in the regulation of enzymatic activity. Caspases can be divided into two groups: the initiators (caspases-8, -9, and -10) and the effectors or the executioners (caspases-2, -3, -6, and -7). Initiator caspases are activated in response to proapoptotic stimuli and require interaction with specific cofactors (Boldin et al., 1996; L i et al., 1997). For example, association of the cofactor F A D D (Fas-associated protein with death domain) with the D E D (death effector domain) of procaspase-8 results in caspase-8 activation. Similarly, APAF-1 (a protease activating factor), the mammalian homolog of the ced-4 gene product, interacts with the C A R D (caspase recruitment domain) of procaspase-9, contributing to its proteolysis (Boldin et al., 1996; Muzio et al., 1996). The additional cofactors, cytochrome c and deoxyadenosine triphosphate are also required for caspase-9 activation (Li et al., 1997). Together, cytochrome c, APAF-1 and pro-caspase-9 form a signaling complex called the apoptosome. Initiator caspases integrate extracellular and cell-autonomous cues to coordinate the activation of a specific set of executioners.  For example, death receptor induced  apoptosis triggers caspase-8 activation (Nguyen et al., 1994; Borner et al., 1994) and cytotoxic agents stimulate caspase-9 activation (Ng and Shore, 1998; X u and Reed, 1998). Further, caspase-9 deficient embryonic stem cells and embryonic fibroblasts are resistant to U V - and irradiation-induced apoptosis.  32  Effector caspases employ three  different strategies to mediate a select program of cell disassembly: (1) caspases inactivate inhibitors of apoptosis, such as I  C A D  , an inhibitor of the caspase-activated  deoxyribonuclease (CAD) (Enari et al., 1998; L i u et al., 1997); (2) caspases destroy cell structures, such as the nuclear lamina, resulting in chromatin condensation (Takahashi et al., 1996; Orth et al., 1996); and (3) caspases reorganize cell structures by deregulating the activity of proteins involved in cytoskeleton regulation, including gelsolin (Kothakota et al., 1997), focal adhesion kinase (FAK), (Wen et al., 1997) and p21-activated kinase (PAK; Rudel and Bokoch, 1997).  Caspase activation also leads to the loss of  phosphatidylserine asymmetry in the plasma membrane, a process that may be critical in the recognition and clearance of apoptotic bodies by phagocytic cells such as macrophages (Blankenberg et al., 1999). Emerging mechanistic evidence suggests that pro-survival Bcl-2-family proteins may function by suppressing caspase-dependent apoptosis. For example, binding of BclXL to Apaf-1 may inhibit Apaf-1 -mediated caspase-9 activation. In contrast, members of the Bax and BH3 Bcl-2 subfamilies may promote apoptosis by inhibiting Bcl-x -Apafl L  association (Pan et al., 1998; Hu et al., 1998). A prerequisite of caspase-9 activation by Apaf-1 is the presence of sufficient quantities of the cofactors ATP and cytochrome c. It has also been proposed that loss of cytochrome c and other oxidative species from the mitochondria, controlled by Bcl-2 family proteins, ensures the demise of a cell even i f the downstream executor caspases fail or are inactivated (Thornberry and Lazebnik, 1998)  1.5. Sphingomyelin Signal Transduction Pathway 1.5.1. Ceramide Generation and Metabolism  33  A wide variety of physiological signals, such as those generated by cytokines and growth factors, and various apoptotic stimuli including T N F - a and FasL, can activate the sphingomyelin pathway resulting in the production of the lipid second messenger ceramide (N-alkysphingosine) (Mathias et al., 1998). Generation of ceramide can occur by de novo synthesis involving ceramide synthase or by sphingomyelin hydrolysis involving various sphingomyelinases (Spiegel et al., 1996; Kolesnick, 1991; Spiegel and Merrill, 1996). De novo synthesis of ceramide occurs when  SpHngjrrine  nfrydrc.jicmlcto  •°<1>P>  HO  v^V  0,I>  °  0,J  Sphlngoslne  OH  'tl o  I ' o"  cnK  xu > «_ S e i n e 4 il1o>1-CoA  SIP ^  OH  1." I'  101 j CH  Pt»gih(»1Kuncilimlne  \  Figure 1.7. Ceramide synthesis pathways. Mathias, S., Pena, L.A., and Kolesnick, R.N. (1998). Biochem., J., 335, 465-480.  serine and palmitoly-CoA undergo condensation to form 3-ketosphinganine.  3-  ketosphinganine is quickly reduced to dihydrosphingosine by NADPH-dependent reductase and acylated by ceramide synthase (sphinganine N-acyltransferase) yielding  34  dihydroceramide. Introduction of a trans-A, 5 double bond into dihydroceramide generates ceramide. Ceramide generation can also occur by hydrolysis of sphingomyelin. Various sphingomyelinases can hydrolyze the phosphodiester bond of sphingomyelin yielding ceramide and phosphocholine.  Sphingomyelinase isoforms can be grouped into five  catagories: (1) an acid sphingomyelinase first identified as a lysosomal enzyme defective in persons with types A and B Niemann-Pick disease (Levade, et al., 1986); (2) a ubiquitous, Zn -stimulated, acid sphingomyelinase (Schissel et al., 1996); (3) a membrane bound, Mg -dependent, neutral sphingomyelinase (Spence, 1993); (4) a 2+  cytosolic, cation-independent neutral sphingomyelinase (Okazaki et al., 1994); and (5) an alkaline sphingomyelinase found in the intestinal mucosa and bile (Nyberg et al., 1996; Duan etal., 1996). Newly synthesized ceramide may accumulate transiently in the cell before being converted into various metabolites.  Hydrolysis of ceramide generates sphingosine and  phosphorylation of sphingosine by sphingosine-kinase generates sphingosine-1-phosphate (Spiegel et al., 1996). ceramide  Phosphorylation of ceramide by ceramide kinase generates  1-phosphate (Bajjalieh et al., 1989; Kolesnick, 1990) and addition of  phosphocholine to ceramide by sphingomyelin-synthase regenerates sphingomyelin (Kolesnick 1990).  In addition, glycosylation of ceramide in the Golgi apparatus by  glucoslyceramide transferase produces various complex glycosphingolipids (Koch et al., 1996) that can function as second messengers for such diverse processes as proliferation (Spiegel et al., 1996; Gomez-Munoz et al., 1997), differentiation (Koesnick and Golde, 1994; Mathias et al., 1993; Ballou et al., 1990; K i m et al., 1991), growth arrest (Jayadev  35  et al., 1995; Dbaido et al., 1995) and apoptosis (Brenner et al., 1998; Schwandner et al., 1998).  1.5.2. Ceramide and Apoptosis Early evidence supporting a role for ceramide in apoptosis emerged from biochemical studies involving cell-permeable ceramide analogs; for example, Hannun and coworkers (1993) observed that C2-ceramide could mimic the toxic effects of T N F a in U937 cells. Additional studies involving cell-free systems revealed that TNF-a or ionizing radiation could act on cellular membranes to generate ceramide and initiate apoptosis (Haimovitz-Friedman et al., 1994; Dressier et al., 1992).  Furthermore,  ceramide-induced cell death is accompanied by D N A cleavage, chromatin condensation and organelle dismantling, all hallmarks of apoptotic morphology. Production of the proapoptotic lipid mediator, is initiated in cells in response to numerous stresses, including ionizing radiation (Haimovitz-Friedman et al., 1994; Michael et al., 1997; Chmura et al., 1997; Bruno et al., 1998), chemotherapeutic drugs (Bose et al., 1995; Jaffrezou et al., 1996; Zhang et a l , 1996; Bradshaw et al., 1996; Whitman et al., 1997), U V light (Datta et a l , 1997b), hyperosmolarity (Kyriakis et al., 1994, 1995) and activation of the TNF receptor (Obeid et al, 1993). One mechanism of ceramide-mediated apoptotic signaling is thought to involve activation of the stress-activated protein kinase cascade (SAPK/JNK) (Verheij et al., 1996; Coroneos et al., 1996; Cuvillier et al., 1996; Westwick et al., 1995). The J N K pathway is activated in response to various stress stimuli, such as U V irradiation, hyperosmolarity, cytokines, and chemotherapeutic drugs leading to the trans-activation of  36  various transcription factors, such as c-jun and jun-D, (Fanger et al., 1997) and the subsequent transcription of death promoting genes, such as Fas ligand and TNF-a (Zhang et al., 2000; Le Niculescu et al., 1999). Moreover, in response to physical, chemical and environmental stresses, JNK translocates to the mitochondria where it can phosphorylate Bcl-2 and Bcl-x , presumably leading to their inactivation (Fan et al., 2000). L  Several studies link ceramide-induced apoptosis to activation of the J N K signaling pathway.  For example, exposure of U937 monoblastic leukemia cells and  bovine aortic endothelial cells to ionizing radiation, U V light, or TNF-a results in rapid ceramide generation and JNK-dependent apoptosis (Verheij et al. 1996). Additionally, treatment of cells with exogenous  sphingomyelinase or cell-permeable  ceramide  derivatives activates the J N K signaling cascade (Westwick et al. 1995) and disruption of JNK signaling by overexpression of dominant-negative c-jun abrogates ceramide-induced apoptosis.  Finally, B cells from patients with N P D are resistant to UV-induced J N K  activation yet retain responsiveness to ceramide analogs (Huang et al., 1997). Ceramide may activate the JNK signaling pathway either via transforming-growth-factorp-activated kinase (TAK1) (Shirakabe et al., 1997) or via the small G-protein Rac-1 (Brenner et al., 1997). Taken together, these data suggest an essential role for the JNK signaling pathway in ceramide-mediated apoptosis. In addition to activation of the JNK pathway, ceramide may regulate apoptosis by altering mitochondrial function. The role of ceramide in mitochondria-dependent cell death is two-fold: (1) to disrupt the mitochondrial membrane potential ( A ^ ) (Castedo et al., 1996; Pastorino et al., 1996; Susin et al., 1997; Szalai et al., 1999) and (2) to generate reactive oxygen species (ROS) (Gudz et al., 1997; Garcia-Ruiz et al., 1997). Work by  37  Szalai and colleagues (1999) suggest that ceramide may promote A^-loss by reducing the threshold level of calcium required for PT. Additionally, ceramide-induced A^-loss may be mediated by a ceramide-activated protein phosphatase (CAPP; discussed below). Consequent  to  ceramide-induced  mitochondrial  dysregulation,  apoptogenic factors are released from the mitochondria including AIF.  several AIF is a  ubiquitous flavoprotein that undergoes mitochondrio-nuclear translocation upon exposure to various death inducing agents, including ceramide (Susin et al., 1999). Moreover, nuclear translocation of AIF occurs in the presence of caspase inhibitors, suggesting the existence of caspapse-independent death mechanisms. Once in the nucleus AIF induces chromatin condensation and D N A fragmentation (Susin et al., 1999).  1.5.3. Direct Targets of Ceramide Action Three putative targets of ceramide action have been described in mammals: ceramide-activated protein phosphatase (CAPP); ceramide-activated protein kinase (CAPK); and protein kinase CC,. CAPP is a member of the protein phosphatase 2A (PP2A) family of serine/threonine phosphatase (Doborowsky et al., 1993; Law and Rossie, 1995). During ceramide-mediated apoptosis, CAPP may promote mitochondrial PT by dephosphorylating Bcl-2 Ser  70  (Ruvolo et al., 1999) directly or through the  dephosphorylation and inactivation of P K C a (Lee et al., 1996). Further, studies described in Chapter 5 suggest that P K B Ser  473  may be a target of CAPP activity resulting in a  decrease in P K B activity. C A P K was first identified as a 97 kDa membrane-bound, proline-directed, serine/threonine-specific protein kinase (Mathias et al., 1991; Joseph et al., 1993; Liu et  38  al., 1994).  Studies by Yao and coworkers (1995) suggested that C A P K mediates  proliferative and pro-inflammatory responses to TNF-a by phosphorylation of c-Raf-1, leading to E R K activation. In contrast, work by Y u and colleagues (1997) demonstrated CAPK-mediated E R K inactivation via a M E K 1 dependent pathway. Moreover, work by the Kharbanda group (2000) suggested that C A P K functions to couple the TNF-a receptor to the JNK cascade. Together these studies showed that ceramide might promote apoptosis through activation of the stress-activated pathways (JNK), and possibly through inhibition of the E R K pathway.  As discussed above, E R K may couple pro-survival  signals to Bad inactivation. This highlights how ceramide may use several levels of cross-talk to initiate cell death, which may be both cell type and stimulus specific. Several research findings have identified the atypical P K C isoform, VKCC,, as a ceramide activated kinase, for example, treatment of NIH-3T3 fibroblasts cells with ceramide results in a threefold increase in PKCi^ activity both in vivo and in vitro (Lozano et al, 1994). Moreover, work by Wang and colleagues (1999) and Muller and coworkers, (1995) suggests that ceramide is a bifunctional lipid second messenger; stimulating PKCt^ activity at low concentrations and inhibiting PKCt; function at high concentrations. During ceramide-mediated apoptosis, PKC£J translocates to the nucleus, where it is thought to regulate components of the transcriptional machinery (Bertolaso et al., 1998).  1.6.  Summary A plethora of extracellular molecules regulate cell cycle progression, proliferation,  differentiation and apoptosis.  In the hemopoietic system,  granulocyte-macrophage  colony-stimulating factor (GM-CSF) binds to cell surface receptors resulting in the  39  activation of several intracellular signal transduction cascades.  Among these are the  PI3K-PKB and the Ras-ERK signal transduction pathways. In addition, the lipid second messenger ceramide may also function as a modulator of P K B - and ERK-dependent signaling. Several research findings suggest that these signaling pathways may converge on members of the Bcl-2 family (review by Adams and Cory, 1998). While these studies have been useful in delineating the intracellular function of Bcl-2 family members, the primary molecular mechanisms by which these signaling pathways function to regulate Bcl-2 family members has not been completely defined. There are three outstanding questions that I addressed in this thesis:  1) Is there a role for PI3K-PKB in regulating Bcl-2 family member expression?  In  addition, are Bcl-2 family members regulated at the post-translational level by the PI3KP K B signaling pathway?  2) The pro-survival Bcl-2 family member Mcl-1 is controlled by an immediate-early transcription factor (Wang et al., 1998). Do cytokines utilize the PI3K or E R K pathways in this process?  Additionally, do the PI3K or E R K pathways play a role in Mcl-1  regulation at the translational level?  3) Ceramide may inhibit PI3K, leading to a decrease in P K B activation (Zundel and Garcia, 1998). Do the effects of ceramide on PI3K-PKB signaling result in modulation of Bcl-2 family members, such as Mcl-1?  40  1.6.1. Hypotheses My working hypothesis is two-fold: 1) Various pathways mediate changes in Bcl-2 family member expression in response to cytokine stimulation. 2) Cross-talk between PI3K-PKB, Ras-ERK, and ceramide-signaling pathways plays a critical role in Bcl-2 family member regulation.  1.6.2. Objectives These hypotheses led to three objectives that I wanted to pursue: 1) To determine whether PI3K, M E K or ceramide plays a role in the regulation of specific Bcl-2 family members. 2) To examine the mechanism of regulation of Mcl-1 in hematopoietic cells. 3) To further define the role of ceramide in the regulation of PI3K and P K B .  2. M A T E R I A L S A N D M E T H O D S  2.1. Antibodies and reagents. TRIZOL reagent was purchased from Canadian Life Technologies (Burlington, ON). The RiboQuant Multi-Probe RNase Protection Assay System, including the multi-probe template sets mAPO-2 (45354P), hAPO-2 (45121P) and hAPO-2c (45609P) were purchased from Pharmingen (San Diego, CA). The antiMcl-1 antibody (sc-819) was purchased from Santa Cruz.  The anti-Bcl-x (B22630) L  antibody was from Transduction Laboratories (Lexington, K Y ) . Bak specific antibodies  41  were purchased from Upstate Biotechnologies (Lake Placid, N Y ; 06-536) and from Transduction Laboratories (Lexington, K Y ) .  Anti-Bax specific antibodies were from  Upstate Biotechnologies (Lake Placid, N Y ; 06-499) and from Santa Cruz (Santa Cruz, C A ; sc-493) and anti-Bad antibodies were purchased from Santa Cruz (Santa Cruz, C A ; sc-943) and from Transduction Laboratories (Lexington, K Y ; B36420). C2-, C2-dihydro-, and Cg-ceramides were purchased from BIOMOL Research Laboratories (Plymouth Meeting, PA). LY-294002 was from Calbiochem (La Jolla, C A ) . U0126 was from Promega (Madison, WI). [ S]-methionine and [a- P]-UTP were purchased from ICN Biomedicals (Costa Mesa, CA). Recombinant human GM-CSF was from R & D Systems (Minneapolis, MN). The anti-phospho-Thr308 P K B antibody (9271), the anti-phosphoSer473 P K B antibody (9270), and the anti-phospho-MAPK (9106) were purchased from New England Biolabs (Beverely, M A ) . The anti-PKB antibody (06-558) and Crosstide were from Upstate Biotechnology Inc. (Lake Placid, N Y ) . Okadaic acid and calyculin A were from Sigma Chemical Co. (Oakville, ON). U0126 was from Promega (Madison, WI). RPMI 1640, fetal bovine serum, and Protein-G Sepharose beads were purchased from Canadian Life Technologies (Burlington, ON).  2 . 2 . Cell Culture Conditions and Stimulations. RPMI 1640 was supplemented with 10% FBS, 10 u M 2-mercaptoethanol (2-Me), 100 units of penicillin G/ml, and 100 u.g of streptomycin/ml prior to using for cell culture. The factor-dependent hematopoietic cell lines MC/9 and TF-1 (American Type Culture Collection) were passaged in RPMI 1640 supplemented with 1% WEHI-3B (mouse IL-3) conditioned medium or 1% C G M I (human GM-CSF) conditioned medium, respectively. Prior to stimulation, cells were  42  starved of cytokine and cultured for 8 h in low-serum medium (0.5% FBS). Cells were then washed 1 time with phosphate-buffered saline (PBS) and incubated at 10 cells/ml in 6  low-serum medium with and without GM-CSF (50 ng/ml).  2.3.  RNase Protection Assays.  Total R N A was isolated from cultured cells using  TRIZOL Reagent (Canadian Life Technologies) and subjected to RiboQuant Multi-Probe RNase Protection Assay System (Pharmingen, San Diego, C A ) according to the manufacturer's specifications.  Briefly, a 2 ug portion of total R N A was incubated  overnight at 56°C with a high-specific-activity, [ P]-labeled anti-sense R N A probe set generated by T7 polymerase-directed in vitro transcription. Irrelevant mouse, human and yeast R N A were also incubated overnight with probe sets to control for non-specific hybridization.  Following hybridization, excess probe and other single-stranded R N A  were subjected to RNase digestion and "RNase-protected" probes were purified and separated on denaturing polyacrylamide gels. Protected mRNA species in the original R N A sample were quantified based on the intensity of the corresponding protected probe fragment as determined by direct quantitation with a Phosphorlmager (Bio Rad). To control for equal loading between samples, the level of each mRNA species was normalized against the level of the housekeeping gene transcript, L32.  2.4. Stimulation and Immunoblotting. Cells were deprived of cytokine and plated in low-serum (0.5%) medium for 8 h. Cells were then restimulated with 10 ng/ml G M - C S F for the indicated times in the presence or absence of a PI3K inhibitor (LY-294002; 50 uM), a M E K inhibitor (U0126; 25 uM) or ceramide analogs (25 uM). Cells were lysed  43  with ice-cold solubilization buffer (lOmM Tris (pH 7.4), 150 m M NaCl, 5 m M E D T A , 1% NP40, 1% deoxycholic acid, 0.25 m M PMSF, 1 u M pepstatin, 0.5 ng/ml leupeptin and 10 ug/ml soybean trypsin inhibitor) and nuclei were pelleted by centrifugation (20,000 x g, 1 min). Supernatants were transferred to new tubes and normalized for total protein using the Pierce B C A protein assay kit (BioLynx, Brockville, ON). A n equal volume of 2X reducing sample buffer was added to each sample followed by boiling for 5 minutes. Immunoblotting procedures were performed as described previously (Duronio et a l , 1992: Welham et al., 1994: Welham and Schrader, 1992). Cell extracts (50 ug) were resolved on SDS-PAGE (12%) and proteins were transferred to nitrocellulose by semi-dry blotting. Membranes were blocked with 5% (w/v) skim milk containing 0.05% sodium azide overnight at room temperature and probed with 1:500 dilution of antibodies specific for Mcl-1, Bak, Bax or BC1-XL at room temperature. detected with horseradish peroxidase-conjugated  Primary antibody was  secondary antibody and enhanced  chemiluminescence.  2.5. Determination of Mcl-1 half-life.  To determine the effect of PI3K- and M E K -  inhibition on the half-life of Mcl-1 in TF-1 cells, exponentially growing cells were precultured for 30 min in methionine-free medium supplemented with 0.5% dialyzed FBS and 10 ng/ml of G M - C S F .  Cells were pulse-labeled with 1 mCi/ml  [ S]-methionine 35  (ICN; 10 mCi/ml, >l,000Ci/mmol) for 15 min at 37°C and chased in growth medium containing 0.5% FBS, lOng/ml GM-CSF and 10 m M methionine in the presence and absence of LY-294002, in the presence and absence of U0126 or in the presence and absence of ceramide. At various times after the chase, 1 x 10 cells per sample (1 mg 7  44  solubilized protein) were lysed in 500 ul of solubilization buffer (lOmM Tris (pH 7.4), 150 m M NaCl, 5 m M E D T A , 1% NP40, 1% deoxycholic acid, 0.25 m M PMSF, 1 u M pepstatin, 0.5 ug/ml leupeptin and 10 ug/ml soybean trypsin inhibitor) immediately followed by removal of nuclei by centrifugation (20,000 x g, 1 min). Whole cell lysates were normalized for total protein using the Pierce assay. The supernatant was transferred to new chilled tubes and pre-cleared 2 x 45 min with 20 ul packed volume of protein-G Sepharose. After pre-clearing, the beads were pelleted and lysates transferred to new chilled  tubes  followed  by  the  addition  of  4  ug  of  anti-Mcl-1  antibody.  Immunoprecipitations were performed overnight at 4°C with continuous mixing. The samples then received 20 ul of a 1:1 suspension of protein-G Sepharose beads in solubilization buffer and mixed at 4°C for an additional 1 h. The beads were pelleted and washed five times with fresh solubilization buffer. Between each wash, the beads and bound Mcl-1 protein were transferred to new chilled tubes to minimize non-specific binding of [ S]-methionine. The beads were then resuspended in 20 ul of 2X SDS 35  sample buffer followed by boiling for 5 min. Mcl-1 immune complexes were resolved by SDS-PAGE (12%) and visualized by autoradiography. The Mcl-1 bands were quantified with a phosphorimager.  2.6. Translation studies. TF-1 cells were starved of cytokine and cultured for 8 h in low-serum medium (0.5% FBS). Cells were then washed 3 times with phosphatebuffered saline (PBS) and seeded in methionine-free medium supplemented with 0.5% dialyzed FBS. After 30 min at 37°C, cells were pretreated with LY-294002 (50 uM),  45  U0126 (25 uM), C6- or C2- ceramide (25 uM), or vehicle alone for an additional 30 min. Pulse-labeling was initiated by adding 1 mCi/ml of [S]-methionine in growth medium 35  containing 0.5% dialyzed FBS arid 10 ng/ml GM-CSF.  At various times after pulse-  labeling, 1 x l O cells were lysed in 500 ul solubilization buffer (lOmM Tris (pH 7.4), 150 7  m M NaCl, 5 m M E D T A , 1% NP40, 1% deoxycholic acid, 0.25 m M PMSF, 1 u M pepstatin, 0.5 ug/ml leupeptin and 10 ug/ml soybean trypsin inhibitor) immediately followed by removal of nuclei by centrifugation (20,000 x g, 1 min). Whole cell lysates were normalized for total protein using the Pierce assay. Cell extracts were pre-cleared and subjected to immunoprecipitation with 4 ug anti-Mcl-1 antibody as described above. Immunoprecipiated complexes were resolved on SDS-PAGE gel and visualized by fluorography. Mcl-1 bands were quantified with a phosphorimager.  2.7.  Stimulation and Immunoprecipitation Conditions.  Prior to stimulation, cells  were starved of cytokine and cultured for 8 h in RPMI 1640 supplemented with 10% fetal bovine serum (FBS). Cells were washed once with PBS and cultured at 10 cells/ml in 7  serum-free RPMI 1640 buffered with 20 m M HEPES (N-[2-hydroxyethyl]piperazine-N'[2-ethanesulfonic acid]), pH 7.2 immediately prior to assay. Cells were incubated at 37°C for 15 min and treated with ceramides or vehicle for 30 minutes prior to the addition of 10 ng/ml G M - C S F for various times, which was previously found to induce maximal tyrosine phosphorylation. In experiments involving okadaic acid or calyculin A , these compounds were added 30 min prior to the addition of ceramide. To stop reactions, cells were pelleted and solubilized in ice-cold lysis buffer (50 m M Tris (pH 7.4), 0.5% (v/v) NP-40, 2.5 m M EDTA, 10 m M NaF, 0.2 m M N a V 0 , 1 ug/ml microcystin-LR, 3  46  4  0.25 m M phenylmethylsulfonyl fluoride, 1 u M pepstatin, 0.5 ug/ml leupeptin, 10 ug/ml soybean trypsin inhibitor) and removal of nuclei by centrifugation at 20,000 rpm for 1 min. Supernatants were incubated with 2 ug anti-PKB-ot antibody at 4°C for 1 hour, with continuous mixing. Immune complexes were captured with 20 ul of Protein-G Sepharose beads at 4°C for 1 hour. The beads were washed 3 times with fresh solubilization buffer and resuspended in l x reducing sample buffer followed by boiling for 5 minutes. Samples were fractionated on 9% SDS-PAGE gels and transferred to nitrocellulose. Blots were blocked in 5% skim milk and incubated with 1:1000 dilution of the appropriate antibody diluted in TBS containing 1% bovine serum albumin. Primary antibody was detected using the appropriate Horseradish peroxidase (POD)-coupled secondary antibody (DAKO), followed by enhanced chemiluminescence Western blot system as instructed by the manufacturer (Amersham Pharmacia Biotech). In one set of studies, experiments were designed to investigate the effect of adding ceramide to cells that were previously stimulated with GM-CSF. TF-1 cells were starved of cytokine as described above, washed once in PBS and resuspended at 1 x 10 cells/ml 7  in serum-free RPMI 1640 buffered with 20 m M HEPES.  Cells were preincubated at  37°C for 15 min followed by GM-CSF (10 ng/ml) stimulation for 30 sec. Stimulation was terminated by washing cells 2 times with HEPES buffered medium followed by resuspension in 1 ml of the same solution. Immediately after washing, the cells were treated with C -ceramide (25 uM) or vehicle for the indicated times. To stop reactions, 6  cells were pelleted and solubilized in ice-cold lysis buffer (50 m M Tris (pH 7.4), 0.5% (v/v) NP-40, 2.5 m M E D T A , 10 m M NaF, 0.2 m M N a V 0 , 1 ug/ml microcystin-LR, 3  4  0.25 m M phenylmethylsulfonyl fluoride, 1 u M pepstatin, 0.5 ug/ml leupeptin, 10 ug/ml  47  soybean trypsin inhibitor). Nuclei-free cell extracts were incubated with 2 ug anti-PKB-oc antibody and immunoprecipitations were performed as described previously.  2.8.  PKB Kinase Assays. Beads with immunoprecipitated kinases were washed three  times with fresh solubilization buffer containing 500 m M NaCl and once with kinase buffer (20 m M HEPES (pH 7.2), 1 m M M g C l , 1 m M E G T A , 1 m M DTT, 0.25 m M 2  PMSF, 1 m M Na3V04, 0.5 ug/ml leupeptin, 1 ug/ml microcystin-LR).  Beads were  resuspended in 25 ul kinase buffer containing 60 u M Crosstide. Five ul of ATP solution (200 u M ATP, 10 uCi of [y- P]ATP in kinase buffer) was added, followed by incubation 32  for 15 min at 30°C. Reactions were stopped by spotting 20 ul of the reaction volume onto 2 cm squares of P81 filter paper, followed by extensive washing with 1% (v/v) phosphoric acid and measurement of associated radioactivity by liquid scintillation counting.  2.9. HPLC Analysis of PI(3,4,5)P3 and PI(3,4)P2. To measure the in vivo labeled lipids directly by HPLC, cells were labeled with 0.5 mCi/ml  P-orthophosphate for two hours  at 37°C in phosphate free-RPMI-1640, stimulated and extracted as described above. The dried lipids were deacylated as described previously (Gold et al., 1994), and applied to a Partisil 10 S A X ion exchange column. Following a 10 min washing of the column with water, a 60 min 0-0.25 M ammonium phosphate gradient was performed, followed by a 50 min 0.25-1.0 M ammonium phosphate gradient. One ml fractions were collected and monitored for radioactivity by scintillation counting. A T P , H-inositol(l,4,5)P3 (ICN) 3  48  and H-inositol(l,3,4,5)P (ICN) were used to calibrate the column and eluted at 75 min, 3  4  84 min, and 106 min, respectively.  3.0. Metabolic Labelling of Bad, Bcl-x , Bak and Bax. Cells were starved of cytokine, L  washed in phosphate-free medium, and then placed in phosphate-free RPMI medium buffered with 10 m M HEPES pH 7.4 with 1 mCi/ml P-orthophosphate at 37°C for 2 32  hours.  Bad, BC1-XL, Bak or Bax was immunoprecipitated from detergent-solubilized  lysates as described above. Immunoprecipitates were fractionated on a 10% gel with an acrylamide-bisacrylamide ratio of 118:1. The gel was dried under heat and vacuum. labelled proteins were detected by autoradiography.  49  3 2  P-  3. ANALYSIS O F BCL-2 F A M I L Y M E M B E R R E G U L A T I O N IN M U L T I P L E HEMOPOIETIC C E L L TYPES 3.1 R A T I O N A L E A N D HYPOTHESIS Cytokine stimulation activates signaling pathways that can directly affect components of the apoptotic machinery to promote cell survival and/or growth. Through binding to their cognate receptors, granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-3 (IL-3) can suppress apoptosis. The exact mechanisms by which GM-CSF and IL-3 mediate cell survival in hemopoietic cells are not fully understood. However, recent reports suggest that they are likely to involve regulation of the Bcl-2 family members (Review by McCubrey et al., 2000).  This may involve  regulation at the mRNA level, the protein level, or post-translational stage.  3.2 RESULTS I began my studies by asking whether various Bcl-2 family members were targets of protein phosphorylation cascades. To start, I examined each of the sequences of mouse Bad, Bax, Bak and Bcl-x with an algorithm that predicts potential phosphorylation sites L  (Blom et al., 1999). The algorithm provided a score from 0.0 to 1.0 for each serine, threonine and tyrosine residue in each protein, with 1.0 representing a high probability for in vivo phosphorylation. The known phosphorylation sites for Bad - Ser , Ser 112  Ser  155  136  and  - all scored above 0.9 (high probability). Table I lists each of the serine, threonine  and tyrosine residues for Bax, Bcl-x and Bak that received a score higher than 0.9. L  Because I found that all of these Bcl-2 family members contain residues  50  Table I - Prediction of potential phosphorylation for Bax, Bcl-xL, Bad and Bak  Serine predictions Protein Pos Bak 91 Bak 117  Context RRYDSEFQT KIATSLFES  Score 0.950 0.988  Prediction *g* *§*  Tyrosine predictions Protein Pos Context Bak 108 AENAYEYFT  Score 0.933  Prediction  Serine predictions Protein Pos Bad 58 Bad 111 Bad 112 Bad 128 Bad 134 Bad 136 Bad 155 Bad 180  Score 0.986 0.997 0.986 0.992 0.976 0.930 0.997 0.995  Prediction *g* *g* *g* *g* *§* *g* *g* *g*  Threonine predictions Protein Pos Context Bad 3 -MGTPKQP Bad 117 YPAGTEEDE  Score 0.916 0.937  Prediction  Serine predictions Protein Pos Bcl-x 23 Bcl-x 56 Bcl-x 73 Bcl-x 168 203 BC1-XL  Context QKGYSWSQF NGNPSWHLA TGHSSSLDA SRIASWMAT AAAESRKGQ  Score 0.960 0.945 0.967 0.940 0.987  Prediction *g* *g* *g* *g* *g*  Tyrosine predictions Protein Pos Context Bcl-x 195 FVDLYGNNA  Score 0.954  Prediction  Serine predictions Protein Pos Bax 15 Bax 55 Bax 87  Score 0.932 0.919 0.996  Prediction *g* *g* *g*  L  L  L  L  Context QEDASATDR RSRHSSYPA SRHSSYPAG EEELSPFRG FRGRSRSAP GRSRSAPPN LRRMSDEFE QMRQSAGWT  L  Context GGPTSSEQI PQDASTKKL VDTDSPREV  51  *Y*  * Y*  with probability scores higher than 0.9, I hypothesized that some of these sites were phosphorylated in whole cells. To determine if these Bcl-2 family members were regulated post-translationally by phosphorylation in response to cytokine stimulation, it was necessary to first confirm the identity of pro- and anti-apoptotic specific bands present on a SDS-PAGE gel.  To  address this matter, Bcl-x , Bak and Bax proteins were immunoprecipitated from L  unstimulated murine MC/9 cells using anti-Bcl-x (Transduction Laboratories), anti-Bak L  (Transduction respectively.  Laboratories)  and  anti-Bax  (Upstate  Biotechnology)  antibodies  Following immunoprecipitation, the samples were fractionated on SDS-  P A G E gels, transferred to nitrocellulose membrane, and subsequently immunoblotted with anti-Bcl-x (Santa Cruz), anti-Bak (Upstate Biotechnologies) and anti-Bax (Santa L  Cruz) polyclonal antibodies.  In the reverse experiment, the various Bcl-2 family  members were immunoprecipitated using the Santa Cruz antibodies and immunoblotted with anti-Bcl-XL (Transduction Laboratories), anti-Bak (Transduction Laboratories) and anti-Bax (Upstate Biotechnology) antibodies. Figures 3.1 and 3.2 verified the presence and apparent molecular mass of Bax and Bak in MC/9 cells. Next, the Bcl-2 homologues were immunoprecipitated from P-orthophosphate32  labeled MC/9 cells lysates stimulated with GM-CSF. Results from these studies (shown in Figure 3.3, 3.4 and 3.5) revealed that BC1-XL, Bak, and Bax were not phosphorylated in response to G M - C S F stimulation or withdrawal. Our lab has previously demonstrated in vivo phosphorylation of the pro-apoptotic protein Bad (Scheid and Duronio, 1998); therefore, to serve as a positive control, Bad was immunoprecipitated and its  52  OQ  DQ  D  D cd  cd  «  GO  >>  CO  Bax  •Bax  21-  CD t d CD GO  CD  B  §  03 GO  453121-  S up CD  S3  cd cd CQ CQ P-  PH  c CO  cd I d CD  CQ <  cs CQ  Blot: Bax (UBI)  Blot: Bax (SC)  GO  • x  x cd  LP: Bax (UBI) Blot: Bax Bax  53  Figure 3.1. The pro-apoptotic protein Bax is expressed in M C / 9 cells. A . MC/9 cells (5 x 10 ) were lysed with solubilization buffer and Bax was immunoprecipitated and blotted with anti-Bax antibodies from Upstate Biotechnologies (UBI) or Santa Cruz (SC). B . Same as in A with varying amounts of cell lysate and additional controls shown. Cell lysates and immuncomplexes were resolved on an 12% polyacrylamide gel, transferred to nitrocellulose and probed with anti-Bax antibodies. 6  54  in >•> fl  «  2  •  PH  ^  ^  H H *  JH PH  PH HH  O PH  <L> G  O -9 <  f  LP: Bak Blot: Bak  Figure 3.2. The pro-apoptotic protein Bak is present in MC/9 ceils. MC/9 cells (1 x 10') were lysed with solubilization buffer and Bak was immunoprecipitated with anti-Bak antibody (Transduction.Laboratories). Cell lysates were resolved on an 10% polyacrylamide gel, transferred to nitrocellulose and probed with anti-Bak antibody (Transduction Laboratories). Proteins were detected with E C L (Amersham).  55  ^ <  GM-CSF (min)  ^  £  0  |  5  10  GM-CSF (min) 0  5  10  I  67' 45  ^  T ***  ^ W ^  Blot:  t*r  «  Autorad  Figure 3.3. Bak is not phosphorylated in response to G M - C S F stimulation in M C / 9 cells. MC/9 cells were starved of cytokine for 8 h and then metabolically labeled with P-orthophosphate for 2 h, followed by stimulation with GM-CSF (50 ng/ml) for the indicated times. Bak was immunoprecitated and fractionated by SDS-PAGE. P labelled proteins were detected by autoradiography. This experiment was performed in duplicate with one set of samples shown. B. The membrane was probed with anti-Bak antibody (Transduction Laboratories). 32  32  56  G M - C S F (min) 0 0  5  5 10 10  Autorad  Figure 3.4. BC1-XL is not phosphorylated in MC/9 cells in response to G M - C S F stimulation. M C / 9 cells were starved of cytokine for 8 h and then metabolically labelled with P-orthophosphate for 2 h, followed by stimulation with GM-CSF for the indicated times. BC1-XL was immunoprecitated and fractionated by SDS-PAGE. P-labelled proteins were detected by autoradiography. The membrane was probed with anti-Bcl-xt antibody (Transduction Laboratories). Arrow indicates position of Bcl-x . * indicates position of putative Bad protein. 32  32  L  57  LP: B c l - x  A 0 32  5  L P : Bax  L  10  0  5  LP: Bad 10  5  5  P-Bad  B  Bad  Figure 3.5. BCI-XL coimmunoprecipitates with Bad. A . M C / 9 cells were starved of cytokine for 8 h and then metabolically labelled with P-orthophosphate for 2 h, followed by stimulation with GM-CSF for the indicated times. BCI-XL, Bak, Bax, and Bad were immunoprecitated and fractionated by SDS-PAGE. Plabelled proteins were detected by autoradiography. This experiment was performed in duplicate with one set of samples shown. B . The membrane was probed with anti-Bad antibody sc-943 (Santa Cruz Biotechnology).  58  phosphorylation state monitored along side BC1-XL, Bak, and Bax.  GM-CSF could  promote a significant increase in Bad phosphorylation, consistent with this earlier work. Serendipitously, these studies led to the finding that Bcl-x coimmunoprecipitates with L  Bad protein in unstimulated and GM-CSF-stimulated MC/9 cells (Figure 3.5). Cytokines have previously been shown to regulate Bcl-XL-Bad association in Bcl-XL-Bad transfected cells (Zha et al., 1996). In addition to confirming this earlier work, this study was the first to demonstrate Bcl-x -Bad association in non-transfected cells. L  In addition to phosphorylation, cytokine-stimulated signaling pathways may regulate the apoptosis threshold by increasing or decreasing Bcl-2 family member protein levels, and this became a focus for my work. Initially, the mRNA levels of various Bcl-2 family members were examined in the same factor-dependent cell line used for the phosphorylation experiments, MC/9.  M C / 9 cells were starved of cytokine for 8 h and  then resuspended in medium containing 0.5% FBS and GM-CSF for 16 h. Total R N A was isolated from the cells using standard protocols, and is shown in Figure 3.6. Multiprobe RNase protection assays were performed using the Riboquant (Pharmingen) mAPO-2 template set as described in Material and Methods section 2.1.4. As shown in Figure 3.7, mRNAs corresponding to the pro-survival proteins Bcl-2, Bcl-w, and BCI-XL and mRNAs corresponding to the pro-apoptotic proteins Bax and Bak were present in MC/9 cells.  GM-CSF stimulation caused an increase in BCI-XL mRNA in a time-  dependent fashion, while it had no effect on the expression of the other Bcl-2 family members tested. I next wanted to see if protein expression levels matched the changes seen in mRNA in response to GM-CSF. For this experiment, MC/9 cells were starved of  59  Figure 3.6. Total R N A isolated from M C / 9 cells. Total R N A was isolated from MC/9 cells using TRIZOL Reagent (Candian Life Technologies) according to the manufacture's specifications. A small portion of each sample was resolved on a 1% agarose gel to determine the integrity of isolated R N A .  60  Figure 3.7. In M C / 9 cells Bcl-xi. m R N A levels increase in response to G M - C S F stimulation. MC/9 cells were plated in low-serum (0.5%) medium with and without GM-CSF A . At 16 h, total R N A was isolated and analyzed by RNase protection assays using the mAPO-2 multiprobe template set (Pharmingen). B . Changes in the mRNA levels induced by 16 h with GM-CSF for Bad, Bax. Bak, Bcl-xi. and Bcl-w were plotted relative to unstimulated mRNA levels (set at 1). Radioactivity was quantitated by a Molecular Imager (Bio-Rad). To control for equal loading between samples, the level of each mRNA species was normalized against the level of the housekeeping gene transcript, L32. The data represent the average of triplicate determinations with error bars representing standard deviation.  61  cytokine and restimulated with GM-CSF or IL-3 for 16 h, and the lysates probed with antibodies specific to mouse Bak, Bax, and Bcl-x proteins. L  revealed that Bcl-x  L  Interestingly, Figure 3.8  protein levels remained unchanged in response to cytokine  stimulation, even though G M - C S F caused an increase in Bcl-x mRNA over the same L  time course. Studies performed in a human model system may provide a greater understanding of the molecular events underlying the regulation of Bcl-2 family members and may grant insight into the role of these proteins in human cellular responses to growth and survival signals.  Therefore, the regulation of Bcl-2 family members in response to cytokine  stimulation was examined in the human erythroleukemia cell line TF-1. Similar to murine MC/9 cells, TF-1 cells are dependent upon exogenous cytokine for growth and survival. TF-1 cells were suspended in low-serum medium containing human GM-CSF for various times.  Total R N A was isolated from the cells and multi-probe RNase  protection assays were performed using the Riboquant hAPO-2 template set. The results in Figure 3.9 revealed that GM-CSF caused an increase in Mcl-1 and Bcl-x  L  mRNA  levels in a time-dependent fashion. In contrast, mRNA species encoding other Bcl-2related proteins did not change significantly, nor did the expression of the housekeeping gene L32. This experiment was repeated numerous times, and the relative increases in BCI-XL and Mcl-1 mRNA are shown in Figure 3.9. The regulation of Mcl-1 and Bcl-x  L  protein levels in response to GM-CSF  stimulation in TF-1 cells was also examined. Similar to the effects on mRNA levels, GM-CSF caused a dramatic increase in Mcl-1 protein levels, suggesting that GM-CSF does indeed regulate Mcl-1 at the transcriptional level. In accordance with my findings  62  Oh  16 h  16 h  (Unstimulated)  IL-3 GM-CSF  Figure 3.8. Protein levels of Bak, Bax, and Bcl-x do not change in response to G M - C S F or IL-3 stimulation. MC/9 cells were plated in low-serum (0.5%) medium containing IL-3 or GM-CSF. At 16 h, MC/9 cells (2 x 10 ) were lysed in solubilization buffer (see Material and Methods) and equal amounts (50 ug) of their protein lysates were analyzed by immunoblotting for the expression of various Bcl-2 family members. L  6  63  Unstim  2 Hrs  4 Hrs  6  Bcl-x  Unstim  L  2 Hrs  4 Hrs  Figure 3.9. G M - C S F treatment increases Mcl-1 and Bcl-x m R N A levels. TF1 cells were deprived of cytokine and plated in low-serum (0.5% v/v) medium for 8 h followed by restimulation with GM-CSF for 0, 2, and 4 h. Total R N A was isolated and analyzed by RNase protection assays using the hAPO-2 multiprobe template set (Pharmingen). Radioactivity was quantitated by a Molecular Imager (Bio-Rad). To control for equal loading between samples, the level of each mRNA species was normalized against the level of the housekeeping gene transcript, L32. The data represent the average of triplicate determinations with error bars representing standard deviation. L  64  Unstim  2h  4h  Mcl-1  Bcl-x  L  Bax  Figure 3.10. Analysis of Bcl-x , Bax and Mcl-1 protein levels following stimulation with G M - C S F . TF-1 cells were starved of cytokine for 16 h and then stimulated with G M - C S F for the indicated times. Equal amounts of detergentsolubilized lysates were fractionated by SDS-PAGE and immunoblotted with anti-Mcl1, anti-Bcl-XL and anti-Bax antibodies. L  65  in MC/9 cells, there was no significant change in the level of Bcl-x protein or in the level L  of other Bcl-2 family members tested (Figure 3.10). I also wanted to examine the expression profile of Bcl-2 family mRNA in primary human cells, to compare with the data generated from TF-1 cells. Eosinophils and basophils play a major role in the pathogenesis of allergic diseases such as asthma (Review by Walsh, 1997; Holgate et al., 2000).  Enhanced survival of basophils and  eosinophils in airway tissues during allergic responses is one of the hallmarks of these disease processes. The severity of inflammation may be a result of defects in pathways controlling eosinophil and basophil apoptosis. To gain a better understanding of the mechanisms underlying primary human eosinophil and basophil apoptosis, I began a collaborative study with Dr. R. Schellenberg of St. Paul's Hospital. Expression of Bcl-2 family members in both primary human eosinophils and basophils was examined.  RNase protection analysis revealed that  mRNAs corresponding to the pro-survival proteins, Bcl-2, Bcl-x , B f l - l and Mcl-1 and L  mRNAs corresponding to the anti-survival proteins Bak and Bax were present in eosinophils (Figure 3.11).  Basophils expressed  Mcl-1 and  BC1-XL/S  mRNAs.  Interestingly, Mcl-1 mRNA level was five-fold higher in eosinophils compared to basophils and Bcl-x  L  mRNA level was six-fold higher in basophils compared to  eosinophils. These findings revealed that human eosinophils have a specific profile of Bcl-2 family mRNA expression distinct from that of basophils.  These observations,  along with a greater understanding of the molecular mechanisms that contribute  66  OH  o  CO  Bcl-x  L  Bfl-  Bak Bax  Mcl-  L3  GAPDH  Figure 3.11. Mcl-1 message level is higher in eosinophils whereas BCI-XL message level is higher in basophils. A . Total R N A was isolated from primary human eosinophils and basophils and analyzed by RNase protection assays using the hAPO-2 multiprobe template set (Pharmingen). Eosinophils also expressed Bfl1 mRNA.  67  to eosinophil and basophil apoptosis may provide an opportunity for therapeutic intervention during allergic reactions. Future studies will compare the responsiveness of various Bcl-2 family members at both the mRNA and protein level to cytokines and chemokines, as well as the potential role of the PI3K pathway in both chemotaxis and survival.  3.3 DISCUSSION The mechanisms by which cytokines function to promote cell survival are not fully understood. Several research studies suggest that cytokines may inhibit components of the apoptotic machinery, such as the pro-apoptotic protein Bad (Datta et al., 1997a; Blume-Jensen et al., 1998) or caspase-9 (Cardone et al., 1996) to protect cells from apoptosis. Other studies suggest that cytokines can activate pro-survival factors, like the Bcl-2 family members Bcl-2 and Bcl-x , to suppress apoptosis. L  The results in this  chapter have compared the expression of Bcl-2 family members in a number of hemopoietic model systems and demonstrate the selective regulation of the pro-survival factors Bcl-x and Mcl-1 by GM-CSF-stimulated signal transduction pathways. L  Work by Sevilla and coworkers (1999) identified BC1-XL as a potential target of the Ets2 transcription factor. The Sevilla group demonstrated cytokine-induced Ets2 transactivation of the Bcl-x  L  promoter in colony-stimulating factor-1  dependent  macrophages. Moreover, constitutive expression of Ets2 protects these cells from cytokine-withdrawal-induced cell death, suggesting a putative role for Ets2 in Bcl-x L  dependent cell survival.  Finally, work by McCarthy (1997) demonstrated E R K -  68  dependent activation of Ets2. A potential role for the Ras-Raf-MEK-ERK signaling pathway in GM-CSF-induced Bcl-x upregulation will be discussed further in Chapter 4. L  The data in this chapter shows GM-CSF-induced increase in Mcl-1 mRNA. M c l 1 protein levels were also upregulated in response to GM-CSF stimulation, providing a possible mechanism whereby GM-CSF may promote survival in hemopoietic cells. G M CSF stimulates both the PI3K-PKB and the Ras-ERK pathways.  In Chapter 4 the  question of whether either of these pathways controls GM-CSF-induced upregulation of Mcl-1 in hemopoietic cells will be addressed in greater detail. Our lab (Scheid and Duronio, 1999) and others (Datta et al., 1997a; Blume-Jensen et al., 1998) have previously demonstrated cytokine-induced phosphorylation of the proapoptotic protein Bad. In my work, I demonstrated that the Bcl-2 family members Bak, Bax, and BCI-XL were not phosphorylated in response to cytokine stimulation, suggesting that the activities of these proteins may be regulated by expression levels, subcellular localization (Puthalakath et al. 1999; Wolter et al., 1997; Xiang et al., 1996) and/or proteolytic cleavage (Gross et al., 1999; Wood and Newcomb, 2000;Clem et al., 1998; Kirsch et al., 1999). The results in this Chapter also show that BCI-XL interacts with both phosphorylated and unphosphorylated forms of Bad in GM-CSF-stimulated MC/9 cells. This finding led to other work in our laboratory showing that Bad is phosphorylated on 112  Ser  by a MEK-dependent pathway, whereas phosphorylation of two other residues •  *  occurs in a MEK-independent manner (Scheid et al., 1999). Ser  112  phosphorylation was  found to be required for dissociation of Bad from BCI-XL. These results demonstrated for the first time the involvement of a Ras-controlled signaling pathway leading to the 69  phosphorylation and inactivation of a pro-apoptotic Bcl-2 family member in mammalian cells (Scheid etal., 1999). Finally, I showed differences in the mRNA expression of Bcl-2 family members between primary human eosinophils and basophils.  This is a significant finding as  eosinophils and basophils have been shown to play a role in the pathogenesis of asthma (Holgate et al., 2000). Further examination of the potential differences in the protein levels of Bcl-2 family members in eosinophils versus basophils may lead to the identification of critical survival pathways operating in these cells and may provide novel therapeutic targets for the treatment of asthma.  70  4. DISTINCT ROLES REGULATION  FOR CERAMIDE,  E R K AND PI3K  IN MCL-1  4.1 RATIONALE AND HYPOTHESIS In hemopoietic cells, GM-CSF exerts its anti-apoptotic effects by activating multiple cellular signaling pathways including the PI3K cell survival pathway and the Ras-Raf-MEK-ERK kinase cascade. In contrast, the apoptotic lipid second messenger ceramide may promote apoptosis by inhibiting components of these pathways. One prosurvival factor known to be a target of GM-CSF stimulation (Chapter 3) is the Bcl-2 prosurvival factor Mcl-1. Thus, my working hypothesis is that PI3K- and ERK-dependent pathways may mediate GM-CSF-induced Mcl-1 upregulation.  4.2 RESULTS To test this hypothesis, I began by examining the mRNA levels of Mcl-1 in cells stimulated with G M - C S F in the presence of the potent and specific M E K inhibitor U0126. As shown in Figure 4.1, blocking the E R K pathway significantly diminished GM-CSF-induced upregulation of Mcl-1 mRNA. Another inhibitor of M E K , PD98059 gave similar results (data not shown). These data revealed that M E K activation was an essential element of GM-CSF-induced Mcl-1 gene expression. BC1-XL message also increased in response to GM-CSF stimulation, so I asked whether M E K was involved in this upregulation. Similar to the effects seen with M c l - l message, Bcl-x message was downregulated by U0126, suggesting the involvement of L  M E K (Figure 4.1). Together, these results suggested that a MEK-controlled pathway regulated BC1-XL transcription.  71  Oh  2h 1 2  Bcl-x  L  3  Mcl-1 4  Hi **»> mm  Bak Bax  Mcl-  L3  GAPDH  ^"^1 ^pil  §Pt  IIIII E w c  -*—*  w 9 CD  CM O  T3  CD  CD CNJ  <d-  E  o  o  ro CN  > _l |  CO i_  0  (J  CD  O  Figure 4.1. M E K activity is required for G M - C S F induced upregulation of M c l m R N A . TF-1 cells were starved of cytokine and cultured overnight in low serum medium (0.5%v/v).Cells were then restimulated with GM-CSF (lane 1, GM-CSF alone ) for 2 h in the presence or absence of LY-294002 (50 u M ; lane 2 ),C6-ceramide (50 u M ; lane i)or the M E K inhibitor U0126 (25 u M ; lane 4 ).Total R N A was isolated and analyzed by RNase protection assays using hAPO-2 multiprobe template set (Pharmingen). Radioactivity was quantitated by a Molecular Imager (Bio-Rad). To control for equal loading between samples,the level of each mRNA species was normalized against the level of the housekeeping gene transcript, L32. Data for the unstimulated, GM-CSF alone and the L Y 294002-treated samples are the average of triplicate determinations and error bars indicate standard deviation. The C6-ceramide and U0126-treated samples are the average of duplicate determinations and the error bars indicate the range.  72  Our lab (Scheid and Duronio, 1995) and others (Yao and Cooper 1995; Alessi et al., 1997; Songyang et al., 1997) showed that PI3K and its downstream effectors PDK1 and P K B constitute a major element of cytokine-mediated cell survival in various cell types. Using RNase protection assays, I asked whether there was a dependence upon PI3K for the expression or stability of Mcl-1 mRNA. In contrast to the effects of inhibiting M E K , inhibition of PI3K with two potent and specific pharmacological inhibitors, LY-294002 and wortmannin (not shown), had no effect on GM-CSF-induced upregulation of Mcl-1 mRNA levels (Figure 4.1). These observations suggested that either the expression or the stability of Mcl-1 mRNA was controlled by a MEK-dependent pathway and not by a PI3K-controlled pathway. I next examined the regulation of Mcl-1 protein by PI3K- and ERK-dependent pathways. TF-1 cells were starved of cytokine and incubated for 8 h in low-serum media. Cells were then restimulated with GM-CSF for 0, 2, and 4 h in the presence or absence of U0126 or PD-98059. The level of Mcl-1 protein was then determined by immunoblot analysis.  As anticipated, M E K inhibition completely abolished GM-CSF-induced  increase of Mcl-1 protein, which is consistent with reduced levels of Mcl-1 mRNA under these conditions (Figure 4.2). Interestingly, this effect was mirrored in cells treated with LY-294002 (Figure 4.2) or wortmannin (not shown).  This suggested that pathways  activated by G M - C S F that increase Mcl-1 protein levels consist of elements controlled by both PI3K and M E K .  Since inhibition of PI3K had no effect on the level of Mcl-1  mRNA, these results suggested that PI3K was controlling an aspect of Mcl-1 protein translation or stability. In contrast to Mcl-1, there was no significant change in the level  73  GM-CSF Unstim  2h  4h  Figure 4.2. PI3K activity and M E K activity are required for GM-CSF-induced M c l 1 upregulation. TF-1 cells were deprived of cytokine, plated in low-serum medium for 8 h and restimulated with GM-CSF in the presence or absence of LY-294002 (50 uM) or the M E K inhibitor U0126 (25 uM).Cells were harvested after 0, 2 and 4 h and equal amounts of protein lysates were analyzed by immunoblotting for the expression of Mcl-1. The same membrane was subsequently reprobed with antibodies specific to Bax, Bak, and BC1-XL.  74  of Bcl-x protein or in the level of other Bcl-2 family members tested (Figure 4.2), L  suggesting that PI3K and M E K were acting specifically on Mcl-1 regulation. To elucidate the role of PI3K in the regulation of Mcl-1 protein levels, I performed pulse-chase experiments. In these experiments, cells grown in the presence of GM-CSF were metabolically labeled with [ S]-methionine, followed by addition of cold methionine for various lengths of time. The half-life of Mcl-1 was determined to be approximately 40 minutes (Figure 4.3), consistent with the half-life previously reported by Chao and coworkers (1998). In two independent experiments, I consistently observed that PI3K-inhibition had no effect on the half-life of Mcl-1.  This suggested that the  PI3K-dependent upregulation of Mcl-1 was not at the level of protein stability or protein degradation. To further investigate the mechanism by which PI3K was regulating Mcl-1 protein levels, translation studies were performed in which cells were metabolically labeled with [ S]-methionine for 1, 3, and 4 h in the presence or absence of LY-294002 33  (Figure 4.4).  Taken together, these results suggested that GM-CSF-induced Mcl-1  upregulation was controlled at the transcriptional level by a MEK-dependent pathway and at the translational level by a PI3K-controlled pathway. Research by several groups suggests that PI3K may activate p70  s6k  in response to  cytokine stimulation resulting in the initiation of protein synthesis (Chung et al., 1994; Valius and Kazlauskas, 1993).  To determine i f PI3K was functioning via p70 s6k  dependent pathway to regulate Mcl-1 protein synthesis in response to GM-CSF stimulation, TF-1 cells were stimulated with GM-CSF in the presence and absence of the potent and specific p70  s6k  inhibitor, rapamycin. As shown in Figure 4.5, treatment with  75  LY-294002 (50 u M )  Chase (min)  CD QL  o 20 40 60 80  o 20 40 60 80  20 0 0  20  40  60  80  Chase time (min) -•-GM-CSF -a-GM-CSF +LY-294002  Figure 4.3. Inhibition of PI3K activity has no effect on the half-life of Mcl-1. A. TF-1 cells were pulse-labelled with [ S]Met for 15 min and chased in low-serum growth medium containing methionine (10 mM) and GM-CSF in the presence or absence of LY-294002 (50 uM). At the indicated times after chase (min), whole cell lysates were prepared and Mcl-1 was immunoprecipitated. Mcl-1 was resolved on SDS-PAGE gel and visualized and quantitated by a Molecular Imager (Bio-Rad). The level of Mcl-1 at each time point was converted to the percentage of Mcl-1 level at the zero time point and plotted to determine the half-lives. This experiment was performed in duplicate with similar results. One set of samples is shown. 35  76  45000 CO  40000 35000  ZD £  30000  |  25000  "g  20000  "§-  15000 10000 5000 0 Fj C  LL  CN  c7)  o  V  o  2  d)  -n CD C  2 3  CD CM O  1 Hr • 3 Hr • 4 Hr  Figure 4.4. Regulation of Mcl-1 protein synthesis by PI3K- and ceramidedependent pathways. TF-1 cells were placed in medium containing [ S ]methionine and then stimulated with G M - C S F alone or GM-CSF with LY-294002, C ceramide or U0126. After 1, 3,or 4 h Mcl-1 was immunoprecipitated,fractionated by SDS-PAGE and quantitated by a Molecular Imager (Bio-Rad). 35  6  77  rapamycin only partially inhibited Mcl-1 upregulation, thus pointing to other effectors of PI3K besides just p70 . s6k  To rule out the question of cross-talk between the Ras-ERK pathway and the PI3K pathway regulating Mcl-1 protein synthesis, TF-1 cells were stimulated with GM-CSF in the presence or absence of LY-294002 or U0126. Cells were then harvested and protein lysates were analyzed by immunoblotting for phospho-ERK.  As expected, the M E K  inhibitor U0126 completely blocked the appearance of phospho-ERK, while PI3K inhibition has no effect on E R K phosphorylation (Figure 4.6).  Taken together these  studies show that signals emerging from PI3K- and Ras-dependent pathways were functioning interdependently to regulate Mcl-1 synthesis in response to GM-CSF stimulation. The generation of ceramide from the breakdown product of sphingomyelin is potentially an important second messenger in apoptosis signaling in a variety of cell types and may serve as a negative regulator of pro-survival pathways (Kolesnick, 1998). For example, ceramide has been shown to downregulate both the Ras-ERK pathway (Yu et a l , 1997) and components of the PI3K-PKB pathway (Zundel and Garcia, 1998; Schubert et al., 2000). This led me to test whether ceramide could have an impact on Mcl-1 transcription or translation. Once again total R N A was isolated from cells stimulated with GM-CSF in the presence or absence of C - or C6-ceramide and subjected to RNase 2  protection assays. The results in Figure 4.1 showed that treatment with C6-ceramide did not effect GM-CSF-induced upregulation of Mcl-1 mRNA, which is consistent with a lack of effect of C6-ceramide on E R K phosphorylation (Figure 4.6). Identical results were obtained when cells were treated with C2-ceramide (data not shown).  78  GM-CSF  LY-294002 C  50  25  10  Rapamycin 100  50  25  Mcl-1  Figure 4.5. p70 activity is partially required for Mcl-1 upregulation. TF-1 cells were deprived of cytokine (lane Q , plated in low-serum medium for 8 h and restimulated with GM-CSF in the presence or absence of the PI3K inhibitor LY-294002 (50 u M , 25 uM or 10 uM) or in the presence or absence of the p70 inhibitor rapamycin (100 ng/ml, 50 ng/ml, or 25 ng/ml). Cells were harvested 6 h after restimulation and equal amounts of protein lysates were analyzed by immunoblotting for the expression of Mcl-1. M>K  79  GM-CSF  +  + +  +  LY-294002 C -Ceramide  +  6  U0126 P-ERK H  GM-CSF  +  + +  +  + +  U0126  +  LY-294002  P-PKB +  GM-CSF LY-294002 C -Ceramide  +  6  P-PKB  Figure 4.6. Inhibition of P K B and M A P K by various inhibitors. TF-1 cells were starved of cytokine for 8 h followed by a 15 min pre-incubation with LY-294002 (50 uM), C6-ceramide (25 uM) or U0126 (25 uM) where indicated, followed by a 10 min stimulation with GM-CSF. Cells were harvested and equal amounts of protein lysates were analyzed by immunoblotting for phospho-ERK (top panel) or phospho-PKB (middle and lower panels).  80  To  explore the possibility that ceramide may promote apoptosis via down-  regulation of PI3K-dependent Mcl-1  protein synthesis, cells were stimulated with G M -  CSF in the presence or absence of C2- or C6-ceramide.  As shown in Figure 4.7 the  addition of C6-ceramide to TF-1 cells blocked GM-CSF induced Mcl-1 protein upregulation, which paralleled the effects of inhibiting PI3K activity.  Further, pulse-  chase analysis (Figure 4.8) and translation studies confirmed that ceramide treatment inhibited GM-CSF-induced upregulation of Mcl-1 at the level of translation (Figure 4.4). Together the data suggests that reduced Mcl-1 protein levels caused by ceramideinhibition of a PI3K-dependent signaling pathway may be a contributing factor in ceramide-mediated cell death.  Use of SHIP-/- Mast Cells in Regulation of Bcl-2 Family Proteins  Our lab has been collaborating with Dr. G. Krystal's group in investigating the regulation of phosphoinositides and P K B by SHIP (manuscript submitted). SHIP is an SH2-containing phosphatase that dephosphorylates PI(3,4,5)P3 at the 5' position to produce PI(3,4)P2 and is the major 5' phosphatase in hemopoietic cells. SHIP loss-offunction transgenic mice display impaired apoptosis and have excessive myeloid cell survival (Helgason et al., 1998; Liu et al., 1998). One reason for this may be that SHIP negatively regulates PI3K function, by reducing the amount of PI(3,4,5)P3 generated by PI3K.  In the previous sections I showed that inhibition of PI3K downregulated BCI-XL  mRNA, but without any effect on BCI-XL protein. I wanted to use the SHIP-/- system to test if upregulaton of PI3K-derived lipids would lead to increased Bcl-2 family member expression. To address the question of whether SHIP is an important component of Bcl-2  81  GM-CSF LY  G  LY  G  Mcl-1  Bak  GM-CSF  B  LY OiM) 50  25  10  C (|LiM) 6  20  10  Mcl-1 Bcl-x  L  Bax  Figure 4.7. C6-ceramide inhibits G M - C S F induced increase in Mcl-1 protein levels. A . TF-1 cells were deprived of GM-CSF, placed in low-serum (0.5%) medium for 16 hours and restimulated with GM-CSF in the presence or absence of C6-ceramide (25 uM)or LY-294002 (50 uM). 4 hours after restimulation, cells were solubilized and equal amounts of protein lysates were analyzed by immunoblotting for the expression of Mcl-1 and Bak. B . Similar to A, except that LY-294002 and C6-ceramide were used at the indicated concentrations and Mcl-1, Bax and BCI-XL were immunoblotted.  82  A  B  +/+  -  Bcl-x  Bcl-w  L  Figure 4.8. The message levels of various Bcl-2 family members tested are present in equal amounts in SHIP+/+ and SHIP -/- B M M C s . A . Total mRNA from SHIP+/+ and SHIP-/- B M M C s was isolated and analyzed by RNase protection assays using the mAPO-2 multiprobe template set (Parmingen). B. Radioactivity was quantitated by a Molecular Imager (Bio-Rad), and Bcl-X[. mRNA was normalized against the level of the housekeeping gene transcript, L32. Error bars represent the range of duplicate experiments.  83  family member regulation in bone marrow mast cells (BMMC), the mRNA and protein levels of Bcl-2 family members from SHIP " and S H I P 7  +/+  B M M C were examined. The  data in Figure 4.8 revealed that mRNAs corresponding to Bad, Bak, Bax, Bcl-2, BC1-XL, and Bcl-w were present in approximately equal amounts in wild type and SHIP knock out BMMC.  Surprisingly, Western blot analysis (Figure 4.9) showed that BC1-XL protein  levels were greatly elevated in SHIP " compared to SHIP , suggesting that SHIP may 7  +/+  negatively regulate the expression of BC1-XL protein.  4.3 D I S C U S S I O N These studies revealed that a SHIP dependent pathway negatively regulates BC1-XL levels in hemopoietic cells. It will be interesting to determine i f SHIP is involved in a feedback regulation via a PI3K pathway to reduce BC1-XL protein levels in B M M C . Other work in our laboratory (manuscript submitted) has shown that SHIP " B M M C have 7  elevated P K B activity, possibly due to an increase in basal levels of PI(3,4,5)P3, suggesting that an increase in P K B activation may lead to the observed increase in BC1-XL expression. These results are consistent with recent studies showing that transgenic mice expressing gag-PKB (a constitutively active form) have greatly elevated Bcl-x protein L  levels in the T-cell compartment (Jones et al., 2000). Future studies will involve pulse-chase experiments to determine i f the increased levels of BC1-XL in SHIP " cells are due to an increase in the half-life of BC1-XL or due to 7  an increase in protein translation. In addition, SHIP " B M M C will be treated with PI3K 7  inhibitors to look at the role of PI3K-PKB signaling pathway in the regulation of BC1-XL protein. Finally, experiments will be performed to look at the level of BC1-XL protein in  84  +/+  _/_  +/+  ./-  Figure 4.9. Bcl-x protein levels are elevated in SHIP knockout cells. SHIP +/+ and SHIP -/- BMMCs were harvested and equal amounts of their protein lysates were analyzed by immunoblotting for the expression of Bcl-x and other proteins as indicated in the figure. This experiment was performed in triplicate with one set of samples shown. L  L  85  MC/9 cells overexpressing the conditionally active version of P K B , p i 10*:ER . Work IM  by Kohn and coworkers (1998) revealed that activation of pllO*:ER™ is sufficient to induce the phosphorylation of PHAS-1 (phosphorylated heat- and acid-stable protein), a key step in the initiation of protein synthesis. It is anticipated that MC/9 pllO*:ER™ transformants will express higher levels of BCI-XL protein in the presence of 4-OHT than in its absence, providing a possible mechanism by which Bcl-x levels may be regulated L  in hemopoietic cells. GM-CSF induced signaling events trigger activation of both the Ras-ERK pathway and the PI3K cell survival pathway. The Ras-MEK-ERK pathway is involved in the transduction of anti-apoptotic signals in a variety of hemopoietic cells and couples survival stimulus initiating at the cell surface to transcription factors controlling gene expression. Our group has recently demonstrated that phosphorylation of the proapoptotic protein Bad at Ser" is mediated by the M E K - E R K pathway and this M E K 2  dependent phosphorylation of Bad may be a contributing factor in the ability of cytokines to promote cell survival (Scheid et al. 1999). This present study suggests that the RasM E K - E R K pathway also serves a role in the transcriptional activation of the pro-survival factor Mcl-1, suggesting that in hemopoietic cells cytokines may suppress apoptosis by inducing de novo gene expression of death antagonists as well as the post-translational modification and inactivation of pro-apoptotic proteins. The Mcl-1 promoter contains a cAMP-response element (CRE-2) site and may be a target of a transcription factor complex containing the cAMP-response element-binding protein (CREB; Wang et al., 1999). Several studies have shown the E R K pathway leading to C R E B transactivation activity (Review by McCubrey et al., 2000). Therefore, in TF-1 cells, Ras signaling to  86  CREB may take place through the Ras-Raf-MEK-ERK pathway resulting in an increase in de novo Mcl-1 gene expression. Unlike inhibiting M E K , blocking PI3K did not alter the upregulation of Mcl-1 mRNA following stimulation with GM-CSF. However, inactivating PI3K did block the increase in Mcl-1 protein synthesis induced by GM-CSF and this effect was not due to an increase in Mcl-1 degradation or alterations in Mcl-1 protein stability. Thus, GM-CSFinduced Mcl-1 upregulation was controlled at the translational level by a PI3K-controlled pathway. M y findings are contradictory to the work of Wang and colleagues (1999) who showed that PI3K regulates Mcl-1 gene expression through the activation of an immediate early transcription factor. In their study Wang and coworkers demonstrated that PI3K inhibitors or dominant negative PI3K mutants block the transcriptional upregulation of Mcl-1 mRNA.  One emerging factor that may contribute to the  discrepancies observed between the two studies involves cross talk between the PI3K and E R K pathways. For example, the Wang group performed most of their work in the IL-3 dependent pro-B cell line BAF/3. In these cells, blocking with a dominant negative p85 inhibits activation of E R K (Craddock, 1999). Furthermore, overexpression of dominant negative p85 was shown to block IL3-induced E R K activation in FDC-P1 cells (Sutor, 1999), but we have shown that inhibition of PI3K has no effect on IL-3-induced E R K activation in MC/9 cells (Scheid, 1996) as well as in FDC-P1 cells (D. Chiu and V.D., in preparation).  Since the studies by Wang and coworkers did not address the effects of  blocking PI3K on E R K activation, it is possible that the effects they see on Mcl-1 mRNA transcription are manifested through a reduction in E R K signaling. In the TF-1 cell line, blocking PI3K had no effect on E R K activation (Figure 4.6). Inhibiting PI3K had no  87  effect on Mcl-1 mRNA levels, however I could abolish Mcl-1 mRNA by inhibiting M E K . Thus, the method of inhibiting PI3K, and the corresponding effects on E R K activity must be considered prior to drawing conclusions about the specific role of PI3K. A wide variety of physiological signals, such as those generated by cytokines and growth factors, can activate the sphingomyelin pathway resulting in the production of the lipid second messenger ceramide. M y studies suggest that ceramide may decrease antiapoptotic signaling in cells by inhibiting PI3K-mediated Mcl-1 upregulation. Reports by several groups have identified P K B as a downstream target of ceramide-mediated apoptosis (Zhou, 1998; Schubert, 2000). Recent work from our laboratory showed that P K B phosphorylation at an activating site, Ser , may be a target of ceramide-activated 473  protein phosphatases (Schubert et al., 2000). Thus my current study suggests that the mechanism by which ceramide may function to inhibit GM-CSF-induced PI3Kdependent increase in Mcl-1 protein is through the inactivation of P K B . A n involvement of P K B in the PI3K-dependent regulation of Mcl-1 protein appears probable, since P K B was shown recently to phosphorylate components of the translational machinery. For example, 4E-BP1 phosphorylation by P K B inactivates the function of 4E-BP1 to repress mRNA translation (Takata et al., 1999; Gingras et al., 1998; Dufner et al.,; 1999).  In  addition, PI3K, PDK1 and P K B may have multiple inputs on p70 . I have shown here s6k  that the effects of rapamycin (and thus complete p70  s6k  inhibition) on Mcl-1 protein  upregulation were not as dramatic as blocking PI3K (see Figure 4.4), thus pointing to other effectors of PI3K besides just p70 . s6k  In summary, through binding to its cognate receptor, GM-CSF can induce antiapoptotic signaling via stimulation of the E R K and PI3K signal transduction cascades.  88  Several research findings suggest that the cytoprotective actions of these signaling pathways may converge on members of the Bcl-2 family, supporting the view that cytokines promote cell survival by increasing signaling of anti-apoptotic pathways as well as by decreasing signaling of pro-apoptotic pathways. M y studies here demonstrated that E R K - and PI3K-dependent pathways were required for GM-CSF-induced upregulation of the Mcl-1 pro-survival factor. In addition, I provided evidence that ceramide-induced apoptosis could occur by inhibiting the translation of Mcl-1 protein. A further understanding of the molecular events underlying regulation of Bcl-2 family members may grant insight into the pathogenesis of disease and provide novel targets for therapeutic intervention.  89  5.  EXAMINATION OF PROTEIN KINASE B (PKB) AS A POTENTIAL  TARGET OF CERAMIDE ACTION  5.1 RATIONALE AND HYPOTHESIS The second messenger ceramide (N-alkysphingosine) has been implicated in a host of cellular processes including growth arrest and apoptosis. Ceramide may augment the execution of apoptosis through the inactivation of pro-survival pathways. Recently, several reports supported this notion by demonstrating negative regulation of the PI3KP K B signaling pathway by ceramide (Basu et al., 1998; Summers et al., 1998; Zundel et al., 1998; Zhou et al., 1998). Thus, ceramide may specifically inhibit PI3K, resulting in a loss of P K B activity or ceramide may negatively regulate P K B activation independently ofPOK.  5.2 RESULTS To investigate the effects of ceramide on P K B activation by cytokines, I began by measuring P K B activity in vitro following exposure of cells to GM-CSF, ceramide, or the PI3K inhibitor LY-294002. In human erythroleukemic TF-1 cells, stimulation with G M CSF resulted in a large increase in P K B activity after 1 or 3-minute treatment (Figure 5.1). Inhibition of PI3K by treatment of cells with LY-294002 almost entirely blocked the activation of P K B . Phosphorylation of E R K was unaffected by ceramide treatment (Figure 5.2) indicating that C6-ceramide was not reducing the signaling capacity of the GM-CSF receptor non-specifically.  90  1 min  7000 S  6000 -  B  5000  3  4000  12000  3 min  10000  3000  u  1  2000 1000  Unstim GMGM+C6 GM+LY  Unstim GMGM+C6 GM+LY  Unstim  G M GM+C  6  GM+LY Blank  B PKB  H  Figure 5.1. C6-ceramide attenuates P K B activation by G M - C S F . A . TF-1 cells were pretreated with C -ceramide (25 uM) or LY-294002 (50 uM) and then stimulated with G M - C S F for 1 min or 3 min. P K B activity was measured in vitro using a peptide substrate (Crosstide). A blank containing protein G-Sepharose was carried through the assay, and its activity (-5,000 cpm) was subtracted from each of the other assay points. B. The reaction products were resolved by SDS-PAGE and transferred onto nitrocellulose. The membrane was immunoblotted with a-PKB antibody to assess loading and to confirm the absence of P K B in the blank sample. Error bars represent the range of duplicate samples. 6  91  Figure 5.2. C -ceramide and LY-294002 do not affect M A P K phosphorylation. TF-1 cells were pretreated for 20 min with 25 u M C -ceramide {lane 1), 50 u M L Y 294002 (lane 2), or 25 u M U0126 (lane 3) and the stimulated with 50 ng/ml GM-CSF for 5 min (lanes 1-4). Cells in lane 5 received no treatment. Cell lysates were normalized for equal protein concentration and probed with anti-phospho-ERK antibody. 6  6  92  In addition, a potent M E K inhibitor, U0126, completely abolished the phosphorylation of E R K in this experiment, whereas LY-294002 had no effect.  Thus, C6-ceramide  specifically reduces the maximal activity of P K B achieved by stimulation of cells with GM-CSF, without affecting the parallel M E K - E R K pathway. I next examined the effects of ceramide on PI3K activity in whole cells. TF-1 cells were metabolically labeled with P-orthophosphate and then stimulated with G M - C S F in 32  the presence or absence of C6-ceramide. Lipids were extracted, deacylated and separated by anion exchange H P L C (Scheid and Duronio, 1998). Figure 5.3 showed the elution profiles corresponding to both glycerol-PI(3,4)P2 and glycerol-PI(3,4,5)P3. Stimulation with GM-CSF caused a significant increase in the amounts of both of these lipids above unstimulated cells. Pre-treatment of cells with C6-ceramide did not affect the increase of either lipid species caused by GM-CSF. However, pre-treatment of cells with LY-294002 abolished the generation of both lipid species.  The total radioactivity loaded onto the  column was very similar between samples, indicating that the differences in radioactivity caused by GM-CSF treatment were due to changes in mass for each lipid.  Thus, C6-  ceramide did not affect the de novo generation of PI(3,4,5)P3 or PI(3,4)P2 caused by G M CSF stimulation. Therefore, the effects of C6-ceramide on P K B were not because of reduced levels of PI3K-generated lipids. P K B activation occurs by multiple phosphorylations on several residues (Alessi et 308  al., 1996a).  Thr  is located in the activation loop of the kinase domain and  phosphorylation by PDK1 is required for activation.  Ser  473  phosphorylation near the  carboxy-terminal region of P K B further potentiates activity. I monitored these  93  PIP, 600  PI(4,5)P2  500  ^  400  ^  300  PI(3,4,5)P  PI(3,4)P2  200  100  0  n  61  63  65  67  69  71  73  75  89  7  Elution Time  1  1  r  9 0 91 9 2 9 3 9 4 9 5 9 6 9 7 9 8  Elution Time  Figure 5.3. C -ceramide does not affect PI3K-generated PI(3,4)P or PI(3,4,5)P . TF1 cells were metabolically labeled with P for 2 h. Cells were either left unstimulated (closed circles) or stimulated with GM-CSF in the presence of ceramide (open circles), L Y 294002 (closed triangles), or vehicle alone (closed squares) for 3 min, and the lipids were extracted as described under "Materials and Methods". Deacylated lipids were fractionated by anion exchange chromatography and detected by liquid scintillation counting. Results are representative of two independent experiments. 6  2  94  3  phosphorylation events separately using phospho-specific antibodies.  In the first  experiment, cells were pretreated with C6-ceramide or vehicle alone and then stimulated for 1, 3 or 5 minutes with GM-CSF. Phosphorylation of P K B at Ser  473  was observed by 1  minute, maximal by 3 minutes, and began to decline by 5 minutes (Figure 5.4). In the presence of ceramide, the extent of Ser  473  phosphorylation was greatly reduced. T h r  phosphorylation was also examined. In contrast to Ser , T h r 473  308  308  phosphorylation was not  altered by ceramide treatment. Treatment of cells with dihydroceramide, an inactive ceramide analog, had no effect (Figure 5.4), consistent with the findings of others (Zhou et al., 1998; Summers et al., 1998). In a separate experiment, I wanted to confirm that 308  Thr  phosphorylation was occurring by a PI3K-controlled pathway. Cells were treated  with either C6-ceramide or LY-294002, and the lysates were probed with anti-phospho308  Thr  (Figure 5.5).  Consistent with Figure 5.4 ceramide treatment had no effect.  contrast, LY-294002 completely abolished T h r  308  In  phosphorylation. This confirmed that  308  Thr  phosphorylation was occurring by a PI3K-activated pathway.  whether ceramide could accelerate P K B Ser  473  Finally, I asked  dephosphorylation, i f added after G M -  CSF stimulation (Figure 5.6). In this experiment cells were stimulated with GM-CSF for 30 seconds, washed, and then ceramide or vehicle was added. distinguish whether  ceramide was blocking Ser  473  In this way I could  phosphorylation or if it was  accelerating its dephosphorylation. Ceramide significantly reduced Ser in  this  set  of experiments,  dephosphorylation (Figure 5.6).  most  consistent  with  an  473  phosphorylation  acceleration  in  Ser  473  This result suggested that the mechanism of Ser  473  dephosphoryaltion by ceramide most likely involved a ceramide-activated protein phosphatase. 95  Control 0 13 5 — —  .  + +  + +  C -Ceramide 0 1 3 5 Time (min) 6  ^ P-S473  -  +  +  P-T308  +  PKB  GM-CSF C -Ceramide 2  C 2  -4- P-S473  Figure 5.4. Ceramide specifically reduces P K B S e r phosphorylation. A . TF-1 cells were pretreated with C6-ceramide for 20 min and then stimulated with GM-CSF for 1, 3, or 5 min. P K B was immunoprecipitated and fractionated by SDS-PAGE. Ser or Thr phosphorylation was monitored by immunoblotting with anti-phospho-Ser or anti-phospho-Thr antibody. Total P K B was immunoblotted to confirm equal loading. B . TF-1 cells were pretreated with C2-ceramide or C2-dihydroceramide for 20 min and then stimulated with GM-CSF for 5 min. Ser phosphorylation was monitored by immunoblotting with anti-phospho-Ser antibody 47j  473  308  473  473  473  96  Contro  C -Cer  LY-294002  0 1 3 5  0 1 3 5  0 1 3 5  6  mm mm •  Time (min) ^-P-T308  Figure 5.5. PI3K inhibition, but not ceramide, block P K B T h r phosphorylation. Cells were treated with C -ceramide, LY-294002 (both at 25 uM), or vehicle and stimulated with GM-CSF for the indicated times. Cell lysates were normalized based on protein concentrations, fractionated by SDS-PAGE and  3 0 8  6  97  Figure 5.6. Ceramide accelerates P K B Ser phosphorylation. Cells were stimulated with GM-CSF for 30 s, washed twice with RPMI 1640 and treated for 5 min with vehicle or C -ceramide. Cell lysates were fractionated by SDS-PAGE and immunoblotted with anti-phospho-Ser . Total P K B was immunoblotted to confirm 6  473  98  The results of Figure 5.6 suggested a mechanism involving ceramide-activated protein phosphatase in the regulation of P K B dephosphorylation. To examine this possibility further, cells were co-treated with ceramide and okadaic acid, a PP2A phosphatase inhibitor previously reported to inhibit ceramide-activated phosphatases (Dobrowsky et al., 1993), followed by stimulation with GM-CSF. Figure 5.7 showed the activity of P K B in each of these conditions. Okadaic acid was ineffective in reversing the decrease in activity caused by ceramide. This was consistent with previous reports (Summers et al., 1998; Zhou et al., 1998), and at first suggested that ceramide was not affecting P K B through dephosphorylation. However, I noticed that cells treated only with okadaic acid and GM-CSF also had reduced P K B activity. This suggested that okadaic acid might interfere with the normal activation of P K B , which may be independent of the inhibitory actions of ceramide.  Immunoblotting for Ser  473  phosphorylation demonstrated that  okadaic acid fully restored the decreased phosphorylation of this residue caused by ceramide (Figure 5.8). Because okadaic acid was restoring Ser  473  phosphorylation, but  could not restore kinase activity, I monitored the phosphorylation state of the other -J A O  regulatory site, Thr  . Surprisingly, okadaic acid, either in the presence or absence of  ceramide, blocked Thr  phosphorylation (Figure 5.8).  I then performed additional  experiments to examine the effects of okadaic acid on P K B phosphorylation. As shown in Figure 5.9, okadaic acid did not affect the kinetics or extent of Ser induced by GM-CSF.  However, at all times examined T h r  308  473  phosphorylation  phosphorylation was  significantly reduced. To confirm the involvement of a serine phosphatase in these processes, additional experiments were performed with a functionally distinct phosphatase inhibitor, calyculin 99  Figure 5.7. PKB is a substrate for a ceramide-activated phosphatase. Cells were pretreated with 1 u M okadaic acid (O.A.) for 20 min followed by C6-ceramide or vehicle for 20 min. Cells were then stimulated with GM-CSF for 3 min. P K B was immunoprecipitated and activity was measured in vitro using Crosstide as a substrate. Error bars represent the range of duplicate samples.  100  GM-CSF C -Cer O.A. 6  + + +  + + -  + -  EXP EXP  P-S473  —  —  —  —  P-S473  P-T308  PKB  Figure 5.8. P K B Ser is a substrate for a ceramide-activated phosphatase. Immunoprecipitates from two separate kinase assays were fractionated by SDS-PAGE and probed for Ser phosphorylation (designated Exp. 1 and 2). A portion of the immunoprecipitate was also probed for T h r phosphorylation and for total P K B . 473  308  101  O.A. Control - 1 3 5 7 13 5 7 — m m m m m m m m  Time (min) * P-S473 « P-T308  PKB S S S l i IS5SS <<4 IgG H  Figure 5.9. Okadaic acid inhibits T h r phosphorylation. Cells were treated with 1 u M okadaic acid (O.A.) or vehicle (Control) for 20 min followed by GM-CSF for the indicated times. P K B was immunoprecipitated, fractionated by SDS-PAGE and probed for Ser phosphorylation, T h r phosphorylation or total P K B . 473  308  102  A . Figure 5.10 showed that cells pretreated with ceramide and calyculin A restored Ser phosphorylation. In another experiment, calyculin A was compared with okadaic acid. Both inhibitors restored Ser  473  phosphorylation equally during ceramide treatment (Figure  5.10). Also both are shown here to inhibit T h r  308  phosphorylation, demonstrating that  this effect was not unique to okadaic acid. As a control to show that these phosphatase inhibitors were not disrupting the generation of PI(3,4,5)P3 following  GM-CSF  stimulation, lipid analysis was also performed. GM-CSF-stimulated generation of PI(3,4,5)P3 remained unaffected. Together these results indicated that (1) the effects of ceramide on Ser okadaic acid  473  phosphorylation were through the activation of a phosphatase, and (2)  and calyculin  A could  inhibit  an activity necessary  for T h r  308  phosphorylation. 5.3 D I S C U S S I O N Recently, three groups have studied the effects of ceramide on PI3K and P K B activation. Zundel and Giaccia (1998) provided evidence that PI3K is a direct target of ceramide, with its inhibition leading to decreased P K B activation. In contrast, Zhou and coworkers (1998) and Summers and coworkers (1998) provided evidence that ceramide does not affect PI3K activation, but rather inhibits P K B directly. In these three reports, PI3K activity was determined by immunoprecipitating PI3K (either directly or associated with tyrosine phosphorylated proteins) followed by in vitro kinase assays using PI as a substrate.  Since this method does not examine the de novo accumulation of the PI3K  reaction products, I felt this issue required further examination, given the importance of PI3K in many different signaling pathways and the potential importance of ceramide as inducer of apoptosis. Therefore, I measured the de novo 3'-phosphoinositide production  103  A  GM-CSF C -Ceramide Calyculin A 4  •  T  <  P-S473  < PKB  GM-CSF C -Ceramlde Calyculin A Okadak Acid  D  ft  < P-S473  « P-T308 M  <« P K B  Figure 5.10. Calyculin A restores ceramide inhibition of Ser . A . Cells were treated with 50 n M calyculin A or vehicle (ethanol) for 20 min followed by GM-CSF for 5 min. Lysates were fractionated by SDS-PAGE, probed for Ser phosphorylation and reprobed for total P K B . B. Cells were treated with either 50 n M calyculin A , 1 u M okadaic acid, or vehicle (ethanol) for 20 min and stimulated with GM-CSF for 5 min. Lysates were fractionated by SDS-PAGE and probed for Ser phosphorylation, reprobed for T h r phosphorylation and then reprobed for total P K B . 47J  473  473  308  104  in the presence of ceramide following stimulation with GM-CSF.  In contrast to L Y -  294002, which completely abolished PI(3,4,5)P3 and PI(3,4)P2 generation, ceramide had no effect on the generation of these lipid species. Thus, I conclude that ceramide does not regulate the activation of PI3K. Under the same conditions, I measured P K B activity and found it to be lowered by 50-60% by ceramide. This suggested to me that ceramide was altering the activation of P K B independently of any effect on PI3K. Ceramide could be acting on upstream kinases that regulate P K B , or it may block to some extent its translocation to the plasma membrane. Ser  473  Closer examination of the regulatory sites of P K B demonstrated that only  phosphorylation was largely attenuated by ceramide treatment.  For T h r  to  308  become phosphorylated, both PDK1 and P K B must bind PI(3,4,5)P3 to induce a 308  conformational change providing access for P D K 1 .  The observation that Thr  phosphorylation was not affected by ceramide confirms that P K B retained access to PI(3,4,5)P3, most likely through translocation to the plasma membrane, consistent with a lack of affect of ceramide on PI3K. Thus, my results demonstrated that the reduction in P K B activity was due to reduced overall Ser  473  phosphorylation.  In order to understand the mechanism by which ceramide was reducing Ser phosphorylation, I asked i f this was due to a ceramide-activated phosphatase.  473  Little  information is known about the critical enzymes responsible for returning P K B to an inactive state following receptor activation. However, ceramide has been demonstrated to activate a PP2A-like phosphatase activity (CAPP) through unknown mechanisms. This activity is sensitive to the phosphatase inhibitor okadaic acid (Dobrowsky et al., 1993), and okadaic acid has been used to implicate CAPP in the dephosphorylation of Bcl-2, Rb, 105  and P K C isoforms (Lee et al., 1996; Dbaibo et al., 1995; Ruvolo et al., 1999). In my experiments, okadaic acid fully restored the reduced phosphorylation of Ser  473  caused by  ceramide, consistent with the hypothesis that the effects of ceramide on Ser  473  phosphorylation were due to phosphatase activation. While these results cannot support a definitive conclusion, they are consistent with CAPP being the mediator of P K B dephosphorylation at Ser . 473  I also examined the effects phosphorylation.  of okadaic acid and calyculin A on T h r  308  Interestingly, I found that both compounds greatly reduced T h r  308  phosphorylation, suggesting that a dephosphorylation event is necessary for PDK-1 catalyzed T h r  308  phosphorylation. The reduction in T h r  308  phosphorylation by okadaic  acid coincided with reduced activity. Thus, my experiments have revealed an unexpected mechanism of regulation of T h r  308  phosphorylation.  This was surprising, given that  PDK1 is constitutively active. One possible mechanism is that an inhibitor protein of PDK1 exists which is activated by phosphorylation. Yet another possible mechanism of regulation is by phosphorylation of PDK1 itself, which has recently been reported (Casamayor et al., 1999). In addition, my findings that PDK1 -catalyzed Thr , but not 308  PDK2-catalyzed Ser  473  phosphorylation, is reduced by okadaic acid would argue that the  two enzymes are distinct. Some researchers have suggested that PDK2 is the integrinlinked kinase (Delcommenne et al., 1998), distinct from PDK1, and it will be interesting to see i f ceramide similarly reduces ILK-phosphorylated substrates through phosphatase activation. In conclusion, I have demonstrated the selective targeting of Ser  473  of P K B by a  ceramide-activated phosphatase and have conclusively shown that ceramide had no effect  106  on the  lipids generated following  activation of PI3K.  This  ceramide-mediated  dephosphorylation may have profound effects on the activities of other downstream targets of P K B , such as caspase-9, Forkhead transcription factors, and GSK-3. However, preliminary studies revealed that treatment of cells with C2- or C6-ceramide analogs had no effect on GSK-3 phosphorylation. In addition, work by Fujita and coworkers revealed that the P K B phosphorylation site found in human caspase-9 is absent in mouse caspase-9 suggesting that caspase-9 phosphorylation and inactivation by P K B may not be physiologically relevant (Fujita et al., 1999).  Thus, the most plausible candidate for  PKB-dependent survival appears to be the Forkhead family of transcription factors. Future studies should focus on the role of Forkhead mediated transcription during ceramide-induced apoptosis. Of  equal  significance, ceramide-activated  phosphatases may target other  phosphorylated proteins containing the conserved FXXF(S/T)(Y/F) motif corresponding to Ser  473  of P K B .  This carboxy-terminal phosphorylation motif is present in p70  (Thr  ) and in the atypical P K C ' s . PRK1/2 contain PDK-2 pseudosubstrate domains that  s6k  do not require phosphorylation for activation, and the activity of these kinases may be immune to ceramide treatment. Thus, the possible effect of ceramide on other protein kinases that may be regulated by modulation of the PDK2-substrate residue will have to be investigated.  107  6. O V E R A L L D I S C U S S I O N  6.1 Phosphorylation of Bcl-2 Family Members in Hemopoietic Cells Cytokines such as GM-CSF and IL-3 probably mediate survival by inhibiting components of the apoptotic machinery.  Direct phosphorylation of Bcl-2 family  members by kinases activated by G M - C S F or IL-3, as well as dephosphorylation by phosphatases, could represent an important part of this control. Several precedents exist in this regard. For example, the pro-apoptotic protein Bad is a downstream target of multiple kinases, possibly including P K B (Datta et a l , 1997a; del Peso et al., 1997), ERK-controlled Rsks (Scheid et al., 1999; Bonni et a l , 1999) and cAMP-activated P K A (Harada et al., 1999; Datta et al., 2000). Besides hemopoietic-specific cytokines, other growth factors, such as such as nerve growth factor and insulin-like growth factor-1 modulate Bad.  Phosphorylation of Bad neutralizes its ability to mediate apoptosis,  through a poorly understood mechanism (reviewed by Datta et al., 2000).  The  multiplicity of different survival pathways leading to Bad phosphorylation may represent a redundancy to ensure inactivation during signaling through PI3K, Ras-ERK or c A M P generation. Initially, I was interested in whether other Bcl-2 family members may undergo cytokine-stimulated phosphorylation, similar to Bad. Analysis of the primary sequence of Bax, Bak, and Bcl-x identified several potential serine/threonine phosphorylation sites L  (Table 1). In addition, Bcl-x contains a flexible loop domain, previously shown to be a L  site of phosphorylation in Bcl-2 (Chang et al., 1997). To test this possibility, I first established immunoprecipitation conditions for Bax, Bak and Bcl-x , as well as Bad, and L  108  then monitored their phosphorylation state using  P-orthophosphate-labelling. Although  Bad was clearly a target of GM-CSF-activated kinases, I did not detect changes in the phosphorylation level of the other family members examined. Thus, GM-CSF-mediated cell survival does not appear to involve changes in the phosphorylation state of Bax, Bak or BC1-XL.  These experiments revealed that endogenous Bad associates with endogenous Bclx under both starvation and stimulation conditions. This was the first study to observe L  Bcl-x -Bad association in vivo in untransfected cells, and contributed to a study we L  published identifying M E K as an upstream regulator of Bad phosphorylation (Scheid et al., 1999). I also attempted to identify which sites of Bad were phosphorylated when bound to Bcl-x , as this might give some insight into the mechanism that Bad inactivates L  BC1-XL. These efforts are ongoing. Although the phosphorylation of Bcl-x , Bax and Bak did not change with L  stimulation, an unexplored possibility was that cytokines might alter the relative expression levels of Bcl-2 homologous proteins. Therefore, the next focus of my research was to study cytokine-dependent, transcriptional and translational regulation of various Bcl-2 family members.  6.2 A n a l y s i s o f B c l - 2 f a m i l y E x p r e s s i o n i n M u r i n e a n d H u m a n H e m o p o i e t i c C e l l s  RNA-protection assays were initially performed with R N A isolated from the murine factor-dependent cell line MC/9. I began my studies by isolating R N A from cells that were deprived of cytokine for 16 hours, conditions that have previously been shown to induce apoptosis in M C / 9 cells (Scheid and Duronio, 1998). Using a multi-probe  109  template set, mRNAs corresponding Bcl-2, Bcl-w, BCI-XL, Bax, Bak and Bad were detected. During restimulation with cytokine, only Bcl-x  L  mRNA levels increased  substantially. Other family members, such as Bak, Bax and Bad did not change significantly over time. This suggests that survival factors such as IL-3 and GM-CSF may activate signaling pathways that function to increase or sustain Bcl-x mRNA. levels; L  for example, Dumon and colleagues (1999) have shown that cytokines can stimulate BclXL transcription via a Jak2-dependent  mechanism. In addition, some studies have  demonstrated a rapid increase in Bcl-x mRNA in response to other survival hormones L  and growth factors (Sui et al., 2000; Puthier et al., 1999). Interestingly, when protein levels were subsequently determined by immunoblot analysis, little or no change in Bclx protein was observed over the same time course. It may be that a small amount of L  mRNA is sufficient to sustain BCI-XL protein levels; conversely BCI-XL may have a long half-life. Previous studies from our lab (Scheid et al., 1995) have shown that MC/9 cells begin to undergo apoptosis during the time points examined therefore it is unlikely that changes in BCI-XL protein are responsible for the cytoprotective effects of GM-CSF or IL3.  6.3. GM-CSF selectively regulates Mcl-1 expression The expression of Bcl-2 family mRNA in human cell lines was also examined. In the factor-dependent cell line TF-1, mRNAs corresponding to Bcl-x , Bcl-x , Bik, Bak, s  L  Bax and Mcl-1 were present. Similar to my findings in MC/9 cells, Bcl-x mRNA was L  upregulated by cytokine stimulation or decreased during cytokine withdrawal. Moreover,  110  like the M C / 9 cells, Bcl-x protein levels did not change significantly under these L  conditions. Expression of another Bcl-2 family member, Mcl-1, was also examined in TF-1 cells. Mcl-1 is a pro-survival factor originally identified based on its upregulation in a human myeoblastic leukemia cell line that was induced to differentiate along the monocyte/macrophage pathway (Kozopas et al., 1993). While the exact role of Mcl-1 in differentiation is unknown, Mcl-1 can act as a survival factor in multiple hemopoietic cell types both in tissue culture (Zhou et al., 1997) and when expressed in transgenic mice (Zhou et al., 1998).  Recent work by Korsmeyer and coworkers showed that Mcl-1  knockout is embryonic lethal suggesting that in addition to its pro-survival function, M c l 1 plays a critical role in embryonic development.  TF-1 cells were incubated in the  presence of GM-CSF and the mRNA and protein level of Mcl-1 were examined. G M CSF stimulation causes an increase in Mcl-1 mRNA and protein levels, suggesting that GM-CSF may mediate survival through the up-regulation of pro-survival factors such as Mcl-1. Thus of all the Bcl-2 family members tested, Mcl-1 is unique in that its mRNA and protein levels are markedly affected by GM-CSF stimulation. The mechanism by which Mcl-1 exerts its antiapoptotic influence is at present unclear.  Several reports suggest that under apoptosis-inducing conditions, the pro-  apoptotic protein Bax undergoes homodimerization to promote apoptosis, whereas the pro-survival factor Bcl-2 forms Bcl-2:Bax heterodimers to suppress apoptosis and promote cell survival. Work by Wang and colleagues (1998) suggest that Mcl-1 can also heterodimerize with Bax to enhance cell viability in hematopoietic FDC-P1 cells. Thus, GM-CSF-induced upregulation of Mcl-1 protein may promote cell survival through an  111  increase in Mcl-1 :Bax heterodimers. Through the use of cross-linking reagents, future studies can attempt to address this issue further.  It should also be noted that several  studies have reported that dimerization among the Bcl-2 family members is a detergentinduced phenomenon and therefore may not be physiologically relevant (Hsu and Youle 1998).  6.4. R o l e of M E K i n M c l - 1 T r a n s c r i p t i o n  I next wanted to understand the signaling pathways that impact on Mcl-1 transcription and translation. Ligand-conjugated GM-CSF receptor activates a number of well-studied signaling pathways including Ras and its downstream targets. Research studies over the past several years have implicated Ras, and some of its downstream effectors, including Raf, in anti-apoptotic signaling.  For example, Kinoshita and  coworkers (1995) have demonstrated regulation of Bcl-2 expression by a Ras/Raf pathway in hematopoietic cells. In addition, work from our lab has recently revealed that phosphorylation of Bad on Ser-112 occurs by a MEK-dependent mechanism, and this phosphorylation regulates its binding with BCI-XL. Activation of Ras, leading to ERK1 and ERK2 activation, is associated with increased immediate-early gene expression.  Research by several groups  has  demonstrated ERK-dependent regulation of E l k l and camp response element (CRE) binding protein (CREB) transcription factors (Vanhoutte et al., 1999; Davis et al., 2000). For example, following activation, E R K undergoes translocation to the nucleus where it can directly phosphorylate and activate Elk-1. Once activated, Elk-1 can bind to serum response elements (SRE) located in the promoter regions of immediate early genes, such  112  as the c-fos transcription factor and cyclin D l (Lavoie et al., 1996). In addition, activated E R K can directly phosphorylate and activate p90 . ERK-dependent p90 rsk  rsk  activity has  been shown to phosphorylate C R E B resulting in the binding of C R E B to C R E elements in the promoter of c-fos and other immediate-early genes (Xing et al., 1996). p90  rsk  can  directly phosphorylate c-fos resulting in an increase in c-fos transcriptional activity (Bruning et al., 2000). Recent work by Wang and colleagues has shown the presence of a CRE-2 binding motif in the Mcl-1 promoter region and has demonstrated that IL-3 dependent stimulation of the Mcl-1 gene requires a CREB-like protein (Wang et al., 1999). In addition to a CRE-2 site, the Mcl-1 promoter also contains a sis-inducible element (SIE) very similar to the SIE binding motif found in the c-fos gene promoter (Wagner et al., 1990; Rajotte et al., 1996).  Thus in TF-1 cells, cytokine-stimulated  activation of the E R K pathway can lead to the activation of various immediate-early transcription factors necessary for Mcl-1 gene transcription. To determine i f E R K was required for GM-CSF-stimulated increase in Mcl-1 protein, two specific M E K inhibitors were employed. U0126 and PD-98059 block the activation of the ERKs by GM-CSF. I found that inhibition of M E K with U0126 or PD98059 significantly inhibited GM-CSF-induced increase in Mcl-1 mRNA. To assess the role of E R K in Mcl-1 protein translation, cells were again treated with the M E K inhibitors U0126 or PD98059 in the presence of GM-CSF.  As expected, the M E K  inhibitors blocked the GM-CSF-induced elevation of Mcl-1 protein. This was consistent with the effects of M E K inhibition on reduced transcriptional upregulation of Mcl-1 mRNA in response to GM-CSF. Thus GM-CSF-mediated cell survival may involve the  113  upregulation of death antagonists, such as Mcl-1, as well as the post-translational modification and inhibition of death effectors, like Bad.  6.5. Role of PI3K in Mcl-1 Translation In keeping with the finding that E R K regulates GM-CSF-induced Mcl-1 transcription, I wanted to know i f this pathway and/or a PI3K-controlled pathway regulates Mcl-1 protein translation.  Although I had determined that inhibition of the  parallel, PI3K-PKB pathway had no effect on Mcl-1 mRNA, I wanted to know i f this pathway might still be important for Mcl-1 protein expression in response to GM-CSF stimulation. To determine the role of PI3K in cytokine-stimulated Mcl-1 regulation, the PI3K pathway was selectively blocked with wortmannin or LY-294002, which had no effect on the E R K pathway. Addition of the PI3K inhibitors wortmannin or LY-294002 inhibited GM-CSF-induced upregulation of Mcl-1 protein.  Thus, these experiments  define separate pathways that impact on Mcl-1 expression; (1) a MEK-dependent pathway involved in transcriptional regulation, and (2) a PI3K-controlled pathway involved in translational regulation or enhanced  protein stability.  Pulse-chase  experiments would argue against an effect of PI3K on increasing Mcl-1 stability, and thus I conclude that PI3K regulates the translation of Mcl-1. There are indications that PI3K and its downstream target P K B may be centrally involved in translational control. Recent work by several groups suggest that P K B may be involved in regulating protein synthesis by phosphorylation of the mRNA cap protein, eIF4B, as well as its inhibitory binding protein, 4EBP1 (Khaleghpour et al., 1999; Takata et al., 1999). Thus, GM-CSF-induced PI3K activity may lead to PKB-dependent  114  phosphorylation events required for the initiation of Mcl-1 protein synthesis. There are no pharmacological inhibitors of P K B , however, experiments are currently underway to introduce a conditionally active form of P K B into TF-1 cells in order to test the hypothesis that a PI3K-PKB-dependent pathway leads to GM-CSF-induced Mcl-1 upregulation. Additional PI3K-dependent pathways that may be involved in Mcl-1 translation include serum- and glucocorticoid-regulated kinase (SGK; Park et al., 1999), P K C isoforms, Bruton's tyrosine kinase (BTK), PDK1, and Vav (review by Toker, 2000). For example, PDK1 has been shown to phosphorylate and activate p70  s6k  (Pullen et al., 1998;  Alessi et al., 1997) in a PI3K-dependent manner (Balendran et al., 1999) and P K C has been shown to regulate the translation of the upstream stimulating factor-2 (USF2). USF2 is a transcription factor thought to have an important role in the proliferation of hematopoietic cells through its regulation of various cyclins and p53 (Zhang et al., 1998). The results presented in Chapter 4 conflict with published accounts of PI3K-PKB dependent transcriptional regulation of Mcl-1. PI3K  mutants and PI3K  Through the use of dominant negative  inhibitors, Wang and coworkers  (1999)  demonstrate  transcriptional upregulation of Mcl-1 mRNA in the IL-3 dependent cell line, BAF/3. One obvious difference between the Wang study and my results is the difference in cell lines studied.  Recent reports by Welham and coworkers (1999) have demonstrated PI3K-  independent wortmannin-sensitive E R K activity in BAF/3 cells. Further, the Karnitz group (1995, 1999) has shown that overexpression of dominant negative p85 can block IL-3 induced E R K activation in FDC-P1 cells. The Wang group did not address the effect of blocking PI3K on E R K activation nor did they examine the role of E R K activity  115  in regulating Mcl-1 transcription.  Thus the PI3K-PKB-mediated effects on Mcl-1  transcription observed by Wang and colleagues may be due to an inhibition of E R K activity and not necessarily a decrease in PI3K-PKB signaling. In the TF-1 cell line that I used, inhibiting PI3K activity had no effect on E R K activation. support a role for PI3K in translational regulation of Mcl-1  Together my results  and a role for E R K in the  transcriptional regulation of Mcl-1. The Wang study suggests that Mcl-1 transcription requires a CREB-like binding protein and indicate that a PI3K-PKB dependent pathway phosphorylation of C R E B Ser . MEK-dependent p90 133  result in phosphorylation of C R E B Ser  may be leading to  activity has also been shown to  rsk  in response to cytokine stimulation (Xing et a l ,  133  1996), thus I would argue that in the TF-1 hematopoietic cell line, C R E B transcriptional regulation of Mcl-1  gene may be occurring via a ERK-dependent and not a PI3K-  controlled pathway. Alternatively, Mcl-1 transcription could be regulated by other ERKdependent transcription factors as discussed in section 6.3.  6.6. SHIP as a regulator of BCI-XL The effects of PI3K inhibition on BCI-XL mRNA transcription were interesting, and suggested that PI3K and its downstream target PKB may play a role in Bcl-x protein L  expression. Although I could not detect changes in Bcl-x in MC/9 cells during treatment L  with PI3K inhibitors, it may be that chronic suppression of PI3K-derived signals was necessary to modulate BCI-XL protein. The SH2-containing inositol 5' phosphatase SHIP, functions as a key regulator of PI(3,4,5)P and PI(3,4)P levels in hematopoietic cells (Liu 3  2  et al., 1999). Liu and coworkers (1999) have shown that bone marrow-derived mast cells  116  from SHIP"" are resistant to cell death induced by a variety of apoptotic-stimuli including growth factor-withdrawal. To determine the role of SHIP in the regulation of apoptosis, the mRNA and protein levels of various Bcl-2 family members were analyzed in SHIP knockout cells. The mRNA levels of several Bcl-2 family members were found to be present in equal amounts in both S H I P  +/+  and SHIP " cells. Surprisingly, BC1-XL protein 7  levels were greatly elevated in SHIP " cells, suggesting that in B M M C SHIP may 7  negatively regulate BC1-XL expression. The PI3K-generated molecular  switches  to  phospholipids PI(3,4)P  regulate  the  activity  and  2  of  PI(3,4,5)P  downstream  3  function  as  serine/threonine  phosphorylation cascades in response to growth factor stimulation. For example, both PI(3,4)P2 and PI(3,4,5)P3 have been shown to regulate the activities and localization of PDK1, PKB and Btk in response to cytokine stimulation (review by Toker, 2000). Work by L i u and colleagues (1999) has revealed that SHIP " mice have elevated levels of 7  PI(3,4,5)P3 and PKB activity. Thus one way that SHIP may regulate Bcl-x is through L  downregulation of PI(3,4,5)P3 signaling pathways, possibly involving enzymes such as PDK1 and P K B . Recent work by Jones and coworkers (2000) supports the idea of a PI3K-PKBcontrolled pathway regulating BC1-XL protein levels.  The Jones group used T  lymphocytes overexpressing v-PKB to show that a PKB-dependent pathway regulates Bcl-x  L  expression at the translational level.  In contrast, research by Packham and  coworkers (1998) has demonstrated the selective regulation of BC1-XL protein levels by a PI3K-independent, Jak2-dependent  pathway.  117  The contradictory findings may be  explained by the fact that the Packham group utilized 32D.3-derived transfectants whereas my studies and those of Jones and coworkers were performed with primary cells. Continuing studies will involve treating SHIP" " bone marrow derived mast cells 7  with the PI3K inhibitors LY-294002 or wortmannin to see i f PI3K inhibition reduces the amount of BCI-XL protein back to wild type levels.  Another approach would be to  retrovirally introduce kinase-dead mutants of PDK1 or P K B and see if these also interfere with BCI-XL upregulation in SHIP " mice. The generation of PI3K knockout mice would 7  help to define a role for PI3K in BCI-XL regulation. Finally, one might predict that cells derived from PTEN-deficient mice might also display elevated BCI-XL protein since PTEN acts similarly to SHIP in elevating PI(3,4,5)P and P K B activity (Stambolic et al., 3  1998).  6.7. Ceramide negatively regulates Mcl-1 protein translation  Apoptotic signaling mediated by ceramide can occur by several mechanisms.  different  Recent work suggests that ceramide may induce apoptosis by activating  pro-death pathways such as the stress-activated protein kinase c-Jun N-terminal kinase signaling cascade (Verheij et al. 1996; Wang et al., 1999; Bourbon et al., 2000) and by promoting dephosphorylation of the pro-survival protein Bcl-2 (Ruvolo et al., 1999) and the pro-apoptotic protein Bad (Basu et al., 1998).  Ceramide may also augment the  execution of apoptosis by the inactivation of pro-survival pathways.  Recently, several  reports have supported this notion by demonstrating negative regulation of ceramide on the PI3K signaling pathway (Zundel and Giaccia et al., 1998).  118  To investigate the possibility that ceramide may decrease anti-apoptotic signaling by inhibiting GM-CSF-induced PI3K-dependent Mcl-1 upregulation, cells were treated with cell permeable ceramide analogs, and stimulated with GM-CSF. It was found that ceramide could inhibit GM-CSF-induced increase in Mcl-1 at the translational level, while having no effect on Mcl-1 transcription. Other Bcl-2 family members were also examined (Bcl-x , Bak and Bax) and were unaffected by ceramide treatment. L  These  results suggest that ceramide-mediated apoptosis may involve the downregulation of M c l 1 via a PI3K-dependent pathway in hematopoietic cells.  6.8. C e r a m i d e inhibits P K B by p r o m o t i n g dephosphorylation of S e r  4 7 3  Relatively little is known about the way in which ceramide acts upon signaling pathways. Zundel and Giaccia (1998) reported that ceramide specifically inhibits PI3K, which in turn results in the loss of P K B activation, a regulatory target of PI3K activity. Two other reports also demonstrated the negative effects of ceramide on P K B activation (Basu et al., 1998; Zhou et a l , 1998; Summers et al., 1998); however, they suggest that ceramide-mediated P K B inhibition occurs via a PI3K-independent pathway.  Here I  provide biochemical evidence that ceramide regulates P K B activity not through PI3K modulation, but rather by selectively accelerating P K B S e r  473  dephosphorylation, a residue  critical for maximal P K B activation. This reduction in phosphorylation could be restored by pretreatment of cells with okadaic acid or calyculin A , two potent phosphatase inhibitors.  This study suggests that 3-phosphoinositide-dependent  kinase (PDK)-2-  targeted phosphorylation of P K B may be a target of a ceramide-activated phosphatase.  119  The reduction of P K B phosphorylation at Ser  and the parallel decrease in  activity caused by ceramide may be significant contributors to ceramide-mediated apoptosis (Schubert et al., 2000). At present, the mechanism by which P K B protects against apoptosis is not fully understood. Some groups have identified Bad as a target of P K B phosphorylation (Datta et al., 1997a; Blume-Jensen et al., 1998; del Paso et al., 1997) supporting the theory that ceramide induces apoptosis by inhibiting PKB-mediated Bad phosphorylation. However, we (1998) and others (Hinton and Welham, 1999) have provided examples in which one can dissociate endogenous Bad phosphorylation from endogenous P K B activation and PI3K-dependent survival. With respect to P K B inactivation, ceramide may disrupt the ability of P K B to prevent apoptosis by phosphorylating transcription factors. In Caenorhabditis elegans, genetic experiments have ordered signaling through the insulin-like receptor Daf-2 to Age-1 (PI3K homologue), Pdk-1 and A K T activation, with Daf-16 phosphorylation, which promotes longevity and prevents developmental arrest at the dauer stage (Paradis et a l , 1998). Null mutations in the pdk-1 gene cause constitutive arrest in the dauer stage, whereas activating mutations rescues null mutations of daf-2 or age-1. Daf-16 is the C. elegans homologue of the mammalian Forkhead transcription factor.  Several groups  have shown P K B phosphorylation of Forkhead members in mammalian cells (Brunet et al., 1999; Kops et al., 1999; Rena et al., 1999; Tang et al., 1999). Phosphorylation of Forkhead by P K B stimulates its export from the nucleus.  This may prevent the  transcription of pro-apoptotic proteins, including the Fas ligand. Thus, ceramide may prevent nuclear export of Forkhead transcription factors by reducing P K B activation. Further, as discussed above, P K B inactivation may prevent the initiation of protein  120  synthesis of pro-survival factors, such as Mcl-1. It will be interesting to see i f Mcl-1 is regulated via a P K B controlled signaling pathway in hematopoietic cells.  6 . 9 . Summary My studies of the regulation of Bcl-2 family members have revealed distinct roles for the PI3K and E R K pathways in regulating the pro-survival factor, Mcl-1.  I have  found that while E R K activity is required for regulation of Mcl-1 gene expression, there is a need for PI3K activity in regulation of protein expression. I provide evidence that ceramide may promote apoptosis by inhibiting cytokine-stimulated Mcl-1 protein synthesis. In addition, these studies reveal that ceramide may inhibit cell survival through the down-regulation of P K B activity via a ceramide-activated protein phosphatase. Finally, the experiments presented here indicate that BC1-XL protein levels may be negatively regulated by the src homology 2 (SH2)-containing inositol 5' phosphatase, SHIP.  121  7. B I B L I O G R A P H Y  Abraham, R.T. (1998). Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr. Opin. Immun., 330-336 Adam-Klages, S., Ada, D., Wiegmann, K., Struve, S., Kolanus, W., Schneider-Mergener, J., and Kronke, M . (1996). F A N , a novel WD-repeat protein, couples the p55 TNFreceptor to neutral sphingomyelinase. Cell, 86, 937-947. Adams, J.M., and Cory, S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science, 281, 1322-1326. Ahmed, N . N . , Franke, T.F., Bellacosa, A., Datta, K . , Maria-Eugunia, G.P., Taguchi, T., Testa, J.R., and Tschlis, P.N. (1993). The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene, 8, 1957-1963. Alberti, S. (1998). A phosphoinositide-binding sequence is shared by P H domain target molecules-a model for the binding of P H domains to proteins. Proteins, 31, 1-9. Alessi, D.R. and Cohen, P. (1998a). Mechanism of activation and function of protein kinase B. Curr. Opin. Gen..Dev., 8, 55-62. Alessi, D.R., Kozolwski, M.T., Weng, Q.P., Morrice, N . , and Avruch, J. (1998b). 3phosphoinositide dependent protein kinase 1 (PDK1) phosphorylates and activates the p70S6 kinase in vivo and in vitro. Curr. Biol, 8, 69-81. Alessi, D.R., Deak, M . , Casamayor, A . , Caudwell, F.B., Morrice, N . , Norman, D.G., Gaffney, P., Reese, C.B., MacDougall, C.N., Harbison, D., Asworth, A., and Bownes, M . (1997a). 3-phosphoinositide-dependent protein kinase-1 (PDK-1): structural and functional homology with Drosophila DSTPK61 kinase. Curr. Biol, 7, 776-789 Alessi, D.R., James, S.R., Downes, C P . , Holmes, A . B . , Gaffney, P.R.J., Reese, C.B., and Cohen, P. (1997b). Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Boc. Curr. Biol, 7, 261-269. Alessi, D.R., Andjelkovic, M . , Caudewell, B., Cron, P., Morrice, N . , Cohen, P., and Hemmings, B.A. (1996a). Mechanism of activation of protein kinase B by insulin and IGF-1. EMBOJ., 15, 6541-6551. Alessi, D.R., Caudwell, F.B., Andjelkovic, M . , Hemmings, B.A. and Cohen, P. (1996b). Molecular basis for the substrate specificity of protein kinase B : comparison with M A P K A P kinase-1 and p70s6 kinase. FEBS Lett., 399, 333-338.  122  Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T., and Saltiel, A.R. (1995). PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270, 27489-24795.  Andjelkovic, M . , Alessi, D.R., Meier, R., Fernandez, A., Lamb, N.J.C., Freeh, M . , Cron, P., Cohen, P., Lucocq, M . , and Hemmings B.A. (1997). Role of translocation in the activation and function of protein kinase B . J. Biol. Chem., 272, 31515-31524. Andjelkovic, M . , Jakubowicz, T., Cron, P., Ming, X.F., Han, J.W., and Hemmings, B.A. (1996). Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. U.S.A., 93, 5699-5704.  Andreotti, A . H . , Bunnell, S.C., Feng, S., Berg, L.J., and Schreiber, S.L. (1997). Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature, 385, 93-97. Antonsson, B., Conti, F., Ciavatta, A . , Montessuit, S., Lewis, S., Martinou, L . , Bernasconi, L . , Bernard, A . , Mermod, J.J., Mazzei, G., et al., 1997. Inhibition of Bax channel-forming activity by Bcl-2. Science. 277, 370-372. Bae, J., Leo, C P . , Hsu, S.Y., and Hsueh, A.J. (2000). MCL-1 S, a splicing variant of the antiapoptotic BCL-2 family member M C L - 1 , encodes a proapoptotic protein possessing only the BH3 domain. J. Biol. Chem., 275, 25255-25261. Bajjalieh, S.M., Martin, T.F.J., and Floor, E. (1989). Synaptic vesicle ceramide kinase. A calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles. J. Biol. Chem., 264, 14354-14360. Bakhshi A . , Jensen, J.P., Goldman, P., Wright, J.J., McBride, O.W., Epstein, A . L . Korsmeyer, S.J. (1985). Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around J H on chromosome 14 and near a transcriptional unit on 18. Cell, 41, 899-906. Balendran, A . , Currie, R., Armstrong, C.G., Avruch, J., and Alessi, D.R. (1999). Evidence That 3-Phosphoinositide-dependent Protein Kinase-1 Mediates Phosphorylation of p70 S6 Kinase in Vivo at Thr-412 as well as Thr-252. J. Biol. Chem,. 274, 3740037406. Balendran, A., Casamayor, A., Deak, M . , Paterson, A . , Gaffney, P., Currie, R., Downes, C P . , and Alessi, D.R. (1991). PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol, 9, 393-404.  123  Ballou, L.R., Barker, S.C., Postlethwaite, A . E . and Kang, A . H . (1990). Sphingosine potentiates IL-1-mediated prostaglandin E2 production in human fibroblasts. J Immunol, 145,4245-4251. Basu, S., Bayoumy, S., Zhang, Y., Lozano, J., and Kolesnick, R. (1998). B A D enables ceramide to signal apoptosis via Ras and Raf-1. J. Biol. Chem., 273, 30419-30426. Bazan, J.F. (1990). Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. U.S.A., 87, 6934-6938. Bellacosa, A . , Chan, T.O., Ahmed, N . N . , Datta, K . , Malstrom, S., Stokoe, D., McCormick, F., Feng, J., and Tsichlis, P. (1998). Akt activation by growth factors is a multiple-step process: The role of the P H domain. Oncogene, 17,313-325. Bellacosa, A . , Franke, T.F., Gonzalez-Portal, M.E., Datta, K . , Taguchi, T., Gardner, J., Cheng, J.Q., Testa, J.R., and Tsichlis, P.N. (1993). Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications. Oncogene, 8, 745-754. Bellacosa, A., Testa, J.R., Staal, S.P., and Tsichlis, P.N. (1991). A retroviral oncogene Akt, encoding a serine-threonine kinase containing an SH2-like region. Science, 274277. Berra, E., Diaz-Meco, M.T., and Moscat, J. (1998). The activation of p38 and apoptosis by inhibition of erk is antagonized by the phosphoinositide 3-kinase/akt pathway. J. Biol. Chem., 273, 10792-10797. Bertolaso, L., Gibellini, D., Secchiero, P., Previati, M . , Falgione, D., Visani, G., Rizzoli, R., Capitani, S., and Zauli, G. (1998). Br. J. Haematol., 100, 541-549. Bingle, C D . , Craig, R.W., Swales, B . M . , Singleton, V . , Zhou, P., and Whyte, M . K . (2000). Nucleotide Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death. J. Biol. Chem., 275, 22136-22146. Blair, L . A . C , Bence-Hanulec, K . K . ; Metha, S., Franke, T., Kaplan, D., and Marshall, J. (1999). Akt-dependent potentiation of L channels by insulin-like growth factor-1 is required by neuronal survival. J. Neurosci, 19,1940-1951. Blankenberg, F., Narula, J., and Strauss, H.W. (1999). In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure. J. Nucl. Cardiol, 6, 531-9. Review. Blenis, J. (1993). Signal transduction via the M A P kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. U. S. A., 90, 5889-5892.  124  Blom, N . , Gammeltoft, S., and Brunak, S. (1999). Sequence- and Structure-Based Prediction of Eukaryotic Protein Phosphorylation Sites. J. Mol. Biol., 294, 1351-1362. Blomberg, N . , Baraldi, E., Nilges, M . , Saraste, M . (1999). The P H superfold: a structural scaffold for multiple functions. Trends Biochem. Sci., 24, 441-445. Blume-Jensen, P., Janknecht, R., and Hunter, T. (1998). The kit receptor promotes cell survival via activation of PI3-kinase and subsequent AKT-mediated phosphorylation of Bad on Serl36. Curr. Biol, 8, 779-782. Boldin, M . , Goncharov, T., Goltsev, Y . , and Wallach, D. (1996). Involvement of M A C H , a novel MORTl/FADD-interacting protease, in Fas/APO-1 and TNF receptorinduced cell death. Cell, 85, 803-816. Bonni, A . , Brunet, A . , West, A.E., Datta, S.R., Takasu, M . A . , and Greenberg, M . E . (1999). Cell survival promoted by the Ras-MAPK signaling pathway by transcriptiondependent and-independent mechanisms. Science, 286, 1358-1362. Bonser, R.W., Thompson, N.T., Randall, R.W., Tateson, J.E., Spacey, G.D., Hodson, H.F., and Garland, L.G. (1991). Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil. Br. J .Pharmacol., 103, 1237-41. Borkhardt, A . , Repp, R., Haas, O.A., Leis, T., Harbott, J., kreuder, J., Hammermann, J., Henn, T., and Lampert, F. (1997). Cloning and characterization of A F X , the gene that fuses to M L L in acute leukemias with a t(X;l I)(ql3;q23). Oncogene, 14, 195-202. Borner, C , Martinou, I., Mattmann, C , Irmler, M . , Schaerer, E., Martinou, J.C., and Tschopp, J . (1994). The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis. J. Cell. Biol, 126, 1059-1068. Bose, R., Verheij, M . , Haimovitz-Friedman, A., Scotto, K., Fukus, Z., and Kolesnick, R. (1995). Ceramide synthase mediates daunorubicin-induced apoptosis: A n alternative mechanism for generating death signals. Cell, 82, 405-414. Boulton, T.G., Nye, S.H., Robbins, D.J., Ip, N . Y . , Radziejewska, E., Morgenbesser, S.D., DePinho, R.A., Panayotatos, N . , Cobb, M . H . , and Yancopoulos, G.D. (1991). ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell, 65, 633-675. Bourbon, N . A., Yun, J., and Kester, M . (in press). Ceramide directly activates P K C zeta to regulate a stress-activated protein kinase signaling complex. J. Biol. Chem. [pub ahead if print]  125  Bradshaw, C , Ella, K., Thomas, A., Qi, C , and Meier, K . (1996). Effects of Ara-C on neutral sphingomyelinase and mitogen- and stress-activated protein kinases in Tlymphocyte cell lines. Biochem. Mol. Biol. Int., 40, 709-719. Brenner, B., Ferlinz, K . , Grassme, H . , Weller, M . , Koppenhoefer, U . , Dichgans, J., Sandhoff, K . , Lang, F., and Gulbins, E. (1998). Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases. Cell Death Differ., 5, 29-37. Brenner, B., Koppenhoefer, U., Weinstock, C., Linderkamp, O., Lang, F., and Gulbins, E. (1997). Fas- or Ceramide-induced Apoptosis Is Mediated by a Racl-regulated Activation of Jun N-terminal Kinase/p38 Kinases and GADD153. J. Biol. Chem., 272, 2217322181. Brott, B.K., A.essandrini, A., Largaespada, D.A., Copeland, N.G., Jenkins, N.A., Crews, C M . , and Erikson, R.L. (1993). M E K 2 is a kinase related to M E K 1 and is differentially expressed in murine tissues. Cell Growth Differ., 4, 921-929. Brown, C.B., Pihl., C.E., Murray, E.W. (1997). Oligomerization of the soluble granulocyte-macrophage colony-stimulating factor receptor: identification of the functional ligand-binding species. Cytokine, 9, 219-225. Brunet, A . , Bonni, A . , Zigmond, M.J., Lin, M.Z., Juo, P., Hu, L.S., Anderson, M.J., Arden, K . C , Blenis, J., and Greenberg, M . E . (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96, 857-868. Bruning, J . C , Gillette, J.A., Zhao, Y . , Bjorbaeck, C , Kotzka, J., Knebel, B., Avci, H . , Hanstein, B., Lingohr, P., Moller, D.E., Krone, W., Kahn, C.R., and Muller-Wieland, D. (2000). Ribosomal subunit kinase-2 is required for growth factor-stimulated transcription of the c-Fos gene. Proc. Natl. Acad. Sci. U. S. A., 97, 2462-2467. Brunn, G.J., Williams, J., Sabers, C , Wiederrecht, G., Lawrence, J . C , and Abraham, R.T. (1996). Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBOJ., 15, 5256-5267. Bruno, A.P., Laurent, G., Averback, D., Demur, C , Bonnet, J., Bettaieb, A., Levade, T., and Jaffrezou, J.P. (1998). Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death Diff, 5, 172-182. Burgering, B.M.T., and Coffer, P.J. (1995). Protein kinase B (c-Akt) in phosphatidylinositol 3-OH kinase signal-transduction. Nature, 376, 599-602. Butterfield, L., Storey, B., Maas, L., and Heasley, L. (1997). c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J. Biol. Chem., 212, 10110-10116. '  126  Cardone, M . H . , Roy, N . , Stennicke, H.R., Salvensen, G.S., Franke, T.F., Stanbridge, E., Frisch, S., and Reed, J.C. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-1321. Carpenter, C.L., and Cantley, L.C. (1996). Phosphoinositide 3-kinase and the regulation of cell growth. Biochim. Biophys. Acta., 1288, 11-16. Casamayor, A., Morrice, N . A . , and Alessi, D.R. (1999). Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem. J., 342, 287-292. Castedo, M . , Hirsch, T., Susin, S.A., Zamzami, N . , Marchetti, P., Macho, A . , and Kroemer, G. (1996). Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J. Immunol, 157, 512-521. Chang, B.S., Minn, A.J., Muchmore, S.W., Fesik, S.W., and Thompson, C B . (1997). Identification of a novel regulatory domain in Bcl-x and Bcl-2. EMBO J., 16, 968-977. L  Chao, D.T., and Korsmeyer, S.J. (1998). BCL-2 family: regulators of cell death. Annu. Rev. Immunol, 16, 395-419. Chao, J-R., Wang, J-M., Lee, S-F., Peng, H-W., Lin, Y - H . , Chou, C-H., L i , J - C , Huang, H - M . , Chou, C-K., Kuo, M-L., Yen, J. J-Y., and Yang-Yen, H-F. (1998). mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response. Mol. Cell. Biol,  18,4883-4898.  Charest, D.L., Mordret, G., Harder, K.W., Jirik, F., and Pelech, S.L. (1993). Molecular cloning, Expression, and characterization of the human mitogen-activated protein kinase p44erkl. Mol. Cell. Biol, 13,4697-4690. Cheatham, B., Vlahos, C.J., Cheatham, L., Wang, L., Blenis, J., and Kahn, C R . (1994). Phosphatidylinositol 3-kinase activation is required for insulin stimulation of p70S6 kinase, D N A synthesis, and glucose transporter translocation. Mol. Cell. Biol, 14, 49024911. Chen, R.-H., Su, Y . - H . , Chuang, R . L . C , and Chang, T.-Y. (1998). Suppression of transforming growth factor beta-induced apoptosis through a phosphatidylinositol 3kinase/Akt-dependent pathway. Oncogene, 17, 1959-1968. Cheng, A . , Ma, Y . , Moore, M . , Hemmings, B . A . , and Taylor, S.S. (1998). Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositidedependent protein kinase. Proc. Natl. Acad. Sci. U.S.A., 95, 9849-9854.  127  Chittenden, T., Flemington, C , Houghton, A . B . , Ebb, R.G., Gallo, G.J., Elangovan, B., Chinnadurai,G., and Luts, R.J. (1995a). A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBOJ., 14, 5589-5596. Chittenden, T., Harrington, E.A., O'Connor, R., Flemington, C , Lutz, R.J., Evan, G.I., and Guild, B.C. (1995b). Induction of apoptosis by the Bcl-2 homologue Bak. Nature, 374, 733-736. Chmura, S., Mauceri, H., advani, S., Heimann, R., Beckett, M . , Nodzenski, E., Quintans, J., Kufe, D., and Weichselbaum, R. (1997). Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation. Cancer Res., 57, 4340-4347. Chmura, S.J., Nodzenski, E., Crane, M . A . , Virudachalam, S., Hallahan, D.E., Weichselbaum, R.R., and Quintans, J. (1996). Cross-talk between ceramide and P K C activity in the control of apoptosis in WEHI-231. Adv. Exp. Med. Biol., 406, 39-55. Chung, J., Grammer, T.C., Lemon, K.P., Kazlauskas, A., and Blenis, J. (1994). PDGFand insulin-dependent p70S6K activation mediated by phosphatidylinositol 3-OH kinase. Nature, 370, 71-75. Cifone, M.G., Roncaioli, P., De Maria, R., Camarda, G . M . , Santoni, A., Ruberti, G., and Tseti, R. (1995). Multiple pathways originate at the Fas/APO-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J., 14, 5859-5868. Cifuentes, M.E., Honkanen, L., and Rebechi, M . J . (1993). Proteolytic fragments of phosphoinositide-specific phospholipase C-8i: catalytic and membrane binding properties. J. Biol. Chem., 268, 11586-11593. Clark-Lewis, I., Sanghera, J.S., and Pelech, S.L. (1991). Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase. J. Biol. Chem., 266, 15180-15184. Cleary, M . L . and Sklar, J. (1995). Nucleotide sequence of a t(14:18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. U.S.A., 82, 7439-7443. Clem R.J., Cheng, E.H., Karp, C.L., Kirsch, D.G., Ueno, K . , Takahashi, A . , Kastan, M.B., Griffin, D.E., Earnshaw, W.C., Veliuona, M . A . , and Hardwick, J . M . (1998). Modulation of cell death by B c l - X L through caspase interaction. Proc. Natl. Acad. Sci. U.S.A., 95, 554-559  128  Coffer, P.J., and Woodgett, J.R. (1991). Molecular-cloning and characterization of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur. J. Biochem., 201, 475-481. Cohen, P.S., Letterio, J.J., Gaetano, C , Chan, J., Matsumoto, K . , Sporn M.B., and Thiele, C.J. (1995). Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cancer Res., 55, 2380-2386. Conradt, B., and Horvitz, H . (1998). The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell, 93, 519529. Coroneos, E., Wan, Y . , Panuska, J.R., Templeton, D.J., and Kester, M . (1996). Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. Biochem. J., 316, 13-17 Craddock, B.L., Orchiston, E.A., Hinton, H.J., and Welham, M.J. (1999). Dissociation of apoptosis from proliferation, protein kinase B activation, and B A D phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling. J. Biol. Chem., 274, 1063310640. Crews, C M . , Alessandrini, A . , and Erikson, R.L. (1992). The primary structure of M E K , a protein kinase that phosphorylates the E R K gene product. Science, 258, 478480. Cross, D.A., Alessi, D.R. Cohen, P., Andjelkovich, M . , and Hemmings, B.A. (1995a). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 378, 785-789. Cross, M.J., Stewart, A . , Hodgkin, M . N . , Kerr, D.J., and Wakelam, M . J . (1995b). Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinase. J. Biol. Chem., 270, 25352-25355. Cross, D.A.E., Alessi, D.R., Vandenheede, J.R., McDowell, H.E., Hundal, H.S., and Cohen, P. (1994). The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem. J., 303, 21-26. Crowder, R.J., and Freeman, R.S. (1998). Phosphatidylinositol 3-kinase and akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J. Neuroscl, 18,2933-2943.  129  Currie, R.A., Walker, K.S., Gray, A . , Deak., M . , Casamayor, A . , Dowries, C.P., Cohen, P., Alessi, D.R., and Lucocq, J. (1991). Role of phosphatidylinositol 3,4,5-triphosphate in regulating the activity and localization for 3-phosphoinositide-dependent protein kinase-1. Biochem. J., 337, 575-583. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P.G., Cosos, O.A., Gutkind, J.S., and Spiegel, S. (1996). Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature, 381, 800-803. Da Silva, L., Howard, O.M.Z., Rui, H., Kirken, R.A., and Farrar, W.L. (1994). Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of the prolactin receptor. J. Biol. Chem. 269, 1867-18270. Damen, J.E., Liu, L . , Rosten, P., Humphries, R.K., Jefferson, A . B . , Majerus, P.W., and Krystal, G. (1996). The 145-kDa protein induced to associate with She by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5phosphatase. Proc. Natl. Acad. Sci. USA., 93, 1689-1693. Datta, S.R., Katsov, A . , Hu, L., Petros, A . , Fesik, S.W., Yaffe, M . B . , and Greenberg, M . E . (2000). 14-3-3 proteins and survival kinases cooperate to inactivate B A D by BH3 domain phosphorylation. Mol. Cell., 6, 41-51. Datta, S.R., Dudek, H . , Tao, X . , Masters, S., Fu, H . , Gotoh, Y . , and Greenberg, M . E . (1997a). Akt phosphorylation of B A D couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-341. Datta, R., Kojima, H . , Banach, D., Bump, N.J., Talanian, R.V., Alnemri, E.S., Weichselbaum, R.R., Wong, W.W., and Kufe, D.W. (1997b). Activation of a CrmAinsensitive, p3 5-sensitive pathway in ionizing radiation-induced apoptosis. J. Biol. Chem., 272, 1965-1969. Datta, K., Bellacosa, A., Chan, T.O., and Tschlis, P.N. (1996). Akt is a direct target of the phosphatidylinositol 3-kinase. J. Biol. Chem., 271, 30836-30839. Datta, K . , Franke, T.F., Chan, T.O., Makris, A . , Yang, S.-L, Kaplan, D.R., Morrison, D.K., Golemis, E.A., and Tsichlis, P.N. (1995). A H / P H domain-mediated interaction between Akt molecules and its potential role in Akt regulation. Mol. Cell. Biol., 15, 2304-2310. Davis, R.J., Bennicelli, J.L., Macina, R.A., Nycum, L . M . , Biegel, J.A., and Barr, F.G. (1995). Structural characterization of the F K H R gene and its rearrangement in alveolar rhabdomyosarcoma. Hum. Mol. Genet, 4, 2355-2362. Davis, S., Vanhoutte, P., Pages, C , Caboche, J., and Laroche, S.. (2000). The M A P K / E R K cascade targets both Elk-1 and c A M P response element-binding protein to  130  control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J. NeuroscL, 20, 4563-4572. Dbaibo, G.S., Pushkareva, M . Y . , Jayadev, S., Schwartz, J.K, Horowitz, J.M., Obeid, L . M . , and Hannun, Y . A . (1995). Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc. Natl. Acad. Sci. U.S.A., 92, 1347-1351. de Vries-Smits, A . M . M . , Burgering, B.M.T., Leevers, S.J., Marshall, C.J., and Bos, J.L. (1992). Involvement of p21ras in activation of extracellular-signal regulated kinase 2. Nature, 357, 602-604. del Peso, L., Gonzalez-Garcia, M . , Page, C., Herrera, R., and Nunez, G. (1997). Interleukin-3-induced phosphorylation of Bad through the protein kinase Akt. Science, 278, 687-689. Delcommenne, M . , Tan, C., Gray, V . , Rue, L., Woodgett, J., and Dedhar, S. (1998). Phosphoinositide-3-OH kinase dependent regulation of glycogen synthase kinase-3 and protein kinase B/Akt by the integrin-linked kinase. Proc. Natl. Acad. Sci. USA., 95, 11211-11216. Deng, X . , Ruvolo, P., Carr, B., and May, W. (2000). Survival function of ERK1/2 as IL3-activated, staurosporine-resistant Bcl2 kinases. Proc. Natl. Acad. Sci. U.S.A., 97, 15781583. Dennis, P.B., Pullen, N . , Kozma, S.C., an dThomas, G. (1996). The principle rapamycin-sensitive p70S k phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol. Cell. Biol, 16,6242-6251. A  Dent, P., Haser, W., Haystead, T.A.J., Vincent, L.A., Roberts, T.M., and Sturgill, T . M . (1992). Activation of mitogen-activated protein kinase by v-raf in NIH3T3 cells and in vitro. Science, 257, 1404-1407. Deprez, J., Vertomment, D., Alessi, D.R., Hue, L., and Rider, M . H . (1997). Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J. Biol. Chem., 272, 17269-17275. Dhand, R., Hara, K . , Hiles, I., Bax, B., Gout, I., Panayatou, G.m, Fry, M.J., Yonezawa, K., Kasuga, M . , and Waterfield, M . D . (1994). PI3-kinase: structural and functional analysis of intersubunit interactions. EMBO J., 13,511-521. Dobrowsky, R.T., Kamibayashi, C , Mumby, M.C., and Hannun, Y . A . (1993). Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem., 268, 15523-15530.  131  Domina, A . M . , Smith, J.H., and Craig, R.W. (2000). Myeloid cell leukemia 1 (MCL1) is phosphorylated through two distinct pathways, one associated with extracellular signalregulated kinase activation and the other G2/M accumulation or protein phosphatase 1/2A inhibition. J. Biol. Chem., 275, 21688-21694. Dressier, K . A . , Mathieas, S., and Kolesnick, R . N . (1992). Tumor necrosis factor-a activates the sphingomyelin signal transduction pathway in a cell-free system. Science, 255, 1715-1718. Duan, R.D., Hertervig, E., Nyberg, L., Hauge, T., Sternby, B., Lillienau, J., Farooqi, A . , and Nilsson, A . (1996). Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences. Dig. Dis. Sci., 41, 1801-1806. Dudek, H . , Datta, S.R., Franke, T.F., Birnbaum, M.L., Yao, R.J., Copper, G . M . , Segal, R.A., Kaplan, D.R., and Greenber, M . E . (1997). Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science, 275, 661-665. Dufner, A., Andjelkovic, M . , Burgering, B . M . , Hemmings, B.A, and Thomas, G. (1999). Protein kinase B localization and activation differentially affect S6 kinase 1 activity and eukaryotic translation initiation factor 4E-binding protein 1 phosphorylation. Mol. Cell. Biol, 19, 4525-4534. Dumon, S., Santos, S.C., Debierre-Grockiego, F., Gouilleux-Gruart, V . , Cocault, L . , Boucheron, C , Mollat, P., Gisselbrech, S., and Gouilleux, F. (1999). IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene, 18, 4191-4199. Duronio, V . , Scheid, M.P., and Ettinger, S. (1998). Downstream signaling events regulated by phosphatidylinositol 3-kinase activity. Cell. Signal, 10, 233-239. Duronio, V . , Clark-Lewis, I., Federspiel, B., Wieler, J., and Schrader, J.W. (1992). Tyrosine phosphorylation of receptor P subunits and common substrates in response to interleukin-3 and granulocyte-macrophage colony stimulating factor. J. Biol. Chem., 267, 21856-21863.-239. Duronio, V . , Welham, M.J., Abraham, S., Dryden, P., and Schrader, J.W. (1991). p21Ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity, but not tyrosine phosphorylation of GAP. Proc. Natl. Acad. Sci. USA., 89, 1587-1591. Enari, M . , Sakahira, H . , Yokoyama, H . , Okawa, K . , Iwasmatsu, A . , and Nagata, S. (1998). A caspase-activated DNase that degrades D N A during apoptosis, and its inhibitor ICAD. Nature, 391,43-50.  132  Escobedo, J.A., Navankasattusas, Kavanaugh, W . M . , Milfay, D., Fried, V . A . , and Williams, L.T. (1991). cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor. Cell, 65, 75-82. Eskes, R., Desagher, S., Antonsson, B., and Martinou, J.C. (2000). Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol, 20, 929-935. Eskes, R., Antonsson, B., Osen-Sand, A., Montessuit, S., Richter, C., Sadoul, R., Mazzei, G., Nichols, A . , and Martinou, J.C. (1998). Bax-induced cytochrome c release from mitochondria is independent of the permeability transition pore but highly dependent on M g i o n s . J. Cell. Biol, 143, 217-224. 2+  Eves, E . M . , Xiong, W., Bellacosa, A., Kennedy, S.G., Tsichilis, P.N., Rosner, M.R., and Hay, N . (1998). Akt a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol Cell Biol, 18,2143-2152. Fan, M . , Goodwin, M . , V u , T., Brantley-Finley, C , Gaarde, W.A., and Chambers, T.C. (2000). Vinblastine-induced Phosphorylation of Bcl-2 and B c l - X L are Mediated by J N K and Occur in Parallel with Inactivation of R a f - l / M E K / E R K Cascade. J. Biol. Chem. 275, 29980-29985. Fanger, G., Gerwins, P., Widmann, C , Jarpe, M . , and Johnson, G. (1997). M E K K s , GCKs, M L K s , PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr. Opin. Genet. Dev., 7, 61-1 A. Farrow, S.N., White, J.H.M., Martinou, I., Raven, T., Pun, K-T., Grinham, C.J., Martinou, J - C , and Brown, R. (1995). Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature, 374, 731-733. Feinstein, E., Kimchi, A . , Wallach, D., Boldin, M . , and Varfolomeev, E. (1995). The death domain: A module shared by proteins with diverse cellular functions. Trends Biochem. Sci., 20, 342-344. Ferby, I.M., Waga, I., Sakanaka, C , Kume, K . , and Shimizu, T. (1994). Wortmannin inhibits M A P K kinase activation induced by platelet-activating factor in guinea pig neutrophils. J. Biol. Chem., 269, 30485-30488. Ferguson, K . M . , Lemmon,- M . A . , Schlessinger, J., and Sigler, P.B. (1994). Crystal structure at 2.2 A resolution of the pleckstrin homology domain from human dynamin. Cell, 79, 199-209. Franke, T.F., Kaplan, D.R., Cantley, L.C., and Toker, A . (1997). Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-biphosphate. Science, 275, 665668.  133  Franke, T.F., Yang, S.I., Chan, T.O., Datta, K., Kazlauskas, A., Morrison, D.K., Kaplan, D.R., and Tsichlis, P.N. (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell, 81, 727-736. Freeh, M . , Andjelkovic, M . , Ingley, E., Reddy, K . K . , Falck, J.R., and Hemmings, B.A. (1997). High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase B and their influence on kinase activity. J. Biol. Chem., 272, 8474-8481. Fry, M.J., Panayotou, G., Dhand, R., Ruiz-Larrea, F., Gout, I., Nguyen, O., Courtneidge, S.A., and Waterfield, M.D. (1992). Purification and characterization of a phosphatidylinositol 3-kinase complex from bovine brain by using phosphopeptide affinity columns. Biochem J., 288, 383-393.  Fujita, E., Jinbo, A . , Matuzaki, H . , Konishi, H . , Kikkawa, U . , and Momoi, T. (1999). Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochem. Biophys. Res. Comm., 264, 550-555. Fukuda, M . , Gotoh, Y., and Nishida, E. (1997). Interaction of M A P kinase with M A P kinase kinase: its possible role in the control of nucleocytoplasmic transport of M A P kinase. EMBOJ., 16, 1901-1908. Fukunaga, R., and Hunter, T. (1997). M N K 1 , a new M A P kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBOJ., 16, 1921-1933. Garcia-Ruiz, C , Colell, A . , Mari, M . , Morales, A . , and Fernandez-Checa, J.C. (1997). Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem., 272,11369-11377. Gingras, A . C , Kennedy, S.G., O'Leary, M . A . , Sonenberg, N . , and Hay, N . (1998). 4EBP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev., 12, 502-513. Gold, M.R., Duronio, V . , Saxena, S.P., Schrader, J.W., and Aebersold, R. (1994). Multiple cytokines activate phosphatidylinositol 3-kinase in hemopoietic cells. Association of the enzyme with various tyrosine-phosphorylated proteins. J. Biol. Chem., 269, 5403-5412. Gomez-Munoz, A . , Frago, L., Alarez, L., and Varela-Nieto, I. (1997). Stimulation of D N A synthesis by natural ceramide 1-phosphate. Biochem J., 325, 435-440. Gout, I., Dhand, R., Hiles, I.D., Fry, M.J., Panayatou, G., Das, P., Truong, O., Tottym, N . , Hsuan, J., Booker, G.W. et al. (1993). The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell, 75, 25-36.  134  Gout, I., Dhand, R., Panayatou, G., Fry, M.J., Hiles, I., Otsu, M . , and Waterfield, M.D. (1992). Expression and characterization of the p85 subunit of the phosphatidylinositol 3kinase complex and a related p85 beta protein by using the baculovirus expression system. Biochem. J., 288, 395-405. Greulich, H . , and Erikson, R.L. (1998). A n analysis of M e k l signaling in cell proliferation and transformation. J. Biol. Chem.,273, 13280-13288. Gross, A . , Y i n , X . - M . , Wang, K . , Wei, M . C . , Jockel, J., Milliman, C., ErdjumentBromage, H . , Tempst, P., and Korsmeyer, S.J. (1999). Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while B c l - X L prevents this release but not tumor necrosis factor-Rl/Fas Death. J. Biol. Chem., 274, 1156-1163 Gross, A., Jockel, J., Wei, M.C., and Korsmeyer, S.J. (1998). Enforced dimerization of B A X results in its translocation, mitochondria dysfunction and apoptosis. EMBO J., 17, 3878-3885. Gudz, T., Tserng, K . , and Hoppel, C. (1997). Direct Inhibition of Mitochondrial Respiratory Chain Complex III by Cell-permeable Ceramide. J. Biol. Chem., 272, 2415424158. Guinebault, C , Payrastre, B., Racaud-Sultan, C , Mazarguil, H . , Breton, M . , Mauco, G., Plantavid, M . , and Chap, H . (1995). Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase. J. Cell. Biol, 129, 831-842. Gupta, S., Barrett, T., Whitmarsh, A . J . , Cavanagh, J., Sluss, H.K., Derijard, B., and Davis, R.J. (1996). Selective interaction of J N K protein kinase isoforms with transcription factors. EMBOJ., 15,2760-2770. Gupta, S., Campbell, D., Derijard, B., and Davis, R.J. (1995). Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science, 267, 389-393. Haimovitz-Friedman, A . , Kan, C C , Ehleiter, D., Persaud, R.S., McLoughlin, M . , Fuks, Z., and Kolesnick, R . N . (1994). Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med., 180, 525-535. Hajduch, E., Alessi, D.R., Hemmings, B.A., and Hundal, H.S. (1998). Constitutive activation of protein kinase B a by membrane targeting promotes glucose and system A amino acid transport, protein synthesis and inactivation of glycogen synthase kinase-3 in L6 muscle cells. Diabetes, 47, 1006-1013.  135  Haldar, S., Basu, A . , and Croce, C M . (1998). Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. Cancer Res., 58, 1609-1615. Haldar, S., Basu, A . , and Croce, C M . (1997). integrity. Cancer Res., 57, 229-233  Bcl2 is the guardian of microtubule  Haldar, S., Jena, N . , and Croce, C M . (1995). Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA., 92, 4507-4511.  Hanada, M . , Krajewski, S., Tanaka, S., Cazals-Hatem, D., Spengler, B.A., Ross, R.A., Biedler, J.L., and Reed, J.C. (1993). Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res., 53, 4978-4986. Hanks, S.K., Quinn, A . M . , and Hunter, T. (1998). The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science, 241, 42-52. Hannun, Y . (1994). The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem., 269, 3125-3128. Hannun, Y . A . , and Obeid, L . N . (1995). Ceramide: A n intracellular signal for apoptosis. Trends Biochem. Sci., 20,13-11.  Hara, K . , Yonezawa, K . , Sakaue, H . , Ando, A . , Kotani, K . , Kitamura, T., Kitamura, K . , Ueda, H., Stephens, L., Jackson, T.R., Hawkins, P.T., Dhandm, R., Clark, A.E., Holman, G.D., Waterfield, M.D., and Kasuga, M . (1994). 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for R A S activation in C H O cells. Proc. Natl. Acad. Sci. U.S.A., 91, 7415-7419.  Harada, H., Becknell, B., Wilm, M . , Mann, M . , Huang, L.J., Taylor, S.S., Scott, J.D., and Korsmeyer, S.J. (1999). Phosphorylation and inactivation of B A D by mitochondriaanchored protein kinase A . Mol. Cell., 3, 413-422. Harlan, J.E., Hajduk, P.J., Yoon, H.S., and Fesik, S.W. (1994). Pleckstrin homology domains bind to phosphatidylinositol-4,5-biphosphate. Nature, 371, 168-170. Haslam, R.J., Koide, H.B., and Hemmings, B.A. (1993). Pleckstrin domain homology. Nature, 363, 309-310. Hausler, P., Papoff, G., Eramo, A . , Reif, K . , Cantrell, D.A., and Ruberti, G. (1998). Protection of CD95-mediated apoptosis by activation of phosphatidylinositol 3-kinase and protein kinase B. Eur. J. Immunol, 28, 57-69. Helgason, C D . , Damen, J.E., Rosten, P., Grewal, R., Sorensen, P., Chappel, S.M., Borowski, A., Jirik, F., Krystal, G., and Humphries, R.K. (1998). Targeted disruption of  136  SHIP leads to hemopoietic perturbations, lung pathology and shortened lifespan. Genes. Dev., 12, 1610-1620. Hengartner, M.O. (1996). Programmed cell death in invertebrates. Curr. Opin. Genet. Dev., 6, 34-38.  Hiles, I.D., Otsu, M . , Volinia, S., Fry, M.J., Gout, I., Dhand, R., Panayotou, G., RuizLarrea, F., Thompson, A . , Totty, N . et al. (1992). Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell, 70, 419-429. Hillion, J., Le Coniat, M . , Jonveaux, P., Berger, R., and Bernard, O.A. (1997). AF6q21, a novel partner of the M L L gene in t(6;l I)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood, 90,3714-3719. Hilton, D.J., Watowich, S.S., Murray, P.J., and Lodish, H.F. (1995). Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor. Proc. Natl. Acad. Sci. U.S.A., 92, 190-194. Hinton, H.J., and Welham, M.J. (1999). Cytokine-induced protein kinase B activation and Bad phosphorylation do not correlate with cell survival of hemopoietic cells. J. Immunol, 162, 7002-7009. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D., and Korsmeyer, S.J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334-336. Holgate. S.T. (2000). The role of mas cells and basophils in inflammation. Clin. Exp. Allergy, 1,28-32 Howe, L.R., Leevers, S.J., Gomex, N . , Nakielny, S., Cohen, P., and Marshall, C.J. (1992). Activation of M A P kinase pathway by protein kinase raf. Cell, 71, 335-342. Hu, P., Mondino, A . , Skolnik, E.Y., and Schlessinger, J. (1993). Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site onp85. Mol. Cell. Biol, 13, 7677-7688. Hu, Q., Klippel., A . , Muslin, A . J . , Frantl, W.J., and Williams, L.T. (1995). Rasdependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase Science, 268, 100-102. Hu, X . , Yee, E., Harlan, J.M., Wong, F., and Karsan, A . (1998). Lipopolysaccharide induces the antiapoptotic molecules, A l and A20, in microvascular endothelial cells. Blood, 92, 2759-65.  137  Hu, Y., Benedict, M . A . , Wu, D., Inohara, N . , Nunez, G. (1998). B c l - X L interacts with Apaf-1 and inhibits Apaf-1 -dependent caspase-9 activation. Proc. Natl. Acad. Sci. U.S.A., 95, 4386 -4391. Hunter, J.J., and Parslow, T.G. (1996). A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J. Biol. Chem., 271, 8521-8524. Hunter, T. (1995). When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell, 6, 1-4.  Hsu, Y-T., and Youle, R.J. (1998). Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem., 273, 10777-10783. Hsu, Y-T., Wolter, K . G . , and Youle, R.J. (1997). Cytosol-to-membrane redistribution of Bax and B c l - X during apoptosis. Proc. Natl. Acad. Sci. U.S.A., 94, 3668-3672. L  Hsu, H . , Xiong, J., and Goeddel, D.B. (1995). The TNF receptor 1-associated protein T R A D D signals cell death and N F - K p activation. Cell, 81, 495-504. Huang, C., Wy, M . , Ding, M . , Bowden, G., and Dong, Z. (1997). Direct Evidence for an Important Role of Sphingomyelinase in Ultraviolet-induced Activation of c-Jun N Terminal Kinase. J. Biol. Chem., 272, 27753-27757. Ihle, J.N. (1995). Cytokine receptor signaling. Nature, 377, 591-594. Ink, B., (1997). Human Bak induces cell death in Schizosaccharomyces pombe with morphological changes similar to those with apoptosis in mammalian cells. Mol. Cell. Biol, 17, 2468-2474. Ito, T., Deng, X . , Carr, B., and May, W.S. (1997). Bcl-2 phosphorylation required for anti-apoptosis function. ./ Biol. Chem., 212, 11671-11673. Jaffrezou, J.P., Levade, T., Bettaieb, A . , Andrieu, N . , Bezombes, C , Maestre, N . , Vermeersch, S., Rousse, A . , and Laurent, G. (1996). Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBOJ., 15, 24172424. Janknecht, R., Ernst, W.H., Pingould, V . , Nordheim, A . (1993). Activation of TCF Elk1 by M A P kinases. EMBOJ, 12, 5097-5104. Jarvis, W.D., Grant, S., and Kolesnick, R.N. apoptosis. Clin. Cancer Res.,2, 1-6.  138  (1996). Ceramide and the induction of  Jarvis, W.D., Kolesnick, R.N., Fornari, F.A., Traylor, R.S., Gewirtz, D.A., and Grant, S. (1994). Induction of apoptotic D N A damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. U.S.A., 91, 73-77. Jaster R., Zhu, Y . , Pless, M . , Bhattachary, S., Mathey-Prevot, B., D'Andrea, A . D . (1997) JAK2 is required for induction of the murine DUB-1 gene. Mol. Cell. Biol., 17, 33643372. Jayadev, S., Liu, B., Bielawska, A . E . , Lee, J.Y., Nazaire, F., Pushkareva, M . , Obeid, L . M . , and Hannun Y . A . (1995). Role for ceramide in cell cycle arrest. J. Biol. Chem., 270, 2047-2052. Jiang, T., Sweeney, G . M . , Rudolf, M . , Klip, A . , Traynor-Kaplan, A . , and Tsiem, R . Y . (1998). Membrane-permeant esters of phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem., 273, 11017-11024. Jiang, Z.H. and Wu, J.Y. (1999). Alternative splicing and programmed cell death. Proc. Soc. Exp. Biol. Med., 220, 64-72. Jones, P.F., Jakubowicz, T., Pitossi, F.J., Maurer, F., and Hemmings, B . A . (1991). Molecular cloning and identification of a serine threonine protein-kinase of the 2ndmessenger subfamily. Proc. Natl. Acad. Sci. USA., 89, 9267-9271. Jones, R.G., Parsons, M . , Bonnard, M . , Chan, V.S., Yeh, W . C , Woodgett, J.R., and Ohashi, P.S. (2000). Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J. Exp. Med., 191, 1721-1734. Joseph, C.K., Byun, H-S., Bittman, R., and Kolesnick, R . N . (1993). Substrate recognition by ceramide-activated protein kinase: Evidence that kinase activity is proline-directed. J. Biol. Chem., 268, 20002-20006. Jurgensmeier, J.M., Krajewski, S., Armstrong, R . C , Wilson, G . M . , Oltersdorf, T., Fritz, L . C , Reed, J . C , and Ottilie, S. (1997). Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe. Mol. Biol. Cell, 8, 325-339. Karnitiz, L . M . , Burns, L . A . , Sutor, S.L., and Abraham, R.T. (1995). Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent M E K activation pathway. Mol. Cell. Biol. 15,3049-3057. Karsan, A., Yee, E., and Harlan, J.M. (1996). Endothelial cell death induced by tumor necrosis factor-a is inhibited by the Bcl-2 family member, A l . J. Biol. Chem., 271, 27201-27204  139  Kauffmann-Zeh, A . , Rodriguez-Vicianna, P., Ulrich, E., Golbert, C , Coffer, P., Downward, J., and Evan, G. (1997). Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and P K B . Nature, 385, 544-548. Kavanaugh, W . M . , Pot, D A . , Chin, S.M., Deuter-Reinhard, M . , Jefferson, A.B., Norris, F.A., Masiarz, F.R., Cousens, L.S., Majerus, P.W., and Williams, L.T. (1996). Multiple forms of an inositol polyphosphate 5-phosphatase forms signaling complexes with She and Grb2. Curr. Biol, 6, 438-445. Kelekar, A . , and Thompson, C B . (1998). Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell. Biol, 8, 324-330. Kelly, K . L . , and Ruderman, N . B . (1993). Insulin-stimulated phosphatidylinositol 3kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low-density membrane vesicle. J. Biol. Chem., 268, 4391-4398. Kennedy, S.G., Wagner, A.J., Conzen, S.D., S.D., Jorden, J., Bellacosa, A . , Tsichlis, P.N., and Hay, N . (1997). The PI 3-kinase/Akt signaling pathway delivers an antiapoptotic signal. Genes Dev., 11,710-713. Khaleghpour, K., Pyronnet, S., Gingras, A . - C , and Sonenberg, N . (1999). Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities. Mol. Cell. Biol, 19, 4302-4310 Kharbanda, S., Saxena, S., Yoshida, K . , Pandey, P., Kaneki, M . , Wang, Q., Cheng, K . , Chen, Y . - N . , Campbell, A., Sudha, T., Yuan, Z . - M . , Narula, J., Weichselbaum, R., Nalin, C , and Kufe, D. (2000). Translocation of S A P K / J N K to Mitochondria and Interaction with Bcl-xL in Response to D N A Damage J. Biol. Chem., 275, 322-327. Khwaja, A . , Rodriguez-Viciana, P., Wennstom, S., Warne, P.H., and Downward, J. (1997). Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBOJ., 16, 2783-2793. Kiefer, M . C , Brauer, M.J., Powers, V . C . , Wu, J.J., Umansky, S.R., Tomei, L.D., and Barr, P.J. (1995). Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature, 374, 736-739. Kim, M - Y . , Linardic, C , Obeid, L., and Hannun, Y . (1991). Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J. Biol. Chem., 266, 484-489. Kinoshita, T., Yokota, T., Arai, K . , Miyajima, A . (1995). Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene, 10, 2207-2212.  140  Kirsch, D.G., Doseff, A . , Chau, B.N., Lim, D.-S., de Souza-Pinto, N.C., Hansford, R., Kastan, M . B . , Lazebnik, Y . A . , and Hardwick, J . M . (1999). Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J. Biol. Chem., 274, 21155-21161 Kitamura, T., Ogawa, W., Sakaue, H., Hino, Y., Kuroda, S., Takata, M . , Matsumoto, M . , Maeda, T., Konishi, H . , Kikkawa, U . , and Kasuga, M . (1998). Requirement for activation of the serine-threonine kinase Akt (Protein Kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol. Cell. Biol., 18, 3708-3710 Klippel, A., Escobedo, M.-A., Wachowicz, M.S., Apell, G., Brown, T.W., Giedlin, M . A . , Kavanagh, W . M . , and Williams, L.T. (1998). Activation of phosphatidylinositol 3kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol. Cell. Biol, 18,5699-5711. Koch, J., Gartner, S., L i , C.-M., Quintern, L.E., Bernardo, K . , Levran, O., Schnabel, D., Desnick, R.J., Schuchman, E.H., and Sandhoff, K . (1996). Molecular cloning and characterization of a full-length complementary D N A encoding human acid ceramidase. Identification of the first molecular lesion causing farber disease. J. Biol. Chem., 271, 33110-33115. Kohn, A . D . , Barthel, A . , Kovacina, K.S., Boge, A . , Wallach, B., Summers, S.A., Birnbaum, M.J., Scott, P.H., Lawrence, J.C., and Rothe, R.A. (1998). Construction and characterization of a conditionally active version of the serine/threonine kinase akt. J. Biol. Chem., 273, 11937-11943. Kohn, A.D., Summers, S.A., Birnbaum, M.J., and Roth, R.A. (1996a). Expression of a constitutively active Akt ser/thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem., 271, 31372-31378. Kohn, A.D., Takeuchi, F., and Roth, R.A. (1996b). Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J. Biol. Chem., 271, 2192021926. Kolesnick, R.N. (1991). Sphingomyelin and derivatives as cellular signals. Prog. Lipid Res., 30, 1-38. Kolesnick, R., and Golde, D.W. (1994). The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell, 11, 325-328. Kolesnick, R . N . , and Herner, M . R . (1990). Characterization of a ceramide kinase activity from human leukemia (HL- 60) cells. Separation from diacylglycerol kinase activity. J. Biol Chem., 265, 18803-18808.  141  Kops, G.J., de Politer, N.D., De Vries-Smits, A . M . , Pwell, D.R., Bos, J.L., and Burgering, B . M . (1999). Direct control of the Forkhead transcription factor A F X by protein kinase B. Nature, 398, 630-634. Kothakota, S., Azuma, T., Reinhard, C , Klippel, A . , Tang, J., Chu, K . , McGarry, T.J., Kirschner, M.W., Koths, K., Kwiatkowski, D.J., and Williams, L.T. (1997). Caspase-3generated fragment of gelsolin: effector of morphological change in apoptosis. Science, 278, 294-298. Kozopas, K . M . , Yang, T., Buchan, H.L., Zhou, P., and Craig, R.W. (1993). M C L 1 , a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. U.S.A., 90, 3516-3520. Kroemer, G., Dallaporta, B., and Resche-Rigon, M . (1998). The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol, 60, 619-642. Kulik, G., and Weber, M.J. (1998). Akt-dependent and independent survival signaling pathways utilized by insulin-like growth factor 1. Mol. Cell. Biol, 18, 6711-6718. Kulik, G., Klippel, A., and Weber, M.J. (1997). Antiapoptotic signaling by the insulinlike growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol, 17, 1595-1606. Kyriakis, J., and Avruch, J. (1996). Sounding the alarm: Protein Kinase Cascades activated by stress and inflammation. J. Biol. Chem., 271, 24313-24316. Kyriakis, J.M., Woodgett, J.R., and Avruch, J. (1995). The stress-activated protein kinases. A novel E R K subfamily responsive to cellular stress and inflammatory cytokines. Ann. NY. Acad. Sci., 766, 303-319. Kyriakis, J., Banerjee, P., Nikilakaki, E., Dai, T., Rubie, E., Ahmad, M . , Avurch, J., and Woodgett, J. (1994). The stress-activated protein kinase subfamily of c-Jun kinases. Nature, 369, 156-160. Kyriakis, J.M., App, H . , Zhang, X.-F., Banerjee, P., Brautigan, D.L., Rapp, U.R., and Avruch, J. (1992). Raf-1 activates M A P kinase-kinase. Nature, 358, 417-420. Lavoie, J.N., L'Allemain, G., Brunet, A., Muller, R., and Pouyssegur, J. (1996). Cyclin DI expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem., 271, 20608-20616. Law, B., and Rossie,S. (1995). The dimeric and catalytic subunit forms of Protein Phosphatase 2A from rat brain are stimulated by C2-ceramide. J. Biol. Chem., 270, 12808-12813.  142  Le Good, J.A., Ziegler, W.H., Parekh, D.B., Alessi, D.R., Cohen, P., and Parker, P.J. (1998) . Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science, 281, 2042-2045. Le Niculescu, H . , Bonfoco, E., Kasuya, Y . , Claret, F.X., Green, D.R., and Karin, M . (1999) . Withdrawal of survival factors results in activation of the J N K pathway in neuronal cells leading to Fas Ligand induction and cell death. Mol. Cell. Biol, 19, 751763. Lee, H.H., Dadgostar, H . , Cheng, Q., Shu, J., and Cheng, G. (1999). NF-kappaBmediated up-regulation of Bcl-x and B f l - l / A l is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. U.S.A., 96, 9136-9141 Leevers, S.J., and Marshall, C.J. (1992). Activation of extracellular signal-regulated kinase, ERK2, by p21 ras oncoprotein. EMBO J., 11, 569-574. Levade, T., Salvayre, R., Blazy-Douste, L. (1986). Sphingomyelinases and NiemannPick disease. J. Clin. Chem. Clin. Biochem., 24, 205-220. L i , P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M . , Alnemri, E.S., and Wang, X . (1997). Cytochrome c and dATP-dependent formation of Apaf-1 /Caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479-489. Lia, F., Rajotte, D., Clark, S.C., Hoang, T. (1996). A dominant negative granulocytemacrophage colony stimulating factor receptor alpha chain reveals the multimeric structure of the receptor complex. J. Biol. Chem., 271, 28287-28293. Lin, K., Dorman, J.B., Rodan, A., and Kenyon, C. (1997) daf-16: A n HFN-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science, 278, 1319-1322. Lioubin, M . N . , Algate, P.A., Tsai, S., Carlberg, K . , Aebersold, A . , and Rohrschneider, L.R. (1996). pl50Ship, a signal transduction molecule with inositol polyphosphate-5phosphatase activity. Genes Dev., 10,1084-1095. Liu, J., Mathias, S., Yang, Z., and Kolesnick, R.N. (1994). Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase. J. Biol. Chem., 269, 3047-3052. Liu, L., Damen, J.E., Hughes, M.R., Babic, I., Jirik, F.R., and Krystal, G. (1997) The src homolgy 2 (SH2) domain of SH2-conatining inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with she and its induction of apoptosis. J. Biol. Chem., 272, 8983-8988.  143  Liu, Q., Sasaki, T., Kozieradzki, I., Dumont, D.J., and Penninger, J.M., (1999). SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes & Dev., 13, 786-791. Liu, X.S., Zou, H., Slaughter, C , and Wang, X . D . (1997). DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger D N A fragmentation during apoptosis. Cell, 89, 175. Liu, X . - X . , Testa, J.R., Hamilton, T.C., Jove, R., Nicosia, S.V., and Cheng, J.Q. (1998). Akt2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through a phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Res., 58, 2973-2977. Lomasney, J.W., Cheng, H.F., Wang, L.P., Kaun, Y . , Liu, S. et al. (1996). Phosphatidylinositol 4,5-bisphosphate binding to the pleckstrin homology domain of phospholipase C-5i enhances enzyme activity. J. Biol. Chem., 271, 25316-25326. Lozano, J., Berra, E., Municio, M . M . , Diaz-Meco, M.T., Dominguez, I., Sanz, L . , and Moscat, J. (1994). Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J. Biol. Chem., 269, 19200-19202 Macias, M.J., Musacchio, A . , Ponstingl, H., Nilges, M . , Saraste, M . , and Oschkinat, H . (1994). Structure of the pleckstrin homology domain from beta-spectrin. Nature, 369, 675-677. Marais R., Wynne J., Treisman, R. (1993). The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell, 73, 381-393. Marzo, I., Brenner, C , Zamzami, N . , Jurgensmeier, J.M., Susin, A.S., Vieira, H.L.A., Prevost, M . - C , Xie, Z., Matsuyama, S., Reed, J . C , and Kroemer, G. (1998). Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis. Science, 281,2027-2031. Mathias, S., Younes, A., Kan, C - C , Orlow, I., Joseph, C , and Kolesnick, R.N. (1993). Activation of the sphingomyelin pathway in intact EL4 cells and in a cell-free system by IL-lp. Science, 259, 519-522. Mathias, S., Dressier, K . A . , and Kolesnick, R.N. (1991). Characterization of a ceramideactivated protein kinase: Stimulation by tumor necrosis factor-a. Proc. Natl. Acad. Sci. U.S.A., 88, 10009-10013. Mathias, S., Pena, L.A., and Kolesnick, R.N. (1998). Signal transduction of stress via ceramide. Biochem., J., 335, 465-80.  144  Maundrell, K . , Antonson, B., Magnenat, E., Camps, M . , Muda, M . , Chabert, C , Gillieron, C , Boschert, U., Vial-Knecht, E., Martinou, J . C , and Arkinstall, S. (1997). Bcl-2 undergoes a phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Racl. J. Biol. Chem., 272, 25238-25242. May, W.S., Tyler, P.G., Ito, T., Armstrong, D.K., Qatsha, K . A . , and Davidson, N . E . (1994). Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis. J. Biol. Chem., 269, 26865-26870. Mayer, B.J., Rens, R., Clark, K . L . , and Baltimore, D. (1993). domain present in diverse signaling proteins. Cell, 73, 629-630.  A putative modular  McCarthy, N.J., Whyte, M . K . B . , Gilbert, C.S., and Evan, G.I. (1997). Inhibition of Ced3/ICE-related proteases does not prevent cell death induced by oncogenes, D N A damage, or the Bcl-2 homologue Bak. J. Cell. Biol, 136, 215-227. McCarthy, S.A., Chen, D., Yang, B.-S., Garcy a-Ramyrez, J.J., Cherwinski, F L , Chen, X . R., Klagsbrun, M.L., Hauser, C.A., Ostrowski, M . C , and McMaon, M . (1997). Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf1. Mol. Cell. Biol, 17,2401-2412. McCubrey, J.A., May, W.S., Duronio, V . , and Mufson, A . (2000). phosphorylation in cytokine signal transduction. Leukemia, 14,9-21.  Serine/threonine  McCubrey, J.A., Steelman, L.S., McKeam, J.P. (1991). Interleukin-3 and phorbol esters induce different patterns of immediate-early gene expression in an interleukin-3dependent cell line. Oncogene Res., 6, 1-12. Meier, P., and Evan, G. (1998). Dying like flies. Cell, 9, 295-298. Meier, R., Alessi, D.R., Cron, P., Andjelkovic, M . , and Hemmings, B . A . (1997). Mitogenic activation, phosphorylation and nuclear translocation of protein kinase Bp. J. Biol. Chem., 272, 30491-30497. Mercurio, F . , and Manning A . M . (1999). Multiple signals converging on N F - K P . Curr. Biol, 11,226-232. Michael, J.M., Lavin, M . F . , and Walters, D. (1997). Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res., 57, 3600-3605.  145  Ming, X.F., Burgering, B . M . , Wennstrom, S., Claesson-Welsh, L., Heldin, C.H., Bos, J.L., Kozma, S.C., and Thomas, G. (1994). Activation of p70/p85 S6 kinase by a pathway independent of p21ras. Nature, 371, 426-429. Minn, A., Velez, P., Schendel, S.L., Liangg, H., Muchmore, S.W., Fesik, S.W., Fill, M . , and Thompson, C.B. (1997). Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature, 385, 353-357. Miyajima, A . , M u i , A . L . , Ogorochi, T., and Sakamaki, K . (1993). Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood, 82, 1960-1974. Moodies, S.A., Willumsen, B . M . , Weber, M.J., and Wolfman, A . (1993). Complexes of Ras-GTP with Raf-1 and mitogen-activated protein kinase kinase. Science, 260, 16581661. Morris, J.Z., Tissenbaum, H.A., and Ruvkun, G. (1996). A phosphotidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature, 382, 536-539. Moule, S.K., Edgell, N.J., Welsh, G.I., Diggle, T.A., Foulstone, E.J., Heesom, K . J . , Proud, C.G., and Denton, R . M . (1995). Multiple signalling pathways involved in the stimulation of fatty acid and glycogen synthesis by insulin in rat epididymal fat cells. Biochem. J., 311, 595-601. Muchmore, S.W., Sattler, M . , Liang, H . , Meadows, R.P., Harlan, J.E., Yoon, H.S., Nettesheim, D., Chang, B.S., Thompson, C.B., Wong, S.-L., Ng, S.-C, and Feskil, S.W. (1996). X-ray and N M R structure of human Bcl-xL, an inhibitor of programmed cell death. Nature, 381, 335-341. Muller, G., Ayoub, M . , Storz, P., Rennecke, J., Fabbro, D., and Pfizenmaier, K . (1995b). P K C zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBOJ., 14,1961-1969 Musacchio, A . , Gibson, T., Rice, P., Thompson, J., and Saraste, M . (1993). The P H domain: a common piece in the structural patchwork of signaling proteins. Trends Biochem. Sci., 18,343-348. Muzio, M . , Chinnaiyan, A . M . , Kischkel, F.C., O'Rourke, K . , Shevchenko, A . , N i , J., Scaffidi, C , Bretz, J.D., Zhang, M . , Gentz, R., Mann, M . , Krammer, P.H., Peter, M.E., and Dixit, V . M . (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85, 817827.  146  Nakanishi, S., Catt, K J . , and Balla, T. (1995). A wortmannin-sensitive phosphatidylinositol 4-kinase that regulates hormone-sensitive pools of inositolphospholipids. Proc. Natl. Acad. Sci. U. S. A., 92, 5317-5321.  Nakanishi, S., Kakita, S., Takahashi, I., Kawahara, K . , Tsukuda, E., Sano, T., Yamada, K., Yoshida, M . , Kase, H . , Matsuda, Y . , Hashimoto, Y . , and Nonomura, Y . (1992). Wortmannin, a microbial product inhibitor of myosin light chain kinase. J. Biol. Chem., 267,2157-2163. Narita, M . , Shimizu, S., Ito, T., Chittenden, T., Lutz, R.J., Matsuda, H . , and Tsujimoto, Y. (1998). Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. U.S.A., 95, 14681-14686 Nave, B.T., Haigh, R.J., Hayward, A . C , Siddle, K . , and Shepherd, P.R. (1996). Compartment-specific regulation of phosphoinositide 3-kinase by platelet-derived growth factor and insulin in 3T3-L1 adipocytes. Biochem. J., 318, 55-60. Ng, F.W.H., and Shore, G . C (1998). B c l - X L cooperatively associates with the Bap31 complex in the endoplasmic reticulum, dependent on procaspase-8 and Ced-4 adaptor. J. Biol. Chem., 273, 3140-3143.  Nguyen, M . , Branton, P.E., Walton, P.A., Oltvai, Z.N., Korsmeyer, S.J., and Shore, G.C. (1994). Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by EIB-defective adenovirus. J. Biol. Chem., 269, 16521-16524. N i , H . , Wang, X.S., Diener, K . , and Yao, Z. (1998). M A P K A P K 5 , a novel mitogenactivated protein kinase (MAPK)-activated protein kinase, is a substrate of the extracellular-regulated kinase (ERK) and p38 kinase. Biochem. Biophys. Res. Comm., 243, 492-496. Nicholson, D.W., and Thornberry, N . A . Biochem. Sci., 22, 299-306  (1997). Caspases:  killer proteases. Trends  Nishinakamura, R., Miyajima, A . , Mee, P.J., Tybulewicz, V . L . , and Murray, R. (1996). Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-5 functions. Blood, 2458-2464. Nishinakamura, R., Nakayama, N . , Hirabayashi, Y . , Inoue, T., Aud, D., McNeil, T., Azuma, S., Yoshida, S., Toyoda, Y., Arai, K . , and et al. (1995). Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL-3 receptor-deficient mice are normal. Immunity, 2, 211-222. Nyberg, L., Duan, R.D., Axelson, J., and Nilsson, A. (1996). Identification of an alkaline sphingomyelinase activity in human bile. Biochim. Biophys. Acta., 1300, 42-48.  147  Obeid, L . M . , Linardic, C M . , Karolak, L.A., and Hannun, Y . A . (1993). Programmed cell death induced by ceramide. Science, 259, 1769-1771. O'Connor, L., Strasser, A . , O'Reilly, L.A., Hausmann, G., Adams, J.M., Cory, S., and Huang, D.C.S. (1998). Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBOJ., 17, 384-395. Okada, T., Sakuma, L., Fukui, Y . , Hazeki, O., and U i , M . (1994). Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem., 269, 3563-3567. Okazaki, T., Bielawska, A . , Domae, N . , Bell, R . M . , Hannun, Y . A . (1994). Characteristics and partial purification of a novel cytosolic, magnesium-independent, neutral sphingomyelinase activated in the early signal transduction of 1 alpha, 25dihydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem., 269, 40704077. Oltvai, Z.N., Milliman, C.L., Korsmeyer, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homologue, Bax, that accelerates programmed cell death. Cell, 74, 60919. Orth, K., Chinnaiyan, A . M . , Carg, M . , Froelich, C.J., and Dixit, V . M . (1996). The CED3/ICE-like Protease Mch2 Is Activated during Apoptosis and Cleaves the Death Substrate LaminA. J. Biol. Chem., 271, 16443-16446. Otsu, M . , Hiles, I., Gout, I., Fry, M.J., Ruiz-Larrea, F., Panayalou, G. Thompson, A . , Dhand, R., Hsuan, J., Totty, N . , et al. (1991). Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell, 65,91-104. Ozes, O.N., Mayo, L.D., Gustin, J.A., Pfeffer, S.R., Ozes, O..M., and Donner, B.D. (1999). N F - K P activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature, 401, 82-5. Packham, G., White, E.L., Eischen, C M . , Yang, H . , Parganas, E., Ihle, J.N., Grillot, D.A., Zambetti, G.P., Nunez, G., Cleveland, J.L. (1998). Selective regulation of B c l - X L by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev., 12,2475-87. Pan, G.H., O'Rourke, K., and Dixit, V . M . (1998). Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem., 273, 5841-5845.  148  Paradis, S., and Ruvkun, G. (1998). Caenorhabditis elegans Akt/PKB transduces insulin recptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev., 12, 2488-2498. Parganas, E., Wang, D., Stravopodis, D., Topham, D.J., Marine, J.C., Teguland, S., Vanin, E.F., Bodner, S., Colamonici, O.R., van Deursen, J.M., Grosveld, G., and Ihle, J.N. (1998). Jak2 is essential for signaling through a variety of cytokine receptors. Cell, 93, 385-395. Park, J., Leong, M.L., Buse, P., Maiyar, A.C., Firestone, G.L., and Hemmings, B . A . (1999). Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinasestimulated signaling pathway. EMBO J., 18, 3024-3033. Pastorino, J., Simbula, G., Yam,amoto, K . , Glascott, P.J., Rothman, R., and Farber, J. (1996). The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J. Biol. Chem., 21'1,29792-29'}'98. Pawson T. (1994). SH2 and SH3 domains in signal transduction. Adv. Cancer Res., 64, 87-110. Pfizenmaier, K . (1995). PKC<^ is a molecular switch in signal transduction of TNF-a, bifunctionally regulated by ceramide and arachidonic acid. EMBO J., 14, 1961-1969. Philpott, K . L . , McCarthy, M.J., Klippel, A . , and Rubin, L . L . (1997). Activated phosphatidylinositol 3-kinase and akt kinase promote survival of superior cervical neurons. J. Cell. Biol, 139, 809-815. Pleiman, C M . , Hertz, W . M . , and Cambier, J.C. (1994). Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit. Science, 263, 1609-1612. Pullen, N . , Dennis, P.B., Andjelkovic, M . , Dufner, A . , Kozma, S . C , Hemmings, B.A., and Thomas, G. (1998). Phosphorylation and activation of p70S6k by PDK1. Science, 279, 707-710. Pullen, N . , and Thomas, G. (1997). The modular phosphorylation and activation of p70S6K. FEBSLett., 410, 78-82. Puthalakath, H., Huang, D . C , O'Reilly, L.A., King, S.M., and Strasser, A . (1999). The propapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell, 3, 287-296. Puthier, D., Derenne, S., Barille, S., Moreau, P., Harousseau, J.L., Bataille, R., and Amiot, M . (1999). Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells. Br. J. Haematol, 107, 392-395.  149  Quelle, F.W., Sato., N . , Withuhn, B.A., Inhom, R.C. Eder, M . , Miyajima, A . , Griffin, J.D., Ihle, J.N. (1994). Jak2 associates with the p chain of the receptor for granulocytemacrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol, 14, 4335-4341. c  Rajotte, H.B., Sadowski, A., Haman, K., Gopalbhai, S., Meloche, L , Liu, L., Krystal, G., and Hoang, T. (1996). Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor. Blood, 88, 2906-2916. Ray, L.B., and Sturgill, T.W. (1998). Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo. Proc. Natl. Acad. Sci. USA., 85,3753-3757. Ray, L . B . , and Sturgill, T.W. (1988). Characterization of insulin-stimulated microtubule-associated protein kinase. Rapid isolation and stabilization of a novel serine/threonine kinase from 3T3-LI cells. J. Biol Chem., 263, 12721-12727. Rena, G.S., Guo, S., Cichy, S., Unterman, T.G., and Cohen, P. (1999). Phosphorylation of the transcription factor forkhead family member F K H R by protein kinase B. J. Biol Chem., 214, 17179-17183. Reyes, J.G., Robayna, I.G., Delgado, P.S., Gonzalez, I.H., Agular, J.Q., Rosas, F.E., Fanjul, L.F., and Galarreta, C.M.R. (1996). c-Jun is a downstream target for ceramideactivated protein phosphatase in A431 cells. J. Biol. Chem.,271, 21375-21380. Ricort, J . M . , Tanti, J.F., Obberghen, E . V . , and Le Marchand-Brustel, Y . (1996). Different effects of insulin and platelet-derived growth factor on phosphatidylinositol 3kinase at the subcellular level in 3T3-L1 adipocytes. A possible explanation for their specific effects on glucose transport. Eur. J. Biochem., 239, 17-22. Rinkenberger, J.L., Horning, S., Klocke, B., Roth, K., and Korsmeyer, S.J. (2000). M c l 1 deficiency results in peri-implantation embryonic lethality. Genes Dev., 14, 23-27. Rohn, J.L., Hueber, A-O., McCarthy, N.J., Lyon, D., Navarro, P., Burgering, B.M.T., and Evan, G.I. (1998). The opposing roles of the Akt and c-Myc signaling pathways in survival from CD95-mediated apoptosis. Oncogene, 17, 2811-2828. Rossomando, A.J., Paynes, D . M . , Weber, M.J., and Sturgill, T.W. 91998). Evidence that pp42, a major kinase target protein, is a mitogen-activated serine/threonine protein kinase. Proc. Natl. Acad. Sci. U.S.A., 86, 6940-6943. Rudel, T., and Bokoch, C M . (1997). Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of P A K 2 . Science, 276, 15711574.  150  Ruvolo, P.P., Deng, X . , Ito, T., Carr, B.K., and May, W.S. (1999). Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem., 274, 20296-20300. Ruvolo, P.P., Deng, X . , Carr, B.K., and May, W.S. (1998). A functional role for mitochondrial protein kinase C-a in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem., 273, 25436-25442.  Sable, C.L., Filippa, N . , Filloux, C , Hemmings, B.A., and van Obberghen, E. (1998). Involvement of the pleckstrin homology domain in the insulin-stimulated activation of protein kinase B. J. Biol. Chem., 273, 29600-29606. Saito, M . , Korsmeyer, S.J., and Schlesinger, P.H. (2000). Bax dependent cytochrome-c transport reconstituted in pure liposomes. Nat. Cell. Biol, 2, 553-555. Sakanaka, C , Ferby, I., Waga, I., Bito, H., and Shimizu, T. (1994). On the mechanism of cytosolic phospholipase A2 activation in C H O cells carrying somatostatin receptor: wortmannin-sensitive pathway to activate mitogen-activated protein kinase. Biochem. Biophys. Res. Commun., 205, 18-23.  Salim, K., Bottomley, M.J., Querfurth, E., Zvelebil, M.J. Gout, I., et al. (1996). Distinct specificity in the recognition of phosphoinositides by pleckstrin homology domain of dynamin and Bruton's tyrosine kinase. EMBOJ., 15, 6241-6250. Sato, N . , Sakamaki, K., Terada, N . , Arai, K - L , Miyajima, A . (1993). Signal transduction by the high-affinity G M - C S F receptor: two distinct cytoplasmic regions of the common P subunit responsible for different signaling. EMBOJ., 12, 4181-4189. Sattler, M . , Liang, H., Nettesheim, D., Meadows, R.P., Harlan, J.E., Eberstadt, M . , Yoon, H.S., Shuker, S.B., Chang, B.S., Minn, A.J., Thompson, C.B., and Fesik, S.W. (1997). Structure of Bcl-XL-Bak peptide complex: recognition between regulators of apoptosis. Science, 275, 983-986. Scheid, M.P., Foltz, I.N., Young, P.R., Schrader, J.W., and Duronio, V . (1999). Ceramide and cyclic adenosine monophosphate (cAMP) stimulate c A M P response element binding protein phosphorylation through distinct signaling pathways while having opposite effects on myeloid cell survival. Blood, 93, 217-225 Scheid, M.P., and Duronio, V . (1998). Dissociation of cytokine induced phosphorylation of Bad and activation of PKB/Akt. Involvement of M E K upstream of Bad phosphorylation. Proc. Natl Acad. Sci. USA., 95, 7439-7444.  Scheid, M.P., Charlton, L., Pelech, S.L., and Duronio, V . (1996a). Role of p70S6 kinase in inhibition of cell death by cytokines. Biochem. Cell Biol, 74, 595-600.  151  Scheid, M.P., and Duronio, V . (1996a). Phosphatidylinositol 3-kinase activity is not required for the activation of mitogen-activated protein kinase activity by cytokines. J. Biol. Chem., 271, 18134-18139.  Scheid, M.P., Lauener, R.W., and Duronio, V . (1995). Role of phosphatidylinositol 3OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony stimulating factor. Biochem. J., 312, 1591-62. Schendel, S.L., Azimov, R., Pawlowski, K . , Godzik, A . , Kagan, B.L., and Reed, J.C. (1999). Ion channel activity of the BH3 only Bcl-2 family member, BID. J. Biol. Chem., 274,21932-21936. Schendel SL, Montal M , Reed JC. (1998). Bcl-2 family proteins as ion-channels. Cell Death Differ., 5, 372-80.  Schissel, S.L., Schuchman, E.H., Williams, K.J., and Tabas, I. (1996). Zn -stimulated sphinomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J. Biol. Chem., 271, 18431-18436. 2+  Schubert, K . M . , Scheid, M.P., and Duronio, V . (2000). Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J. Biol. Chem., 275, 13330-13335. Schwandner, R., Wiegmann, K., Bernardo, K., Kreder, D., and Kronke, M . (1998). TNF receptor death domain-associated proteins T R A D D and F A D D signal activation of acid sphingomyelinase. J. Biol. Chem., 273, 5916-5922. Sevilla, L., Aperlo, C , Dulic, V., Chambard, J.C, Boutonnet, C , Pasquier, O., Pognonec, P., and Boulukos, K . E . (1999). The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism. Mol. Cell. Biol, 19, 2624-2634. Shaw, G. (1996). The pleckstrin homology domain: protein module. Bioessays., 18, 35-46.  an intriguing multifunctional  Shimizu, S., Eguchi, Y . , Kamiike, W., Funahashi, Y . , Mignon, A . , Lacronique, V . , Matsuda, H . , and Tsujimoto, Y . (1998). Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc. Natl. Acad. Sci. U.S.A., 95, 1455-1459 Shimizu, S., Eguch,i Y . , Kamiike, W., Waguri, S., Uchiyama, Y . , Matsuda, H . , and Tsujimoto, Y . (1996). Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene, 13, 21-29.  152  Shirakabe, K . , Yamaguchi, K . , Shibuya, H . , Irie, K . , Matsuda, S., Moriguchi, T., Gotoh, Y., Matsumoto, K., and Nishida, E . (1997). TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem., 272, 8141-8144. Skolnik, E . Y . Mangolis, B., Mohammadi, M . , Lowenstein, E . , Fischer, R., Drepps, A . , Ulrich, A., and Schlessinger, J. (1991). Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell, 65, 83-90. Skorski, T., Bellacosa, A., Nieborowska-Skorska, M . , Majewski, M . , Martinex, R., Choi, J.K., Trotts, R., Wlodarski, P., Perrotti, D., Chan, T.O., Wasik, M . A . , Tsichlis, P.N. and Calabretta, B. (1997). Transformation of hematopoietic cells by B C R / A B L requires activation of a PI3K/Akt-dependent pathway. EMBO J., 16, 6151 -6161. Socolovsky, M . , Fallon, A . E . , Wang, S., Brugnara, C , Lodish, H.F. (1999). Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-x(L) induction. Cell, 98, 181-191. Songyang, Z., Baltimore, D., Cantley, L.C., Kaplan, D.R., and Franke, T.F. (1997). Interleukin 3-dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. U.S.A., 94, 11345-11350. Songyang, Z., Shoelson, S.E., Chaudhuri, M . , Gish, G., Pawson, T., Haser, W.G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R.J. et al. (1993). SH2 domains recognize specific phosphopeptide sequences. Cell, 72, 767-778. Soskic, V . , Gorlach, M . , Poznanovic, S., Boehmer, F.D., and Godovac-Zimmermann, J. (1999). Functional proteomics analysis of signal transduction pathways of the plateletderived growth factor beta receptor. Biochemistry, 38, 1757-1764. Spence, M . W . (1993). Sphingomyelinases. Adv. Lipid Res., 26, 3-23. Spiegel, S., Foster, D., and Kolesnick, R. (1996).  Signal transduction through lipid  second messengers. Curr. Opin. Cell. Biol., 8, 159-167.  Spiegel, S., and Merrill, A . H . (1996). regulation. FASEBJ., 10, 1388-1397.  Sphingolipid metabolism and cell growth  Srivastava, R.K., Srivastava, A.R., Korsmeyer, S.J., Nesterova, M . , Cho-chung, Y.S., and Longo, D.L. (1998). Involvement of microtubules in the regulation of bcl-2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell. Biol., 18,3509-3517.  153  Staal, S.P., Hartley, J.W., and Rowe, W.P. (1997). Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc. Natl. Acad. Sci, 74, 3065-3067.  Staal, S.P. (1987). Molecular cloning of the akt oncogene and its human homologues Aktl and Akt2: Amplification of Aktl in a primary human gastric adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A., 84, 5034-5037. Stambolic, V . , Suzuki, A . , de la Pmpa, J.L., Brothers, G . M . , Mirtsbs, C , Sasaki, T., Ruland, J., Penninger, J.M., Siderovski, D.P., and Mak, T.W. (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95, 29-39 Staveley, B.E., Ruel, L., Jin, J., Stambolic, V., Mastronardi, F.G., Heizler, P., Woodgett, J.R., and Manoukian, A . S . (1998). Genetic analysis of protein kinase B(AKT) in Drosophila. Curr. Biol. 8, 599-602.  Stephens, L., Anderson, K . , Stokoe, D., Erdjument-Bromage, H., Painter, G.F., Holmes, A . B . , Gaffney, P,R.J., Reese, C.B., McCormick, F., Tempst, P., et al. (1998). Dual role of phosphatidylinositol-3,4,5-triphosphate in the activation of protein kinase B. Science, 277, 567-570. Stephens, L.R., Eguinoa, A . , Erdjument-Bromage, H . , Lui, M . , Cooke, F., Coadwell, j . , Smrcka, A.S., Thelen, M . , Cadwallader, K., Tempst, P., and Hawkins, P.T. (1997). The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p i 01. Cell, 89, 105-114 Stokoe, D., Stephens, L.R., Copeland, T., Gaffney, P.R., Reese, C.B., Painter, G.F., Holmes, A . B . , McCormick, F., and Hawkins, P.T. (1997). Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science, 277, 567-570. Sublett, J.E., Jeon, I.S., and Shapiro, D.N. (1995). The alveolar rhabdomyosarcoma P A X 3 / F K H R fusion protein is a transcriptional activator. Oncogene, 11, 545-552. Sui, X . , Krantz, S.B., and Zhao, Z.J. (2000). Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways. Br. J. Haematol, 110, 63-70. Summers, S.A., Garza, L.A., Zhou, H . , and Birnbaum, M . J . (1998). Regulation of insulin-stimulated glucose transporter GLUT4 translocation and akt kinase activity by ceramide. Mol Cell Biol, 18, 5457-5464. Susin, S.A., Lorenzo, H.K., Zamzami, N . , Marzo, I., Snow, B.E., Brothers, G . M . , Mangion, J., Jacotot, E., Costantini, P., Loeffler, M.„ Larochette, N . , Goodlett, D.R.,  154  Aebersold, R., Siderovski, D.P., Penninger, J.M., and Kroemer, G.. (1999). Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397, 441-446. Susin, S., Zamzami, N . , Larochette, N . , Dallaporta, B., Marzo, I., Brenner, C., Hirsch, T., Petit, P., Geuskens, M . , and Kroemer, G. (1997). A cytofluorometric assay of nuclear apoptosis induced in a cell-free system: application to ceramide-induced apoptosis. Exp. Cell. Res., 236, 397-403. Susin, S.A., Zamzami, N . , Castedo, M . , Hirsch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M . , Kroemer, G. (1996). Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med., 184, 1331-1341. Sutor, S.L., Vroman, B.T., Armstrong, E.A., Abraham, R.T., Karnitz, L . M . (1999). A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf. J. Biol. Chem., 274, 7002-7010. Suzuki, A., de la Pompa, J.L., Stambolic, V., Elia, A.J., Sasaki, T., del Barco Barrantes, I., Ho, A-, Wakem, A., Itie, W., Khoo, W., et al. (1998). High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice, Curr. Biol, 8, 1169-1178. Szalai, G., Krishnamurthy, R., and Hajnoczky, G. (1999). Apoptosis driven by IP3linked mitochondrial calcium signals. EMBO J., 18,6349-6361. Takahashi, A., Alnemri, E.S„ Lazebnik, Y . A . , Fernandes-Alnemri, T., Litwack, G., Moir, R.D., Goldman, R.D., Poirier, G.G., Kaufmann, S.H., and Earnshaw, W.C. (1996). Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 betaconverting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. U.S.A., 93, 8395-8400. Takashima, A . , Noguchi, K . , Michel, G., Mercken, M . , Hoshi, M . , Ishiguro, K . , and Imahori, K . (1996). Exposure of rat hippocampal neurons to amyloid beta peptide (2535) induces the inactivation of phosphatidylinositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neurosci. Lett., 203, 33-36. Takata, M . , Ogawa, W., Kitamura, T., Hino, Y . , Kuroda, S., Kotani, K . , Klip, A . , Gingras, A.C., Sonenberg, N . , and Kasuga, M . (1999). Requirement for Akt (protein kinase B) in insulin-induced activation of glycogen synthase and phosphorylation of 4EBP1 (PHAS-1). J. Biol Chem., 274, 20611-20618. Tan, Y., man, H., Demeter, M.R., and Comb, M.J. (1999). p 9 0 blocks Bad-mediated cell death via a protein kinase C-dependent pathway. J. Biol. Chem., 214, 34859-67. RSK  155  Tanaka, S., Saito, K . , and Reed, J.C. (1993). Structure-function analysis of the Bcl-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl-2 beta protein restores function as a regulator of cell survival. J. Biol. Chem. 268, 10920-6. Tang, E.D., Nunez, G., Barr, F.G., and Guan, K . L . (1999). Negative regulation of the Forkhead transcription factor F K H R by Akt. J. Biol. Chem. 21 A, 16741-16746. Tanti, J.-F., Grillo, S., Germeaux, T., Coffer, P.J., van Obberghen, E., and le MarchandBrustel, Y . (1997). Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology, 138,2005-2010. Thornberry, N . A . , and Lazebnik, Y . A . (1998). Caspases: enemies within. Science, 281, 1312-1316. Thornberry, N . A . , Bull, H.G., Calaycay, JR., Chapman, K.T., Howard, A.D., Kostura, M.J., Miller, D.K., Molineaux, S.M., Weidner, J.R., and Aunins, J. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature, 356, 768-774. Thorson, J.A., Yu, L.W., Hsu, A . L . , Shih, N . Y . , Graves, P.R., Tanner, J.W., Allen, P.M., Piwnica-Worms, H . , and Shaw, A.S. (1998). 14-3-3 proteins are required for maintenance of RAF-1 phosphorylation and kinase activity. Mol. Cell. Biol., 18, 52295238. Toker, A . (2000). Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol. Pharmacol., 57, 652-8. Review. Toker, A . , and Newton, A . C . (2000). Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J. Biol. Chem., 275, 8271-8274. Tsujimoto, Y . , Gorham, J., Cossman, J., Jaffe, E., Croce, C M . (1985). The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in V D J joining. Science, 229, 1390-93. Valius, M . , and Kazlauskas, A . (1993). Phospholipase C- and Phosphatidylinositol Kinase Are the Downstream Mediators of the PDGF Receptor's Mitogenic Signal. Cell, 73,321-334. van der Geer, P., and Pawson, T. (1995). The PTB domain: a new protein module implicated in signal transduction. Trends Biochem. Sci., 20, 277-80. Review. van Weeren, P . C , de Bruyn, K . M . , de Vries-Smits, A . M . , van Lint, J., and Burgering, B . Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of P K B . 1998. J. Biol.  156  Vanhaesebroeck B , and Alessi, D.R. The PI3K-PDK1 connection: more than just a road to P K B . (2000). Biochem. J., 346,561-76. Vanhaesebroeck, B., Leevers, S.J., Panayotou, G., and Waterfield, M . (1997a). Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci., 22, 267-272. Vanhaesebroeck, B., Welham, M.J., Kotani, K . , Stein, R., Wame, P.H., Zvelebil, M.J., Higashi, K . , Volinia, S., Downward, J., and Waterfield, M . D . (1997b). PllOdelta, a novel phosphoinositide 3-kinase in leukocytes. Proc. Natl. Acad. Sci. U.S.A., 94, 4330-  4335. Vanhoutte, P., Barnier, J.V., Guibert, B., Pages, C., Besson, M.J., Hipskind, R.A., and Caboche, J. (1999). Glutamate induces phosphorylation of Elk-1 and C R E B , along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol. Cell. Biol., 19, 136-146. Vemuri, G.S., and McMorris, F A . (1996). Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival. Development., 122, 25292537. Verheij, M . , Bose, R., Lin, X . H . , Yao, B., Jarvis, W.D., Grant, S., Birrer, M . H . , Szabo, E., Zon, L.I., Kyriakis, J.M., Haimovitz-Friedman, A . , Fuks, Z., and Kolesnick, R . N . (1996). Requirement of ceramide-initiated S A P K / J N K signaling in a stress-induced apoptosis. Nature, 380, 75-79. Vlahos, C.J., Matter, W.F., Hui, K . Y . , and Brown, R.F., (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1 -benzopyran-4one (LY294002). J. Biol. Chem., 269, 5241-5248. Vojtek, A . B . , Hollenberg, S.M., and Cooper, J A . (1993). Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell, 74, 205-214. Wagner, B.J., and Hayes, T.E., Hoban, C.J., and Cochran, B . H . (1990). The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J., 9, 4477-4484. Walker, K.S., Deak, M . , Paterson, A., Hudson, K . , Cohen, P., and Alessi, D.R. (1998). Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. Biochem. J., 331,299-308. Walsh, G . M . (1997). Mechanisms of human eosinophil survival and apoptosis. Clin. Exp. Allergy, 27, 482-487  157  Wang, C.Y., Guttridge, D.C., Mayo, M.W., and Baldwin, A . S . (1999). NF-kappaB induces expression of the Bcl-2 homologue Al/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol, 19, 5923-5929. Wang, H.-G., Pathan, N . , Ethell, I.M., Krajewski, S., Yamaguchi, Y . , Shibasaki, F., McKeon, F., Bobo, T., Franke, T.F., and Reed, J.C. (1999). Ca -induced apoptosis through calcineurin dephosphorylation of Bad. Science, 284, 339-343. 2+  Wang, J-M., Chao, J-R., Chen, W., Kuo, M - L . , Yen, J. J-Y., and Yang-Yen, H-F. (1999). The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol. Cell. Biol, 19,6195-6206. Wang, K . , Gross, A . , Waksman, G., and Korsmeyer, S.J. (1998). Mutagenesis of the BH3 domain of B A X identifies residues critical for dimerization and killing. Mol. Cell. Biol., 18, 6083-6089. Wang, Q., Somwar, R., Bilan, P.J., Liu, Z., Jin, J., and Woodgett, J.R. (1999). Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myocytes. Mol. Cell. Biol, 19,4008-4018. Wang, W., Fisher, E . M . , Jia, Q., Dunn, J.M., Porfiri, E., Downward, J., and Egan, S.E. (1995). The Grb2 binding domain of mSosl is not required for downstream signal transduction. Nat. Genet., 10, 294-300. Wang, Y . - M . , Seibenhener, M . L . , Vandenplas, M . L . , and Wooten, M . W . (1999). Atypical PKCc^ is activated by ceramide, resulting in coactivation of NF-Kp7JNK kinase and cell survival. J. Neuro. Res., 55, 293-302 Waskiewicz, A.J., Flynn, A., Proud, C.G., and Cooper, J A . (1997). Mitogen-activated protein kinases activate the serine/threonine kinases M n k l and Mnk2. EMBO J., 16, 1909-1920. Welsh, G.I., Foulstone, E.J., Young SW, Tavare J . M . , Proud, C.G., and Wen, L.P., (1997). Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase. J. Biol Chem., 272, 26056 Wen, L.P., Fahrni, J.A., Troie, S., Guan, J.L., Orth, K . , and Rosen, G.D. (1997). Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol Chem., 272, 26056-26061. Weng, Q.P., Andrabi, K., Klippel, A., Kozlowski, M . T., Williams, L.T., and Avruch, J. (1995). Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation. Proc. Natl. Acad. Sci. U.S.A., 92, 5744-5748.  158  Westwick, J.K., Bielawska, A.E., Dbaibo, G., Hannun, Y . A . , and Brenner, D.A. (1995). Ceramide activates the stress-activated protein kinases. J. Biol. Chem., 270, 2268922692. Whitman, S., Civoli, F., and Daniel, L . (1997). Protein kinase C II activation by 1- -Darabinofuranosylcytosine is antagonistic to stimulation of apoptosis and Bcl-2a downregulation. J. Biol. Chem., 272, 23481-23484. P  P  Wijkander, I., Hoist, L.S., Rahn, T., Resjo, S., Castan, I., Manganielle, V., Belfrage, P., and Degerman, E. (1997). Regulation of protein kinase B in rat adipocytes by insulin, vanadate and peroxyvanadate. J. Biol. Chem., 272, 21520-21526. Williams, M.R., Arthur, J.S., Balendran, A . , van der Kaay, J., Poli, V . , Cohen, P., and Alessi, D.R. (2000). The role of 3-phosphoinositide-dependent protein kinase 1 in activating A G C kinases defined in embryonic stem cells. Curr. Biol. 10, 439-448. Wolff, R.A., Dobrowsky, R.T., Bielawska, A . , Obeid, L . M . , and Hannun, Y . A . (1994). Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J. Biol. Chem., 269, 19605-19609.  Wolter, K . G . , Hsu, Y.T., Smith, C.L., Nechushtan, A., X i , X . G . , and Youle, R.J. (1997). Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell. Biol. 139, 1281-1292. Wood, D.E., and Newcomb, E.W. (2000). function. Exp. Cell Res., 256,375-382.  Cleavage of Bax enhances its cell death  Xia, Z., Dickens, M . , Raingeaud, J., Davis, R.J., and Greenber, M.E. (1995). Opposing effects of E R K and JNK-p38 M A P kinases on apoptosis. Science, 270, 1326-1331. Xiang, J., Chao, D.T., and Korsmeyer, S.J. (1996). BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. U.S.A., 93, 14559-14563. Xing, H., Kornfeld, K . , and Muslin, A . (1997). The protein kinase K S R interacts with 14-3-3 protein and Raf. Curr. Biol., 7. 294-300. Xing, J., Ginty, D.D., and Greenberg, M . E . (1996). Coupling of the R A S - M A P K pathway to gene activation by RSK2, a growth factor-regulated C R E B kinase. Science, 273, 959-963. Xiong, W . - C , and Parsons, J.T. (1997). Induction of apoptosis after expression of P Y K 2 , a tyrosine kinase structurally related to focal adhesion kinase. J. Cell. Biol., 139, 529-539.  159  Xu, Q., and Reed, J.C. (1998). Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol. Cell, 1, 337-346. Yao, B., Zhang, Y . , Delikat, S., Mathias, S., Basu, S., and Kolesnick, R. (1995). Phosphorylation of Raf by ceramide-activated protein kinase. Nature, 378, 307-310. Yao, R., and Cooper, G . M . (1996). Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity. Oncogene, 13, 343-351. Yao, R., and Cooper, G . M . (1995). Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science, 267, 2003-2006. Yamamoto, K . , Ichijo, H . , Korsmeyer, S.J. (1999). BCL-2 is phosphorylated and inactivated by an A S K l / J u n N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell. Biol, 19, 8469-8478. Yang, E., Zha, J., Jockel, J., Boise, L.H., Thompson, C.B., and Korsmeyer, S.J. (1995). Bad, a heterodimeric partner for B c l - X L and Bcl-2, displaces bax and promotes cell death. Cell, 80, 285-289. Yang, J., Liu, X . , Bhalla, K . , Kim, C.N., Ibrado, A . M . , Cai, J., Peng, T.-I., Jones, D.P., and Wang, X . (1997). Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked. Science, 275, 1129-1132. Y i , T., Mui, A . L . , Krystal., G., Ihle, J.N. (1993). Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3 induced tyrosine phosphorylation and mitogenesis. Mol. Cell. Biol, 13, 7577-7586. Yoshimura, A . (1998). The CIS/AB family; novel negative regulators of J A K signaling pathways. Leukemia, 12, 1851-1857. Yoshimura, A., Zimmers, T., Neumann, D., Longmore, G., Yoshimura, Y., and Lodish, H.F. (1992). Mutations in the Trp-Ser-X-Trp-Ser motif of the erythropoietin receptor abolish processing, ligand binding, and activation of the receptor. J. Biol. Chem., 267, 11619-11625. Yu, W., Fantl, W., Harrowe, G., and Williams, L. (1997). Regulation of the M A P kinase pathway by mammalian Ksr through direct interaction with M E K and E R K . Curr. Biol, 8, 56-64. Yuan, J., Shaham, S., Ledoux, S., Ellis, H . M . , Horvits, H.R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell, 75, 653-60.  160  Zha, J.P., Harada, H . , Yang, E., Jockel, J., Korsmeyer, S.J. (1996). Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not Bcl-XL. Cell, 87, 619-28. Zhang, J., Gao, J.X., Salojin, K . , Shao, Q., Grattan, M . , Meagher, C., Laird, D.W., Delovitch, T.L. (2000). Regulation of fas ligand expression during activation-induced cell death in T cells and by p38 mitogen-activated protein kinase and c-JunNH2-terminal kinase. J. Exp. Med., 191, 1017-1030. Zhang, J., Alter, N . , Reed, J.C., Borner, C., Obeid, L . M . , and Hannun, Y . A . (1996). B c l 2 interrupts the ceramide-mediated pathway of cell death. Proc. Natl. Acad. Sci. U.S.A., 93, 5325-5328. Zhang, P., Liu, B., Kang, S., Seo, M . , Rhee, S., and Obeid, L. (1997). Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J. Biol. Chem., 272, 30615-30618.  Zhang, Y., Yao, B., Dlikat, S., Bayoumy, S., Lin, X . H . , Basu, S., McGinley, M . , ChanHui, P.Y., Lichenstein, H . , and Kolesnick, R. (1997). Kinase suppressor of Ras is ceramide-activated protein kinase. Cell, 89, 63-72. Zhang, Z.C., Nechushtan, H . , Jacob-Hirsch, J., Avni, D., Meyuhas, O., and Razin, E. (1998). Growth-dependent and PKC-mediated translational regulation of the upstream stimulating factor-2 (USF2) mRNA in hematopoietic cells. Oncogene, 16, 763-769. Zheng, C.F., and Guan, K . L . 91993). Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases. M E K 1 and M E K 2 . J. Biol. Chem., 268, 11435-11439.  Zhou, H., Summers, S.A., Birnbaum, M.J., and Pittman, R.N. (1998). Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J. Biol. Chem., 273, 16568-16575.  Zhou, H., Henzel, W.I., Liu, X . , Luschg, A . , and Wang, X . (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in the cytochrome c-dependent activation of capspase-3. Cell, 90, 405-413. Zhou, P., Qian, L., Bieszczad, C.K., Noelle, R., Binder, M . , Levy, N.B., and Craig, R.W. (1998). Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage. Blood, 92, 3226-3239. Zhou, P., Qian, L., Kozopas, K . M . , . and Craig, R.W. (1997). Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood, 89, 630-643.  161  Zundel, W. and Giaccia, A . (1998). Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress. Genes Dev., 12, 1941-1946.  162  

Cite

Citation Scheme:

        

Citations by CSL (citeproc-js)

Usage Statistics

Share

Embed

Customize your widget with the following options, then copy and paste the code below into the HTML of your page to embed this item in your website.
                        
                            <div id="ubcOpenCollectionsWidgetDisplay">
                            <script id="ubcOpenCollectionsWidget"
                            src="{[{embed.src}]}"
                            data-item="{[{embed.item}]}"
                            data-collection="{[{embed.collection}]}"
                            data-metadata="{[{embed.showMetadata}]}"
                            data-width="{[{embed.width}]}"
                            async >
                            </script>
                            </div>
                        
                    
IIIF logo Our image viewer uses the IIIF 2.0 standard. To load this item in other compatible viewers, use this url:
http://iiif.library.ubc.ca/presentation/dsp.831.1-0090421/manifest

Comment

Related Items